Uptake of pharmaceuticals into benthic invertebrates by Giorgis, Alessia
 
 
 
 
 
Uptake of pharmaceuticals into 
benthic invertebrates 
 
 
Alessia Giorgis 
PhD 
 
 
 
 
 
 
 
 
 
University of York 
Environment and Geography 
 
September 2019 
 
 
 
 
 
I 
 
Abstract 
The occurrence, fate and, uptake of active pharmaceutical ingredients (APIs) in the 
environment has received increasing attention from the scientific community. 
Numerous studies investigating the uptake of APIs into aquatic organisms have been 
performed with most of these looking at fish species. However, research 
investigating the uptake of APIs into invertebrates is still limited specifically for 
benthic invertebrates. Therefore, the research presented in this thesis, evaluated the 
fate of pharmaceuticals in sediment and the their uptake into the sediment-dwelling 
worm Lumbriculus variegatus. The experiments in the different chapters were 
conducted in order to explore the influence of  compound physicochemical 
properties and sediment characteristics on the uptake of ionisable pharmaceuticals 
into the lumbricids.  
 
An initial evaluation of Quantitative Structure Actvity Relationships for 
bioconcentration was performed using existing representative fish and invertebrate 
bioconcentration data to elucidate whether these models were suitable for 
predicting the uptake of ionisable chemicals and what properties are essential in 
predicting the ionisable chemical uptake. The models were found to perform poorly 
with few BCFs being predicted to within a factor of 10 of the experimental values. 
 
Laboratory experiments were performed to measure the uptake of four APIs into the 
worms via water-only exposure at different pH values (5.5, 7, 8 and 9).  The APIs 
selected included the weak bases amitriptyline, ketoconazole and norfluoxetine and, 
the weak acid diclofenac. For the three bases, the bioconcentration factor (BCF) 
increased with the increase of the water pH. The opposite was observed for the acidic 
diclofenac with higher uptake being observed at lower pH values.  
 
The sorption behaviour of three APIs (amitriptyline, norfluoxetine, and diclofenac) in 
four types of sediments was also evaluated. Sorption coefficients (Kd and Kf) were 
calculated and we found that the sorption behaviour of the weak basic compounds 
II 
 
was driven by the organic content, whereas, the sorption behaviour of diclofenac was 
driven by the pH.   
 
The influence of sediment properties on the uptake of the ionisable APIs into 
sediment-dwelling lumbricids was investigated for three APIs on two sediment types. 
With these experiments, we demonstrated differences in bioaccumulation of the two 
basic APIs and one acid into L. variegatus and how uptake varies across two 
sediments possessing diverse properties. 
 
In conclusion, our experimental findings produced knowledge on the fate and the 
uptake of ionisable pharmaceuticals in the water-sediment compartment. We 
attempted to explain some environmental properties such as the pH and its influence 
on the uptake into the worms, the sorption behaviour of the APIs and the interactions 
that these APIs, possessing different physicochemical properties, had with some 
sediment characteristics toward the organisms.  
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Chapter 1: Literature review 
1.1  Introduction 
Active pharmaceutical ingredients (APIs) are contained in medicinal products that we 
use every day and are manufactured to treat a disease or prevent symptoms. They are 
designed to have beneficial effects in humans and animals and their use is enormous 
and the release into the environment is ubiquitous (Boxall et al., 2012). Therefore, in the 
ecotoxicology field, the interest in the environmental impacts of APIs has continuously 
increased since the early 1990s (Daughton, 2016). This increasing interest in the 
environmental impacts of APIs is partly due to the fact that it is not until recently that 
analytical methodologies have become available that are able to separate the 
substances with high efficiency in environmental matrices (Ternes, 2001). Researchers 
are also concerned that these molecules could elicit effects on organisms at low 
concentrations such as µg/L or ng/L as a result of their inherent biological activity 
(Daughton and Ternes, 1999).  
To date, a large volume of literature has been published about the occurrence, fate and 
effects of many active pharmaceutical ingredients in different environmental 
compartments (including soil, fresh and marine surface water and sediments) and the 
organisms dwelling in these compartments across the globe.  Therefore, in this chapter, 
our understanding of the environmental occurrence, fate, and effects of APIs is 
presented and the major gaps in our knowledge are identified. The Chapters focus more 
on the sediment compartment which is the main subject of this thesis.  
 
1.2 Current situation of pharmaceuticals in the environment 
1.2.1 Sources of pharmaceuticals entering in the environment 
Pharmaceuticals enter into the natural environment through different pathways (Figure 
1.1). In high-income countries, the main sources of APIs found in the surface waters are 
Wastewater Treatment Plants (WWTP). Generally, the medicine is taken by the patient 
and only a part of it is metabolized. The parent molecules are then released in the urine 
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and feces which are flushed down the toilet into the sewerage system. The sewage is 
then transported to a Wastewater Treatment Plant, where depending on the structure 
of the API and the nature of the WWTP, the API may be removed to some extent. 
Usually, the removal efficiency of APIs in WWTPs range between 60% and 90% (Carballa 
et al., 2004). In Portugal, for example, the removal of 83 pharmaceuticals was 
investigated and their removal efficiency in WTP effluents was found to exceed 70% 
(Paíga et al., 2019). In South Korea, the removal efficiency of 20 pharmaceuticals and 
personal care products in five Wastewater Treatment Plants averaged > 90% (Kumar et 
al., 2011). The efficiency of removal of APIs depends mainly on the technologies 
available in the Plants, as well as the intrinsic physicochemical properties of the 
pharmaceuticals.  
Another potential pathway of pharmaceuticals entering the environment is the use of 
veterinary pharmaceuticals for treating livestock and domestic animals. These 
medicines can be directly released into surface water via use in aquaculture practices. 
In addition, traces of APIs have been found in the soil compartment due to the release 
of slurry and manure from treated animals which are then used as fertilizers (Boxall, 
2004; Kim et al., 2011). Irrigation of soil with reclaimed wastewater has been 
demonstrated to be another source of contamination of APIs in some regions of the 
world (Wu et al., 2014; Pan and Chu, 2017). A study by Biel-Maeso et al., (2018) 
demonstrated the presence of several pharmaceuticals like diclofenac, acetaminophen 
and, caffeine in the soil irrigated by the water from a Wastewater Treatment Plant due 
to their scarce removal by the technologies present in the Plant. Recently, concerns have 
been raised over the contamination of soils with APIs because of the potential leaching 
of APIs to the groundwater (Oppel et al., 2004).  
Manufacturing facilities are another source of contamination of medicines entering into 
the environment (Larsson et al., 2007; Larsson, 2014). For example, Larsson et al., (2007) 
found an incredibly high amount of an antibiotic released from a manufacturing site into 
a wastewater treatment effluent.  Incorrect disposal of medicines by the population 
(through the sink/toilet) could also lead to a discharge of APIs into the sewage system 
and then into the Wastewater Treatment Plants (Bound and Voulvoulis, 2005).  
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Figure 1. 1. The major pathways by which pharmaceuticals enter the environment. 
 
1.2.2 Occurrence and effects of pharmaceuticals in the environment 
Because of their continuous use and release,  the environmental occurrence of active 
pharmaceutical ingredients and their metabolites has been investigated and they have 
been found to be omnipresent in natural environments around the world (Daughton & 
Ternes, 1999). Since the 1990s the literature has grown with monitoring campaigns 
being performed to assess the presence of APIs in different matrices such as surface 
water (Česen et al., 2019; Sousa et al., 2019; Mandaric et al., 2019; Sharma et al., 2019; 
Caldas et al., 2018; Nkoom et al., 2018; Praveena et al., 2018; Moldovan et al., 2018; 
Hossain et al., 2018; Burns et al., 2018); sediment (Battaglin et al., 2018; Zhang et al., 
2018; Biel-Maeso et al., 2017; Agunbiade and Moodley, 2016) and soil (Biel-Maeso et 
al., 2018; Jaimes-Correa et al., 2015; Aznar et al., 2014) in many countries. In these 
studies, APIs are generally reported to be detected at low concentrations ranging from 
ng/L to µg/L in surface water and ng/g or µg/g in sediments and soils. The frequency of 
detection and concentrations of pharmaceuticals varies and depends on several factors 
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such as the sampling site or the proximity to the main source and the season. For 
instance, Kasprzyk-Hordern et al., (2008) analyzed surface water samples from different 
sampling locations of two rivers in Wales. They found high concentrations of the APIs in 
the locations in proximity to the WWTPs. Further down the river, the concentrations 
decreased most likely due to dilution, biodegradation, sorption to sediments or 
photolysis. Weather conditions may influence the presence of pharmaceuticals in rivers 
too. For example, in a study conducted in the Alpine rivers, high detection was reported 
during low river flow (dry season) and the opposite during winter when higher water 
flows occur probably due to more frequent precipitations (Mandaric et al., 2019).  
Pharmaceuticals are designed to target a specific receptor or pathway in humans 
resulting in a beneficial effect but they may have undesired effects on non-target 
organisms possessing the same receptors (Gunnarsson et al., 2008). An example is the 
positive correlation between the presence of endocrine disruptors (17β-estradiol and 
17α-ethinylestradiol) and the feminization of male fishes observed in rivers of England 
and Wales (Gross-Sorokin et al., 2006). In this example, scientists from the Environment 
Agency discovered that the direct exposure to endocrine disruptors induced vitellogenin 
in male fish. Vitellogenin is a female protein that results in an intersex exchange, 
particularly in fish living in treated sewage effluents (Gross-Sorokin et al., 2006). Another 
study exposed fish species (Betta splendens) to three environmentally relevant 
concentrations of an anti-depressant, fluoxetine, to assess impacts on the aggressive 
behaviour of the organisms (Eisenreich and Szalda-Petree, 2015). The authors exposed 
the fish species to different concentrations of fluoxetine and found a reduction in the 
aggressive behaviour of the organisms overtime at higher concentrations of the API.   
Studies have also evaluated the impact of APIs in terrestrial species. In 2004 a study 
conducted by Green et al., (2004) showed a drastic drop in the population sizes of three 
species of vulture in India and Pakistan due to renal failure. They discovered that the 
constant feeding by the birds on livestock carcasses treated with diclofenac was the 
main cause of the decline of the vulture population. More recently, studies have 
demonstrated that environmentally realistic exposure concentrations of fluoxetine alter 
courtship behaviour of a songbird that is well known to feed on invertebrates that live 
nearby wastewater treatment plants (Whitlock et al., 2018).  
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1.2.3 Previous studies on the uptake of pharmaceuticals in aquatic organisms 
Along with toxicity studies, studies have explored the bioconcentration of APIs. 
Typically, these studies assess the uptake of APIs into non-target organisms under 
laboratory conditions. The exposure time used varies and for example for fish, chronic 
exposure of 28 days is recommended by the OECD guideline 305 (OECD, 2012). 
Understanding the uptake of pharmaceuticals is important because it gives an 
understanding of the uptake, depuration and the internal exposure of the APIs within 
the organism. From the 2000s, many studies have been published regarding the uptake 
of pharmaceuticals into fish species (Brooks et al., 2005; Brown et al., 2007; Paterson 
and Metcalfe, 2008; Schultz and Furlong, 2008; Mehinto et al., 2010; Lahti et al., 2011; 
Nallani et al., 2011; Al-Ansari et al., 2013; Steinbach et al., 2016; Du et al., 2016; Chen et 
al., 2017). In these studies, the bioconcentration was evaluated by exposing the fish to 
environmentally relevant concentrations (ng/L and µg/L) over a certain period of time. 
Then, the bioconcentration was derived when an equilibrium between the organism and 
the water concentrations (steady-state) was reached or by deriving the kinetic 
bioconcentration factor.  Different species are used such as fathead minnow, rainbow 
trout, Danio rerio, channel catfish, goldfish. Differences in the bioconcentration 
between the different studies were likely to be the time of exposure, the concentration 
and the experimental conditions. Over the same period of time, from 2000, the number 
of studies on the uptake of pharmaceuticals into invertebrates has been considerably 
lower than for fish species. For some years (2005, 2006, 2007 and 2010) no studies were 
found in the literature on uptake of APIs into invertebrates (Figure 1.2). Recently, 
research investigating the accumulation of APIs into invertebrates has increased in the 
freshwater and marine environment (Dussault et al., 2009; Meredith-Williams et al., 
2012; Bossus et al., 2014; Miller et al., 2015; Ding et al., 2016; Karlsson et al., 2016; 
Miller et al., 2017; Garcia-Galan et al., 2017). Most of the studies use gammarids as non-
target invertebrates for the experiments. Other organisms investigated include 
daphnids, lumbricids, insects and marine molluscs. Ding et al., (2016) exposed groups of 
Daphnia magna to two APIs (roxithromycin and propranolol) via water-only exposure 
and the kinetic bioconcentration factor was derived. Another study by Miller et al., 
(2017) sampled the organisms in different locations from a river in the outer area of 
south London and exposed the gammarids in the laboratory to eight APIs. They derived 
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different bioconcentration factors depending on the different compound and the 
physicochemical properties.  
To date, the discrepancy between fish species bioaccumulation data and invertebrates 
is substantial. Also, research regarding the uptake into sediment-dwelling invertebrates 
is limited making it difficult to interpret the bioaccumulation results due to the diverse 
biological differences among the species. The species selected in the studied mentioned 
above have different species traits that are peculiar of the chosen organism such as 
habitat, feeding habit, respiration, therefore, the bioaccumulation has to be interpreted 
carefully taking into account these differences. 
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Figure 1. 2. The number of publications from 2005 of the uptake of APIs into invertebrates 
(orange columns) and fishes (blue columns). The research on the web was conducted using 
keywords such as “invertebrates”, “uptake”, “fish”, “bioconcentration”, “pharmaceuticals”. 
 
1.3 Bioconcentration, bioaccumulation and biomagnification 
Bioconcentration is a mechanism through which a chemical may be absorbed by non-
target organisms passively via the skin. The degree of bioconcentration of a molecule is 
usually expressed as a bioconcentration factor (BCF), which is the ratio of the 
concentration of the xenobiotic between the body of the organism and the surrounding 
medium, for example, water or in the sediment (biota-sediment accumulation factor, 
BSAF) at the steady-state. The BCF has the unit of L/Kg (Equation 1).  
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                                                                BCF=  
Corganism
Cwater 
                                                Equation 1 
 
Some guidelines have been developed on how to conduct bioconcentrations studies 
such as the OECD method 305 for fish species (OECD 2012) and method 315 for 
invertebrates (OECD, 2008).  
When a steady-state is not reached, toxicokinetic models can be used to estimate the 
rates of uptake and depuration of the molecule. The bioconcentration factor is then 
calculated as the ratio of the uptake kinetic rate constant (Kin, L × kg-1 × d-1), and the 
depuration rate constant (Kout, d-1) into an organism over time (Equation 1).  
 
                                                                BCF =
Kin
Kout
                                               Equation 1                                         
 
Bioaccumulation is the process by which a substance is absorbed by an organism from 
both the surrounding environment and the dietary pathway. The degree of 
bioaccumulation of a molecule is usually expressed using the bioaccumulation factor 
(BAF).  
Ultimately, biomagnification reported as the biomagnification factor (BMF) is the 
concentration of the substance between the prey and the predator. This factor 
measures the amount of chemical transferable from prey to predator, and thus provides 
an indication of the propensity for a molecule to move throughout the food chain.  
 
1.4 Factors influencing the uptake and accumulation of ionisable APIs 
Various factors influence the uptake of ionisable compounds into non-target organisms 
including the physicochemical properties of the compound, environmental conditions 
and biological traits of the study organism. Table 1.1 below gives an overall view of these 
factors that will be described in the following sections. 
 
 8 
 
Table 1 1. Main processes influencing the uptake of ionisable organic compounds in the 
sediment compartment.  
 
Chemical characteristics 
pKa 
The pKa gives an indication of the amount of the ionic form of an ionisable chemical that 
will be present at a given pH value (Manallack, 2007). The majority of the APIs are 
ionisable possessing functional groups that accept or donate protons. These functional 
groups give an indication of whether the chemical acts as a base or an acid. Acidic 
compounds become increasingly undissociated at lower pH and the opposite occurs for 
bases (Rendal et al., 2011b). The neutral and ionic form of the molecule posses diverse 
properties in regard to bioconcentration and toxicity. For instance, it is well documented 
that the ionized form of a molecule is less bioaccumulative than the neutral form due to 
different physicochemical properties and polarities (Rendal et al., 2011b). Thus, the 
dissociation constant of a compound is a key chemical parameter that influences 
lipophilicity, solubility and permeability processes (Manallack, 2007). 
Few experimental pKa values have been measured but different software has been 
developed to predict the pKa of a chemical such as ACD I-lab (ACD I lab, 2015) and 
chemicalize.org (Swain, 2012). For example, ACD I lab helps in understanding the 
charged and the uncharged part of a molecule that is more likely to be reactive with 
biological tissues at a specific pH.  
 
Lipophilicity  
Lipophilicity is a characteristic of a compound that tends to easily dissolve in fatty acids 
and phospholipids and it is described by the logKow which is the logarithm of the n-
octanol-water partition coefficient. Octanol is used as a surrogate to the lipid tissues of 
Factors influencing the bioconcentration of ionisable chemicals 
Chemical Environmental Biological 
pKa 
Log Dow 
Volume distribution 
Water solubility 
pH 
Carbon organic content 
Cation exchange capacity 
Texture (clay, silt, sand) 
Temperature 
Size 
Feeding habits 
Life stage 
Active transport of APIs 
Mode of respiration 
Metabolism 
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an organism. Traditionally the logKow is used to describe the hydrophobicity of a 
compound.For neutral chemicals, the logKow has been used to predict the uptake into 
non-target organisms (Veith et al., 1979; Mackay and Fraser, 2000).     
The logarithmic octanol-water distribution coefficient (logDow) is a measure of the logKow 
but corrected for the pH. For ionisable chemicals, it describes the partitioning of the 
dissociated and un-dissociated form of a chemical as a function of pH. The formula 
contains the dissociation constant (pKa), the pH and the valency (A), therefore, LogDow 
depends on the speciation of a chemical (Rendal et al., 2011a). For ionisable chemicals, 
the LogDow is a better descriptor of the distribution and partitioning of ionic compounds 
between the medium and the cell membrane of an organism (Kah and Brown, 2008), 
(Wen et al., 2012) where pH along with the valency and pKa are combined in a single 
formula shown in equation 2 below. A is -1 for acids and 1 for bases. It is generally 
assumed that the LogKow of charged species is 3.5 units lower than the uncharged species 
(Fu et al., 2009a).  
 
                                                log Dow = log Kow - log (1 + 10)A 
(pH−pKa)
              Equation 2 
 
Volume of distribution 
The volume of distribution is a pharmacological parameter that represents the amount 
of the medicine in the bloodstream of the human body and the fraction that is 
distributed in the tissues. It has been suggested as a potential predictor for estimating 
the sorption behavior of pharmaceuticals in natural soils and sediments and uptake into 
non-target organisms such as invertebrates (Williams et al., 2009; Meredith-Williams et 
al., 2012). 
 
Water solubility  
The water solubility of a chemical has been proposed as a molecular descriptor to 
predict the uptake of compounds into non-target organisms (Chiou et al., 1977; Veith et 
al., 1980). It has been argued that compounds not easily dissolved in water are more 
likely to sorb to hydrophobic surfaces and membranes (Piir et al., 2010); thus, a 
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substance possessing high water solubility is less likely to partition into the lipids of an 
organism and will therefore have a low bioaccumulation factor (Pavan et al., 2008).  
 
Environmental characteristics  
The bioavailability of organic chemicals is strongly affected by water and sediment 
characteristics such as the pH, carbon organic content, the cation exchange capacity 
(CEC), texture and temperature ( Al-Khazrajy and Boxall, 2016).  
 
pH 
pH is a key environmental factor affecting the toxicity and uptake of ionizing 
compounds. Many studies have explored the pH-dependent uptake of organic 
contaminants in key non-target organisms from small invertebrates throughout the 
food-chain up to fish species.  
For example, Nakamura et al., (2008) explored the uptake of the antidepressant 
fluoxetine and its main metabolite norfluoxetine in a fish (Oryzias latipes) at three pH 
values (7, 8 and 9). They found a correlation between the accumulation of fluoxetine 
with pH where high bioaccumulation was seen at high pH.  Similar findings were 
observed by Nichols et al., (2015) analyzing the uptake of the weak base antihistamine 
diphenhydramine in fathed minnow at pH levels of 6.7, 7.7 and 8.7. Also, in this case, 
BCF increased with the increase of the water pH. The influence of pH on uptake into 
smaller organisms has also been investigated. For instance, the crustacean Daphnia 
magna, and a higher plant Salix viminalis were the organisms used to test the toxicity 
and uptake of the weak base chloroquine at pH values of 6, 7, 8 and 9 (Anskjaer et al., 
2013). Increasing toxicity was seen at higher pH. The same result was seen in the study 
of Neuwoehner and Escher, (2011) where they assessed the pH-dependent toxicity of 
five weak bases, fluoxetine, norfluoxetine, propranolol, lidocaine and trimipramine on 
the green algae Scenedesmus vacuolatus. An ion-trapping model was developed to 
describe the specific mode of toxic action of aliphatic amines inside and outside the 
green cell.                                                                                                                               
 
Carbon organic content 
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The organic carbon in waters and sediments is typically generated by decaying 
vegetation and microbial activity and it regulates the distribution and persistence 
tendency of chemicals in the water-sediment system (Rust et al., 2004). Chemicals 
interact with the organic carbon content present in the water or sediment and adsorb 
to the organic carbon content being less free to be taken up by non-target organisms 
(Haitzer et al., 1998). For instance, the toxicity and bioaccumulation of sediment-
associated herbicides, ioxynil, pendimethalin and bentazone have been assessed in the 
sediment-dwelling organisms Lumbriculus variegatus and Chironomus riparius. The 
authors observed that the bioaccumulation and bioavailability of these organic 
pesticides were reduced by the increase of the sediment organic matter (Maënpaä et 
al., 2003). Another study investigated the bioaccumulation of the antiparasite veterinary 
medicine ivermectin in L. variegatus in two sediments containing different organic 
carbon content. A decrease in the uptake of the ivermectin into the worms was observed 
in the sediment with the higher organic carbon content, probably due to the reduced 
availability of the compound bound to the organic matter (Slootweg et al., 2010).  Alsop 
& Wilson, (2019) studied the uptake of three pharmaceuticals into zebrafish and 
demonstrated how the dissolved organic carbon content reduced the bioavailability of 
the compounds and thus the uptake into the organisms.  
 
Texture and cation exchange capacity (CEC) 
Sediment texture (for e.g. clay, sand or silt) and CEC influence the sorption and mobility 
of ionisable chemicals. For example, some antidepressants and antibiotics are positively 
charged at pH around neutrality and they may be strongly linked to clay that is negatively 
charged (Kah and & Brown, 2007; Droge and Goss, 2013). In this way, pH which 
influences the speciation, along with texture and CEC, affects retardation and mobility 
of ionisable compounds (Schaffer et al., 2012) in the natural sediment. 
 
Temperature 
Temperature is an environmental property that influences the bioaccumulation into 
non-target organism. For example, Muijs and Jonker, (2009) evaluated the influence of 
different temperature from 5°C to 24°C on the bioaccumulation of polycyclic aromatic 
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hydrocarbons into the worm L. variegatus and observed that the bioaccumulation 
decreased at lower temperatures probably due to changes in the lipid compositions of 
the worms.  
 
Biological traits 
The uptake of chemicals may vary among different or same taxonomic groups due to 
diverse feeding behaviour, size, life stage, diet composition, etc. (Rubach et al., 2010;  
Rubach et al., 2012).  
 
Size  
The size of an organism could explain the differences in bioconcentration of chemicals 
across species. Recently, several studies have demonstrated how biological traits like 
body-size could better explain the differences in toxicity and uptake among organisms 
belonging to the same taxonomic group or organisms belonging to different taxonomic 
groups. For example, Gergs, et al., (2015) exposed three species that are taxonomically 
and physically different (Daphnia magna, Chaoborus crystallinus and Mesocyclops 
leuckarti) to the fungicide triphenyltin hydroxide and differences in sensitivity of toxicity 
were observed between small body-size and large body-size organisms. The authors 
calculated the LC50 after 48-h and 96-h exposure to the fungicide to the three species 
and lower LC50 values were found for smaller body size organisms than large body size. 
Another study conducted by Wang and Zauke, (2004) on Gammarus zaddachi found a 
negative correlation between the bioconcentration of metals and the body length of the 
organism.  
 
Feeding habits 
An additional biological factor that should be considered during the analysis of uptake 
of toxicants into organisms is their feeding habits and the diet route that may potentially 
influence the accumulation pattern. The feeding strategies of organisms have been 
shown to influence the accumulation of Polychlorinated biphenyls (PCBs) into four 
freshwater benthic invertebrates: Chironomus riparius, Hyalella azteca, Lumbriculus 
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variegatus, and Sphearium corneum (Sidney et al., 2016). In this study, they 
demonstrated the difference in bioaccumulation of the four organisms having different 
feeding habits. For example, H. Azteca, L. variegatus and C. riparius are deposit feeders 
while the mollusca L. corneum is a suspension feeder. Furthermore, depending on the 
feeding habit and the contact with the sediment, some organisms may be partially 
exposed to contaminants attached to the sediment particles. For instance, H. Azteca 
swims mostly in the overlying water but this is not the case for the worm L. variegatus 
that tends to burrow in the sediment having the majority of the body submerged. 
 
Life stage 
The life stage of an organism has been recognized as an important biological trait to 
consider when assessing the bioconcentrations of toxicants. In this regard, differences 
in toxicity were observed for different life-stages (neonates and adults) of a cocepod 
Mesocyclops leuckarti exposed to th fungicide triphenyltin hydroxide (TPT) (Kulkarni et 
al., 2013). Another study conducted on Daphnia magna showed that the 
bioconcentration of a nonylphenol isomer (p353-NP) between adults and neonates 
daphnids differed by a factor of 5.6 (Preuss et al., 2008). 
 
Active transport of APIs  
Along with the passive diffusion transport, the carrier-mediated transport of ionisable 
APIs by specific proteins present on the cell membrane has been recognized as another 
uptake pathway of APIs through the cell membrane. Sugano et al., (2010) explained that 
for pharmaceuticals with low passive permeability and high hydrophilicity, such as 
charged APIs, carrier-mediated transport is another possible uptake pathway of these 
medicines into the cell of the organism. In this case, the transporter needs to be present 
in the study species (Smith et al., 2014).  
 
 
 
Mode of respiration 
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Respiration type is a species trait that has been considered to indicate species sensitivity 
to different contaminants (Baird and Van den Brink, 2007; Rico and Van den Brink, 2015). 
For instance, Meredith-Williams et al., (2012) exposed three invertebrates to several 
pharmaceuticals to evaluate the different uptake of the APIs in relation to the different 
organisms. The authors observed that the uptake in Gammarus pulex was greater than 
in the other organisms and explained the difference in the uptake by the different 
modes of respiration of the organisms. For their uptake experiments, they used the 
shrimp G. pulex, the aquatic insect Notonecta glauca and the aquatic snail Planobarius 
corneus. These organisms possess different modes of respiration: the shrimp uses the 
gills; the insect breathes mainly through the plastrons and the snail through the skin and 
the siphon (Meredith-Williams et al., 2012). The authors argued that the shrimps 
accumulated the pharmaceuticals to a greater extent than the other species because 
they breaths through the gills which is the primary pathway of exposure of 
contaminants. Another study by Nyman et al., (2014) exposed three pesticides to three 
freshwater species, two shrimps (G. pulex and Gammarus fossarum) and one snail 
(Lymnaea stagnalis), to assess the bioaccumulation. They found that the snail 
accumulated more of the compounds than the shrimps due to different species traits 
including the different respiration types.  
 
Metabolism 
The metabolic pathway is a species-specific trait that could explain the different 
bioaccumulative potential of different organisms to toxicants. For example, two fish 
species (Gambusia affinis and Jenynsia multidentate) were exposed to carbamazepine 
and different uptake was observed likely due to the differences in the metabolism of the 
compound between the two species (Valdés et al., 2016).   
 
1.5 Regulations 
In Europe, the EMA (European Medicines Agency) is the body responsible for the 
evaluation and authorization of human and veterinary medicines. Generally, an 
environmental risk assessment is required for new human and veterinary medicinal 
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products before they can be marketed. The risk assessment consists of two phases: 
Phase I and Phase II. The Phase I is an initial screening of the active substance and its 
potential exposure in the environment based on the future use of the substance. The 
predicted environmental concentration (PEC) in the surface water has to be calculated 
and if it is ≥ 1 µg/L, then a Phase II has to be performed. The Phase II testing requires the 
estimation of the physicochemical properties of the substance along with ecotoxicity 
and fate studies following OECD guidelines. For the estimation of the physicochemical 
properties of the active ingredient, the water solubility, Octanol/Water partitioning and 
Dissociation in water are the required tests to perform. For fate, the 
adsorption/desorption studies and biodegradability tests are necessary and ultimately, 
aquatic toxicity studies such as assessment of effects on growth, mortality and 
reproduction with three species belonging to three different trophic levels (algae, 
crustacea and fish species) are needed. In this part, for compounds that accumulate 
throughout the food chain, secondary poisoning involving bioconcentration studies in 
fish species has to be determined. 
The guideline also includes a hazard assessment for persistent, bioaccumulative and 
toxic properties of the active ingredients. Three essential criteria have to be assessed: 
persistence, bioaccumulation, and toxicity.  At the end of the assessment, a substance 
may be classified as toxic, bioaccumulative and persistence (PTB) or very, 
bioaccumulative and very persistence (vPvB). For instance, the first assessment explored 
the persistence in different environmental compartments (for e.g. fresh-estuarine 
water, marine sediments, and soils) through degradation tests (OECD 301, 307, 308, 
309). The second criterion is bioaccumulation (BAF) or bioconcentration (BCF). In this 
evaluation, if a substance possesses a logkow < 4.5, further uptake studies are not 
required; on the other hand, a logkow > 4.5 requires bioconcentration tests in aquatic, 
terrestrial and benthic organisms. Preferably the OECD guideline 305 for fish species is 
used. When studies on bioaccumulation in fish are lacking, then other species rather 
than fish may be considered. Toxicity is the final criterion and mortality endpoints such 
as EC10 or LC10 and NOEC are considered. It involves short and long-term toxicity data 
possibly on invertebrate species like daphnids, algae, and sediment-dwelling organisms 
as well as carcinogenic and mutagenic tests. For these latter tests, information from 
mammal experiments could be used.  
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At the end of the assessment, if the substance is identified of very high concern the 
emission and risk characterization are requested.  The emission characterization 
consists of the analysis of all the potential routes of emission of the substance into the 
environment and consequently the risk that it may pose to ecosystems. If needed, risk 
mitigation approaches are proposed such as: proper labelling and risk mitigation 
through some actions such as the appropriate storage and responsible disposal, the 
releasing of SDSs and the training of personnel. Further, these substances should be 
replaced with alternatives when feasible and their use is granted only if no alternatives 
are found.  
 
1.6 Bioconcentration from sediment 
The presence of APIs in the sediment compartment has been widely investigated in 
different locations (Silva et al., 2011; Camacho-Muñoz et al., 2013; Radović et al., 2015; 
Thiebault et al., 2017). The classes of pharmaceuticals detected include anti-
inflammatories, antidepressants, antibiotics, birth control substances, anti-histamines 
and many others. Concentrations detected in the environment are generally low (ng/g), 
yet, they may represent a potential risk to the organisms dwelling in the natural 
environment (Wilkinson et al., 2017). For example, Liu et al., (2018) detected 8 APIs in 
sediment samples at concentrations of ng/g and some of these APIs were also found to 
accumulate in different tissues of the common carp (Cyprinus carpio).   
Benthic organisms are often exposed to pharmaceuticals associated with sediments. For 
example, worms such as L. variegatus are exposed to them via three pathways: the 
overlying water, the sediment and, the pore water present in between the sediment 
particles (Mäenpää et al., 2008). Hydrophobic APIs entering the water ecosystem bind 
to the sediment being potentially toxic to the organisms dwelling in that compartment. 
Some studies have assessed the routes of uptake of sediment-bound chemicals into L. 
variegatus. Generally, the sediment is spiked with the toxicant which is left to equilibrate 
between the water and the sediment. Then, the organisms are introduced and the 
exposure is followed by a period of depuration where the organisms are introduced to 
the same sediment-water system without the chemical (Maënpaä et al., 2003; Liebig et 
al., 2005; Van Geest et al., 2010).  
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It is important to estimate the exposure of the different routes that can reach the worms 
in order to understand which may pose a threat to a greater extent but little research 
regarding the uptake of sediment-associated chemicals in benthic invertebrates is 
known. Moreover, sediment characteristics play a key role in the uptake of APIs. 
Sediments possess heterogeneous properties (e.g. high/low organic content) and in 
combination with the contaminants' physicochemical properties (water solubility, 
logKow), the APIs may be adsorbed to the sediment becoming less bioavailable to be 
accumulated by the organisms. In this way, an understanding of the sorption behaviour 
of the compound is essential to better evaluate the bioncentration of ionisable APIs for 
the overlying water, the sediment and the pore water exposure. The sorption behaviour 
of a pharmaceutical is generally described by the solid/water partition coefficient (Kd, 
L/Kg). This is the ratio of a chemical partitioned between the water and the soil or 
sediment phase (Equation 3). The standard method to measure this parameter is fully 
described by the OECD guideline 106 (OECD, 2000). For neutral chemicals, the organic 
carbon-normalized sorption coefficient (Koc, L/Kg) is considered to be a better descriptor 
and, to derive this, information on the organic content of the sediment is required 
(Equation 4). 
 
                                                      Kd =   
Csediment 
Cwater
                                                  Equation 3 
   
                                                     Koc = 
 Kd ×100 
OC
                                                        Equation 4 
 
Csediment is the concentration of the compound in the sediment compartment (mg/g); 
Cwater the concentration of the compound in the water phase (mg/ml) and OC is the 
organic carbon.  
 
1.7 A theoretical model of possible pathways of uptake of ionisable 
APIs into sediment-dwelling invertebrates 
The overlying water and sediment are linked. For instance, once a pharmaceutical ends 
up in the surface water, it can be adsorbed ny and be deposited onto the sediment. A 
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resuspension may occur when the flow rate of the river is high as for e.g. during 
perturbations of the system such as floods. Therefore, sorption and desorption 
processes are the main exchange routes between water and sediment, measured by the 
Kd (1). Thus, sediment-dwelling organisms, such as L. variegatus, are exposed to the APIs 
both through the sediment compartment and the overlying water and Kin and Kout can 
be estimated (2 and 3). Also, the pore water present among the sediment particles may 
be a potential route of exposure of the APIs to the worms (4). Because sediment may be 
a sink of contaminants through sorption processes but also a source though 
resuspension in the overlying water column, we must further investigate the extent of 
uptake from all these routes described above in order to better estimate the risk to the 
sediment-dwelling invertebrates. The conceptual scheme of different pathways of APIs 
in the water-sediment system is illustrated in the figure below. Parameterisation of the 
scheme would involve:  
 
1) Adsorption/desorption studies being conducted to estimate the Kd value of the 
APIs sorbed to the sediment;  
2) The estimation of the internal concentrations of the APIs into the worms from 
the overlying water consisting of the water-only exposure of the worms to the 
pharmaceutical followed by an elimination phase during which the internal 
concentration was measured. By using the first-order one-compartment 
toxicokinetic model, we derived the Kin and Kout (uptake and depuration rates) 
and calculated the bioconcentration factor (BCF); 
3) The measurement of internal concentrations of the APIs fromthe sediment 
compartment can be derived similarly to the water-only exposure as described 
above with the only difference that the sediment concentrations are used to fit 
the one-compartment toxicokinetic model to derive the Kin and Kout and then 
estimate the BSAF (=biota-sediment accumulation factor).  
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Figure 1. 3. Conceptual model of the uptake of APIs in the sediment-dwelling worms.  
 
1.8 Aims and objectives 
In the previous paragraphs, the limited knowledge of the sediment uptake of ionisable 
APIs into invertebrates has been highlighted. A better understanding of the uptake of 
ionisable chemicals into sediment-dwelling invertebrates is essential not only because 
there are few studies in the literature addressing this topic but also because it is 
important to comprehend the environmental factors such as pH of the sediments that 
could influence the uptake of these APIs.  
Therefore, in this PhD research, the main aim was to further explore the influence of 
environmental conditions like pH and their interactions with the physicochemical 
properties of the APIs like pKa on the uptake of ionisable APIs into a sediment-dwelling 
invertebrate L. variegatus. This was achieved through different objectives: 
 
• To evaluate the applicability of eight existing representative fish and 
invertebrate bioconcentration models to elucidate whether these models are 
suitable for predicting the uptake of ionisable chemicals and what properties are 
essential in predicting the ionisable chemical uptake (Chapter 2); 
• To assess the influence of different ranges of water pH on the uptake of ionisable 
APIs into benthic invertebrates (Chapter 3); 
• To explore the sorption behaviour of ionisable APIs in different types of sediment 
(Chapter 4); 
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• To determine the impact that sediment properties could have on the uptake of 
ionisable APIs into L. variegatus (Chapter 5); 
• To use the information generated from the above chapters in order to provide 
recommendations for future research and perspective of these chemicals and to 
better categorize the risk (Chapter 6). 
 
1.9 Study compounds selected 
The study compounds selected for the study belong to different therapeutic classes with 
different physicochemical properties. Their pKa values range between 3.9 and 9.6 and 
LogKow values from 4.06 to 4.92. They include acid and basic molecules and are available 
as 14-C radiolabelled pharmaceuticals. The use of radiolabelled compounds allowed for 
a lower detection limit meaning that lower exposure concentrations could be used in 
the experiments similar to the concentrations detected in the environment. (Table 1.2). 
A brief description and environmental issues of the tested APIs raised so far will be given 
below.  
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Test 
compound 
CAS 
number 
Acid/base Therapeutic 
class 
Molecular 
Weight 
(g/mol) 
pKa LogKow Chemical structure Rad(MBq) 
 
 
Amitriptyline 
 
 
549-18-8 
 
 
Base 
 
 
Antidepressant  
 
 
279.19 
 
 
9.4c 
 
 
4.92a 
 
 
 
 
6.00 
 
Diclofenac 
 
15307-86-
5 
 
Acid 
 
Anti-
inflammatory 
 
296.15 
 
3.9b 
 
4.51d 
 
 
 
1.85 
 
 
Ketoconazole 
 
 
65277-42-
1 
 
 
Base 
 
 
Antimycotic 
 
 
531.44 
 
 
6.5b 
 
 
3.78b 
 
 
 
 
0.37 
 
Norfluoxetine 
 
57226-68-
3 
 
Base 
 
Antidepressant 
 
295.31 
 
10.01e 
 
4.16f 
 
 
 
7.51 
Table 1. 2. Structures and properties of the pharmaceuticals studied in the thesis. 
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a Predicted using Advanced Chemistry Development, Inc. (ACD/Labs), (https://ilab.acdlabs.com/iLab2/), accessed 09/01/2018. 
b Experimental using iPie database, (http://i-pie.org/) accessed 09/01/2018. 
c (Al-Khazrajy and Boxall, 2016). 
d (Escher et al., 2017) 
e (Nakamura et al., 2008a). 
f (Karlsson et al., 2016). 
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Ketoconazole- an azole fungicide 
Azole fungicides are antifungal active ingredients used as pesticides to treat plant 
pathogenic fungi (e.g. propiconazole and tebuconazole) and as pharmaceuticals (e.g. 
fluconazole, clotrimazole, ketoconazole, miconazole). They are sold as topical creams or 
oral medications (Chen & Ying, 2015) and their use is large. For instance, in 2005, in 
Switzerland, they were sold with a total sale volume of 1 tonne (Kahle et al., 2008). A 
part of them is flushed into WWTPs where they are not completely removed as a 
consequence, they reach rivers and lakes. Studies into their occurrence and fate in 
sewage waters and in rivers and lakes have been performed in Sweden (Lindberg et al., 
2009); in Belgium (Van De Steene et al., 2010); in Ireland (Lacey et al., 2012); in England 
(Thomas and Hilton,2004) and in China (Huang et al., 2010; Peng et al., 2012). In these 
studies the concentrations detected ranged between ng/L to µg/L and some of them, 
such as fluconazole and clotrimazole, were found to be persistent and not completely 
removed in the wastewater treatment plant and therefore present in the effluents 
(Lindberg et al., 2009; Peng et al., 2012). 
Ketoconazole is an imidazole antifungal active compound. Commonly commercialized 
as an anti-dandruff product, it is administered on the scalp and, after application, it is 
flushed down the drain. It ends up in the receiving surface water through effluents of 
the WWTPs with a small contribution from hospital wastewaters. Ketoconazole is the 
most commonly detected antifungal in rivers, sediment, and soils with clotrimazole, 
miconazole, itraconazole and fluconazole (Liu et al., 2016). The experimental pKa is 6.5, 
the LogKow is 3.78, and in the environment, it can be adsorbed to solid matrices such as 
sediments (Chen and Ying, 2015). In the past years, different papers have investigated 
the potential effect of this pharmaceutical on fish (Hasselberg et al., 2008; Yan et al., 
2013). The results show that exposure, even at low concentrations of ketoconazole, 
compromises the expression of key enzymes present in the metabolic and steroid 
clearance. Studies into the chronic bioconcentration, distribution, metabolism and 
biomarker responses of this toxicant in common carp (Liu et al., 2016) show that 
ketoconazole was highly concentrated in the liver and induces reactive oxygen species 
with increasing exposure time and concentrations.   
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Norfluoxetine and amitriptyline - antidepressants 
Antidepressants are drugs used to treat depressive disorders. They act through different 
mechanisms of action including monoamine oxidase inhibitors, serotonin reuptake 
inhibitors (SSRIs) and serotonin-norepinephrine inhibitors. A 2008 study showed that 
the SSRIs are the most prescribed antidepressants across Europe (Bauer et al., 2008). 
Due to the large use of this group of medicines, antidepressants are still commonly 
detected in surface waters across the globe (Valcárcel et al., 2011; Fedorova et al., 2014; 
ter Laak, Kooij et al., 2014; Gonzalez-Rey et al., 2015a; Wu et al., 2017). Therefore their 
potential risk to aquatic life is gaining more attention and many studies have 
investigated the adverse effects of different antidepressants on non-target aquatic 
species (Xie et al., 2015; Estévez-Calvar et al., 2017; Yang et al., 2018). For example, 
Estévez-Calvar et al., (2017) assessed the impact of the antidepressant sertraline on 
three different taxonomic marine species at their early development stage: the 
crustacean Amphibalanus amphitrite, the rotifer Brachionus plicatilis and the mollusk 
Mytilus galloprovincialis. Sertraline has been found to alter the swimming capacity of A. 
amphitrite and B. plicatilis and to cause the death and the immobilization of the 
organisms. In fish species, the same compound, sertraline, induced antioxidant 
responses when the organisms were exposed to the pharmaceutical and the authors 
also recorded an excessive increase of the swimming activity and a decrease of the 
shoaling activity of the fish (Xie et al., 2015). 
Norfluoxetine is the major metabolite of the SSRI fluoxetine. From the human body, 
fluoxetine is excreted principally in urine and 20% of the applied dose is excreted as 
norfluoxetine (Nałęcz-Jawecki, 2007). The detection of this drug in surface water started 
at the beginning of the 2000s (Kolpin et al., 2002) and since then, numerous studies have 
detected fluoxetine and norfluoxetine ubiquitously (Metcalfe et al., 2003; Kwon and 
Armbrust 2006a; Schultz and Furlong 2008; Calisto and Esteves, 2009). Although 
fluoxetine and norfluoxetine have been detected at low concentrations (ng/L to µg/L), 
in the environment, norfluoxetine has been found to be 50% more toxic than fluoxetine 
in 24 h lethal tests on a protozoan Spirostomum ambiguum and the crustacean 
Thamnocephalus platyurus (Nałęcz-Jawecki, 2007). Another study exposed fish species 
Japanese medaka at environmentally relevant concentrations (from 13 to 15 µg/L) at pH 
7, 8 and 9 and the BCF for fluoxetine and norfluoxetine increased with an increase of the 
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pH of the medium in both the liver and the body (Nakamura et al., 2008). The toxicity of 
fluoxetine and norfluoxetine was also assessed on other aquatic organisms such as algae 
(Neuwoehner and Escher, 2011). They exposed the green algae Scenedesmus vacuolatus 
at six different pHs (from 6.5 to 10) and the EC50 based on the concentrations of the 
cytoplasm was calculated. Here again, they observed an increase of the cytoplasmatic 
EC50 at higher pH. Regarding invertebrates, norfluoxetine was the most recurring 
antidepressant having the highest mean concentration in mussel tissues among the 
other antidepressants investigated by Silva et al., (2015). Ultimately, norfluoxetine has 
been detected in the plasma of sharks at even higher concentrations than the parent 
compound fluoxetine. The possible explanation of this observation is due to the polarity 
of norfluoxetine compared to fluoxetine. In fact, once fluoxetine is metabolized to 
norfluoxetine, the compound becomes less polar and thus, it tends to bioaccumulate 
more than fluoxetine causing detrimental effects (Gelsleichter and Szabo, 2013).  
Amitriptyline is a medicine used to cure symptoms of depression. It is a tricyclic 
antidepressant that inhibits the norepinephrine in the brain and it increases 
neurotransmitter concentrations (www.drugs.com). It has been detected at 
concentrations ranging from 2.2 to 11 ng/L in effluent samples (Togola and Budzinski, 
2008; Kostich et al., 2014). Few studies have investigated the toxicity of this drug in 
aquatic organisms such as freshwater invertebrate Daphnia Magna where an EC50 of 
4.82 mg/L was calculated after 48 h of exposure (Minguez et al., 2014). For fish species, 
bioconcentration assays have been conducted by Ziarrusta et al., (2017): the organisms 
(Sparus aurata)  were exposed to two environmentally relevant concentrations (0.2 and 
10 ug/L) and they found a high accumulation of the drug in the brain and in the gills. The 
results were not surprising because amitriptyline is an antidepressant and the brain 
should be the main target organ. However, another study exposed a brook trout to 
several antidepressants including amitriptyline and, in this study, it was detected only in 
liver tissues (Lajeunesse et al., 2011).  
 
Diclofenac -an anti-inflammatory 
Anti-inflammatory drugs are extensively used in medicine to treat general pain, minor 
injuries, and flu. They belong to the non-steroidal anti-inflammatory group (NSAIDs) and 
worldwide they do not require a prescription from a doctor but they are sold as over-
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the-counter medicines. For example, it has been estimated that the annual global 
consumption of diclofenac was 1443 ± 48 tonnes from 2010 to 2013 (Acuña et al., 2015). 
For this reason, anti-inflammatories are one of the most investigated groups of 
pharmaceuticals in the environment and they have become the subject of interest for 
researchers and regulators. Because of their large use, they are found ubiquitously in 
environmental compartments (rivers, lakes, and soil) with numerous studies 
investigating their presence in environmental matrices. To cite some studies: Camacho-
Muñoz et al., (2013) detected concentrations of diclofenac and naproxen in river 
sediments from Doñana National Park in Spain. Another monitoring study conducted by 
Rivera-Jaimes et al., (2018) in a big city in SouthWest Mexico, Cuernavaca, detected 
ibuprofen, diclofenac, and naproxen as the most commonly present in the samples 
analyzed.  
Diclofenac is one of the most popular analgesics used globally by humans and animals 
for veterinary purposes. Because it is an over-the-counter drug, it is very difficult to 
estimate its global consumption.  It can be applied to the skin or orally administered. It 
is sold under different names such as Voltaren Emulgel in Canada and Europe, Vilini in 
India and Voltaren in USA (www.drugs.com). The first attention to this medicine as a 
potential anthropogenic pollutant started as a result of the sudden decrease (by 95%) in 
vulture populations in India observed during the early 2000s. In that study, the 
researchers discovered that the mortality of the vultures was due to feeding on the 
carcasses of cattle treated with diclofenac. Diclofenac was concentrated in the tissues 
causing renal failure in the vultures (Oaks et al., 2004). From that episode, the number 
of studies regarding the toxicity of diclofenac in non-target organisms increased all over 
the world including studies with aquatic and terrestrial species. For example, a 
freshwater fish (Rhamdia quelen) exposed to environmentally relevant concentrations 
of diclofenac for 21 days showed biochemical reactions including reduction of the 
enzyme catalase, lipid peroxidation and inhibition of SODs in the brain (Guiloski et al., 
2017). Also, a study conducted on an earthworm E. Fetida exposed to short-term assays 
to 18 pharmaceuticals including diclofenac found out diclofenac as one of the most toxic 
NSAIDs in this species (Pino et al., 2015).  
To date, due to the numerous studies that have highlighted the potential negative 
effects of diclofenac in non-target organisms and its widespread detection in 
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environmental matrices, diclofenac has been inserted on the watch list of the European 
Water Framework Directive (2000/60/EC) as a priority substance to be monitored 
constantly in rivers and lakes.  
 
1.10 Study organism 
 
 
Lumbriculus variegatus is a freshwater oligochaete that inhabits sediments of ponds, 
lakes, or marshes of North America and Europe. It tends to burrow in the sediment by 
keeping the head submerged into the top layer of the sediment and the tail undulating 
in the overlying water for respiratory and sensory perception purposes. It feeds on 
decaying vegetation or microorganisms present in the sediment (EPA, Environmental 
Protection Agency, 2000). It possesses two reproduction strategies: sexual and asexual. 
The worm normally reproduces asexually under laboratory conditions. During the 
asexual reproduction, the worm fragments and the posterior part of the body then 
regenerates a new head and thus forms into a new organism (Martinez et al., 2006).  
L. variegatus has been used for decades as a key organism for sediment bioaccumulation 
and toxicity studies of contaminants. It is a species that is easy to cultivate in the 
laboratory, it can be supplied by different companies at a reasonable cost, it can be used 
for short and long-term experiments and it has a large tolerance of different types of 
sediments (Dermott and Munawar, 1992). Because L. variegatus feeds on suspended 
particulate matter in the sediment, it is an ideal organism to assess the dietary route of 
exposure of toxicants attached to the particles of the sediment and the biomagnification 
of these toxicants through the food chain. For example, Mount et al., (2006) conducted 
long-term feeding experiments (21 and 30 days) where L. variegatus was used as a 
possible prey for carrying out dietary exposure experiments of toxicants to two species 
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of fish, fathead minnows (Pimephales promelas) and rainbow trout (Oncorhynchus 
mykiss).   
Therefore, nowadays, L. variegatus is a common species used for standardized 
bioaccumulation and toxicity tests (OECD, 2007), (OECD, 2008) and trophic-transfer 
assays (Ng and Wood, 2008; Dutton and Fisher, 2011).  
In this PhD research, L. variegatus will be exposed to the APIs mentioned abover and the 
main findings will be presented in the following chapters.  
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Chapter 2. Evaluation of models for estimating the bioconcentration 
factor of ionisable compounds 
2.1 Introduction 
Man-made chemicals including pesticides, personal care products, and active 
pharmaceuticals ingredients (APIs) have been detected in various environmental 
compartments where they have the potential to accumulate in biota, (Pal et al., 2010; 
(Huerta et al., 2012; Gonzalez-Rey et al., 2015b). The accumulation of these chemicals 
can cause physiological and behavioral alterations in non-target species exposed 
throughout their lifetime (Brodin et al., 2014; Dzieweczynski et al., 2016; Xie et al., 2015; 
Richmond et al., 2016; Ford and Fong, 2016). As a consequence, bioconcentration is a 
fundamental endpoint in Environmental Risk Assessment and regulatory agencies 
worldwide evaluate thousands of chemicals based on their bioconcentration potential 
during the chemical assessment process (Dimitrov et al., 2005).  
To assess the bioconcentration, a bioconcentration factor (BCF) can be measured based 
on a series of standard protocols for fish species (OECD, 2012) and for sediment-benthic 
oligochaetes (OECD, 2008). Considering the significant number of chemicals to be 
tested, the laboratory effort to determine BCFs (for example for fishes, up to 14 days of 
acclimatization phase is followed by generally the same time for the depuration phase) 
and the number of organisms required for each experiment, measuring BCFs for all 
chemicals of interest would require a massive laboratory effort (Carter et al., 2014;  
Miller et al., 2016). Therefore, several bioconcentration models have been developed in 
order to estimate BCFs from the chemical structure and thereby minimize the need for 
costly experiments. Such models include empirical correlation BCF models (Neely et al., 
1974; Veith et al., 1979; Geyer et al., 1991); and mechanistic models (Mackay and Fraser, 
2000; Barber, 2003; Barber, 2008). These models have been proposed mainly for neutral 
compounds where the hydrophobicity (LogKow) is the main descriptor used to estimate 
the bioconcentration factor.                                                                                                                                         
However, many chemicals are ionisable and become charged at environmentally 
relevant pH values, as monovalent, multivalent acids and bases and zwitterions 
(Karlsson et al., 2016). For instance, Franco et al., (2010) reported that 491 (33%) of a 
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random sample of 1510 chemicals registered in the European Union regulation 
Registration, Evaluation, Authorization and Restriction of Chemicals, (REACH), ionize at 
pH around neutrality. Therefore, in recent years, models to predict the BCF of ionisable 
chemicals have been proposed for selected fish species (Meylan et al., 1999; Fu et al., 
2009b; Erickson et al., 2006; Trapp et al., 2010; Armitage et al., 2013; Nichols et al., 
2015b). On the contrary, very few BCF models have been developed for invertebrates 
(Arnot and Gobas, 2003; Meredith-Williams et al., 2012; Du et al., 2015; Karlsson et al., 
2016). However, an extensive validation of these models has not yet been performed. 
Hence, the present study evaluates the applicability of eight existing bioconcentration 
models in order to elucidate whether these models are suitable for predicting the 
uptake of ionisable chemicals and what properties are essential in predicting the 
ionisable chemical uptake including organisms’ traits and physicochemical parameters.      
 
2.2 Materials and Methods   
2.2.1 BCF Database 
 A total of 132 BCF measurements were collected from the literature. The dataset 
consisted of a total of 42 ionisable compounds including different classes of chemicals: 
pesticides, personal care products, and active pharmaceuticals ingredients. 
Measured BCF data for APIs is limited so given the chemical similarity between 
pesticides and APIs this analysis was done on a large dataset encompassing pesticides, 
active pharmaceutical ingredients and personal care products. The APIs included in this 
study included 35 APIs, 5 pesticides and 2 personal care products.  The entire dataset of 
both acids and bases is available in the Appendix A, Table A.1. They were collected from 
several sources, for example, the iPiE database (http://i-pie.org/) and the open 
literature. BCFs for pesticides were obtained from the Pesticide Properties Database 
(PPDB) (http://sitem.herts.ac.uk/aeru/ppdb/en/) (Lewis et al., 2016). Physicochemical 
properties such as LogKow and pKa were taken from the different papers and if the values 
were not available, they were estimated with predictive software such as Estimation 
Program Interface (v 4.11 EPI Suite™) (US EPA, 2019) and DrugBank 
(https://www.drugbank.ca/) (Wishart et al., 2006). Different studies were selected to 
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provide BCF data from a range of fish species and invertebrates having a range of 
chemicals with different physicochemical properties. For instance, for the chemicals 
included in this study, the logKow ranged between -0.09 and 6.15 and the pKa values 
between 1.7 and 10.5. Experimental pKa was preferred overpredicted, if available. 
Furthermore, the database included not only information about chemical properties (for 
e.g the acidic or basic nature of the chemicals, LogKow, molecular weight, water 
solubility, etc.) but, additional experimental details about the exposure or field 
conditions and organism species were also recorded. For water-only bioconcentration 
studies, different pH values and water properties such as dissolved oxygen and 
conductivity were included in the database, whilst, for sediment bioconcentration 
studies, cation exchange capacity and organic carbon content of the test sediment were 
added. Regarding the exposure conditions, details such as exposure duration, and 
experimental design (flow through, static or renewal) were reported. The organisms 
selected in the data collection were mainly fishes (n=82) and invertebrates (n=50).                                                                                                                                                                                 
Most of the BCF studies on fish species used a steady-state BCF test following the OECD 
305 flow-through exposure (OECD, 2012) where the BCF is calculated as a ratio of total 
radioactivity measured in the fish and the water phase. For invertebrate studies, BCFs 
are generally kinetic BCFs based on the first-order one compartment toxicokinetic model 
(Ashauer et al., 2006; Ashauer et al., 2010; Grech et al., 2017).    
 
2.2.2 Models that were evaluated  
An extensive literature review of bioconcentration models followed the database 
development. A total of eight BCF models were selected and evaluated to assess their 
suitability (Table 2.1) to predict the uptake of ionisable compounds by comparing the 
predicted BCFs to the measured BCFs in the database.   The models included: 
                                                                                                                                    
1. The Chiou et al., (1977) model is a regression model that uses LogS (logarithmic 
water solubility) as the only predictor of the equation. LogS was retrieved from 
DrugBank (https://www.drugbank.ca/) (Wishart et al., 2006) and when the data 
was not available, it was estimated from a Quantitative Structure-Property 
Relationship (QSPR) model (Shayanfar et al., 2010) using the formula:  
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                               LogS = 0.5 - 0.01 × (mp-25) – LogP   ͣ                                       Equation 1 
LogS (mg/L): it is the logarithmic of the water solubility of the medicine;                                                                                                                                      
mp (°C): it is the melting point of the compound;                                                                                                                                                    
ͣLog P= it is the logarithmic partition coefficient and it was recorded from 
Drugbank. 
 
2. The TGD (1996) model is a linear model included in the Technical Guidance 
Document on Risk Assessment of the European Union based on a previous model 
proposed by Veith et al., (1979) regarding the estimation of the BCFs for fish 
species.    
3. The Meylan et al., (1999) and the Arnot & Gobas, (2003)  models are integrated 
into the predictive software EPI Suite and encoded in a computer program called 
BCFBAF, an extension of a previous program called BCFWIN (Ver v 4.11 EPI 
Suite™), (USEPA, 2012). The Meylan model consists of two input parameters: 
LogKow and Σfi which is a summation of several correction factors to apply to the 
chemicals. Each chemical contains a specific functional group to which a specific 
correction factor is applied. For some chemicals, more than one correction factor 
may be applied.                                                                                                                                                           
4. The other model integrated into EPI Suite, is the model proposed by Arnot and 
Gobas, (2003) for lower, middle and upper trophic levels of fish species. The 
model consists of several uptake and elimination input parameters listed in Table 
2.1.    
5. The Meredith-Williams et al., (2012) model has been proposed for two 
invertebrates: Notonecta glauca and Gammarus pulex. The only predictor is the 
pH-corrected liposome-water partition coefficient (LogDlipw), calculated from the 
formula in Equation 2.  
6. The Karlsson et al., (2013) model is a specific model developed for ionisable 
chemicals uptake into a sediment-dwelling invertebrate, Lumbriculus variegatus. 
The input parameters are several: physicochemical parameters such as the pKa 
(constant dissociation of a chemical), environmental parameters as pH internal 
of the species and external of the medium and biological traits like the water 
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content of the species Fw (the lipid content (flip) and the pH-corrected liposome-
water partition coefficient (Dlipw). The latter parameter has been calculated 
based on a formula of  Escher et al., (2008): 
 
                                         LogDlipw = 0.904 × LogDow + 0.515                                Equation 2 
 
The LogDow was obtained from the Henderson-Hasselbach equation, where the 
fraction of the ionized and neutral fraction of the substance at a specific pH was 
determined as shown in Equation 3 and 4.  
 
                                        αion = αneutral × 10i(pH-pKa)                                                   Equation 3 
                               Dow = ƒion × Kow-ion + ƒneutral × Kow-neutral                                                        Equation 4 
 
αion is the activity of the ion at a particular pH; αneutral is the activity of the neutral 
species; ƒion is the ionic fraction of the substance at the studied pH; ƒneutral is the 
neutral fraction of the substance at the studied pH; Kow-ion and Kowneutral are the 
octanol-water partition coefficients for the neutral and ionic species respectively.  
The partition coefficient between octanol and water of the ionic species is assumed 
to be 3.5 log units lower than the neutral species (Trapp and Horobin, 2005). All the 
biological traits (internal pH for both fishes and invertebrates; lipid content in % wet 
weight, the water content in % and organisms’ weight in Kg) were searched in the 
open literature. A lack of data for these biological traits were found; in particular, 
the water content and the internal pH for invertebrates. Thus, specific biological 
traits of the species' order or class were used (Appendix A, Table A.2).  
 
7. The Fu et al., (2009) model in Table 1 is a linear regression model similar to the 
Technical Guidance Model on Risk Assessment 1996 where instead of the Logkow, 
the LogDow (pH-corrected octanol-water partition coefficient) is replaced.  
8. The last model of Table 1 is a model proposed by Dimitrov et al., (2005). The model 
can be used to calculate the baseline BCF of a compound considering the Kow and 
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the Fw (water content of the species); a and n are model parameters reported in the 
paper.             
 
2.2.3 Statistical analysis  
Predicted and measured BCFs were plotted as linear correlations using GraphPad Prism 
version 6.00 for Windows (GraphPad Software, La Jolla California USA, 
www.graphpad.com). The accuracy and applicability of the models were calculated based 
on percentages of BCF data that fit within a factor of 10. Also, the performance of the 
models was tested by performing the Nash-Sutcliffe efficacy test (NSE) with R in order to 
see how well the observed values versus predicted fit the 1:1 line. The Nash-Sutcliffe 
efficiency gives an indication of the goodness of fit of the data. When a value ≥ 0, a good 
match between the modeled and observed data can be concluded; if a value < 0, the 
observed data mean are more accurate than the modeled.   
 
 
 
 
  
Model Equation Species coverage Predictors of the model 
 
 
(Chiou et al., 1977) 
  
Log BCF = 3.41 × Log S - 0.508 
Fish (rainbow trout) 
The model predicts the BCF for a wide range of chemicals such 
as hydrocarbons, aromatic acids, etc only with a 
physicochemical property such as water solubility of the 
chemicals. 
 
Technical Guidance 
Document for Risk 
Assessment of the 
European Union, 
1996 
 
Log BCF = 0.85 × LogKow - 
0.70 
Fishes and specifically fathed 
minnow 
The model calculates the BCF of organic chemicals, considering 
the 𝐋𝐨𝐠𝐊𝐨𝐰, a physicochemical property of the chemicals only. 
 
(Meylan et al., 1999) Log BCF = - 1.37 × LogKow+ 
14.4 + ∑fi 
 
Fishes and specifically fathed 
minnow 
The hypothesis of the model is to provide a better estimation of 
BCF based on the physicochemical property of a chemical as 
𝐋𝐨𝐠𝐊𝐨𝐰 and different correction factors to apply to each 
compound (∑fi). 
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(Meredith-Williams 
et al., 2012) 
 
Log BCF = 0.71 × LogDlipw - 
0.23 
 
Invertebrates and specifically 
Gammarus pulex and 
Notonecta glauca 
The model uses the 𝐋𝐨𝐠𝐃𝐥𝐢𝐩𝐰 which is assumed to be a better 
input physicochemical parameter for the prediction of uptake 
for ionizable compounds. 
 
 
(Karlsson et al., 
2013) 
 
    Fw ×  
1+10(pHint−pKa)
1+10(pHext−pKa)
 +  flip × 
Dlipwater 
 
 
Invertebrates and specifically 
Lumbriculus variegatus 
 
The model proves to better and deeply describe the uptake of 
ionizable compounds linking together physicochemical 
properties such as pKa (constant dissociation of a chemical); 
biological traits as 𝐅𝐰, 𝐟𝐥𝐢𝐩 𝐚𝐧𝐝 𝐃𝐥𝐢𝐩𝐰 (the water content of the 
organism, the lipid content and the liposome water partition 
coefficient) and environmental properties such as pH. 
 
 
 
 
(Arnot and Gobas, 
2003) 
 
BAF = 
Cb
Cw
 = (1- Lb) + [( k1 × φ + 
( kd × β × τ + φ + Ld × Kow)] / ( 
k2 + kE + kG + kM) 
 
 
The model is applicable on 
three general trophic levels 
of fishes (lower, middle and 
upper) 
 
The model assumes specific fish traits: the weight of the 
organism (W); the lipid content of the organism (𝐋𝐛); lipid 
content of the lowest trophic level (𝐋𝐝); environmental 
conditions such as the concentration of particulate organic 
carbon (𝛘𝐏𝐎𝐂); concentration of dissolved organic carbon 
(𝛘𝐃𝐎𝐂)  and physicochemical properties of the chemicals (𝐊𝐨𝐰) 
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Table 2. 1. Summary table for selected BCF models including their predictors and applicability domain. 
 
-LogS  (mg/L): water solubility of the chemical; 
-LogKow: octanol-water partition coefficient; 
-Σfi: summation of correction factors to apply to the chemicals. Each chemical contains a specific functional group to which a specific correction 
factor is applied;  
-LogDlipw: logarithmic of the liposome-water partition coefficient;  
-LogDow: logarithmic of the pH-corrected octanol-water partition coefficient;  
-Fw (%): water content of an organism; 
- ƒlip (%, wet weight): lipid content of the organism; 
-Cb (mg/Kg): concentration of a chemical in the upper trophic level; 
-Cw (mg/L): is the concentration of the chemical in the unfiltered water;  
in order to be more representative of natural uptake of 
chemicals for fish species in aquatic environments. 
 
(Fu et al., 2009a) 
Log BCF = 0.85 × LogDow - 
0.70 
The model has been applied 
to fish species 
The model proposes and assumes that the 𝐋𝐨𝐠𝐃𝐨𝐰, a 
physicochemical property (pH-corrected octanol-water 
partition coefficient) is a better input parameter to describe the 
uptake of ionizable compounds. 
 
(Dimitrov et al., 
2005) 
 
Log BCFmax = log 
Kown
(aKow+12n)
 + 
Fw 
 
 
Fish species and in particular 
for salmonids and cyprinids. 
The model predicts base-line BCFs assuming several mitigating 
factors as molecular descriptors, the octanol-water partition 
coefficient (𝐊𝐨𝐰)  and fish biological traits such as water 
content 
( 𝐅𝐰). 
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-Ld (1 %):  lipid content of the lowest trophic level organism;  
-Lb (20 %): lipid content of the organism; 
-W (Kg): the weight of the organism; 
-χPOC (5 X 10-7 g/mL): concentration of particulate organic carbon; 
- χDOC (5 X 10-7 g/mL): concentration of dissolved organic carbon; 
-T (  ̊C): mean water temperature; 
-k1 ( 
1
[(0.01+ 
1
Kow
)× W0.4]
 ):  uptake rate constant; 
-φ  (
1
(1+ χPOC ×0.35 × Kow  + χDOC  ×0.1 ×0.35 × Kow
 ): the fraction of the free bioavailable chemical to be taken up by the organisms in the water;  
-kd (
0.02 × W−0.15× e0.06 × T 
5.1 × 10−8× Kow+2
): is the rate of uptake of the chemical via the diet;  
-β: biomagnification process; it is an empirical value to calibrate the model;  
-τ:  the maximum level of trophic dilution that occurs for substances that are metabolized at a significant rate in organisms of a food web and by 
default is 1; 
-k2 ( 
k1
Lb × Kow
): is the elimination rate constant; 
 -kE (0.125 × kd): fecal egestion rate constant; 
-kG (0.0005 × W
−0.2):  elimination rate constant through growth dilution;  
- kM (day
−1): metabolic transformation rate constant.            
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2.3 Results and discussion      
 
Comparisons of experimental BCFs against BCF values predicted using the different 
models are shown in Figure 2.1. Specifically, for fish models, an over-prediction of BCFs 
was observed for the models proposed by Dimitrov et al., (2005); TGD (1996) and 
Meylan et al., (1999), while the Fu et al., (2009) and Arnot and Gobas (2003) models 
show more scattered BCF data. In the Dimitrov et al., (2005) model, BCFs typically fell 
below the 1:1 line, more precisely in the 1:0.1 range or even below the 0.1 line. The 
Chiou et al., (1977) model is the only model where no BCFs were predicted within a 
factor of 10 of the experimental values .                                                                                                                                                                            
Also, two models specifically developed for invertebrates have been evaluated: the 
Meredith-Williams et al., (2012) and Karlsson et al., (2013) models. They show two 
opposite trends: the Karlsson et al., (2013) model over-estimated the BCFs, between 2 
and 6 log-units, whereas, the Meredith-Williams et al., (2012) model under-estimated 
BCFs. Most of the data are shifted in the 1:10 range or above resulting in a slight negative 
prediction.  
Along with the correlations, a table showing the accuracy of the predicted BCF data that 
fall within a factor of 10 of the different models is given in Table 2.2. Correlations 
including the acids and zwitterions and the bases and zwitterions only have been tested 
too, assuming that some models may be more appropriate to predict the uptake of the 
acids rather than bases and vice-versa. The graphs of the models are provided in the 
Appendix Figures A.1 and A.2. The results of the Nash-Sutcliffe Efficacy test are shown 
in Table 2.3. All models showed poor performance with the NSE values below zero. The 
worst model performance was observed for the Chiou et al., (1977) model with a NSE of 
-140.45 being obtained for acids and zwitterions; -92.37 for acids, bases and zwitterions 
and -93.8 for bases and zwitterions respectively. For the other fish models, the NSE 
ranged from -7.86 for the Dimitrov et al., (2005) model for acids and zwitterions to -0.38 
of Arnot and Gobas (2003) model for bases and zwitterions. The same negative results 
for the invertebrate models were seen with the Meredith-Williams et al., (2012) model 
having slightly better performance than the Karlsson et al., (2013) model.  
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Figure 2. 1. Relationships of predicted and measured BCF data for the eight selected BCF 
models in fish and invertebrate species. Note the different scale of the axes. The fish BCF data 
include zwitterions obtained from the iPie database (http://i-pie.org/). In this database, BCF 
data were not available for invertebrates and zwitterions and therefore invertebrate data 
included acids and bases only. 
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 Table 2. 2. Percentages of BCFs predicted within a factor of 10 for acids, bases, and zwitterions 
in fish and invertebrates species. Accuracy is determined as a percent of predicted values 
within a factor of 10 of the corresponding measured BCF. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model Accuracy (%) for 
acids, bases and 
zwitterions 
Accuracy (%) for acids 
and zwitterions 
Accuracy (%) for bases 
and zwitterions 
Fish BCF models 
Dimitrov et al., 2005 39 39.2 31.7 
TGD, 1996 45.1 50.9 42.8 
Meylan et al., 1999 46.3 50.9 33.3 
Chiou et al., 1977 0 0 0 
Fu et al., 2009 43.9 35.2 42.8 
Arnot and Gobas 
2003 
46.3 47 49.2 
Invertebrate BCF models 
Karlsson et al., 2013 9.80 16.6 11.5 
Meredith-Williams 
et al., 2012 
35.2 20.8  38.4 
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Table 2. 3. NSE calculated for acids, bases, and zwitterions of predicted and measured BCF data 
for the eight selected BCF models in fish and invertebrate species.  
 
 
                                                                                                     
 
 
 
 
 
 
 
 
 
Model NSE for acids, 
bases and 
zwitterions 
NSE for 
acids and 
zwitterions 
NSE for bases and zwitterions 
Fish BCF models 
Dimitrov et al., 
2005 
-6.99 -7.86 -6.34 
TGD, 1996 -0.49 -0.63 -0.82 
Meylan et al., 1999 -1.14 -1.18 -1.52 
Chiou et al., 1977 -92.37 -140.45 -93.8 
Fu et al., 2009 -0.44 -0.56 -0.75 
Arnot and Gobas 
2003 
-0.66 -1.27 -0.38 
Invertebrate BCF models 
Karlsson et al., 
2013 
-3.7 -3.32 -4.55 
Meredith-Williams 
et al., 2012 
-0.64 -0.43 -1.27 
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Fish BCF models 
The chemicals selected in this study cover a range of physicochemical properties but 
also different exposure scenarios such as the presence or absence of food, the duration 
of the test exposure and the different exposure media. For example, water and 
sediment BCFs of diclofenac have both been recorded. Due to the complexity of the BCFs 
analyzed in the sediment compartment, where environmental parameters (such as the 
carbon organic content or the nature of the sediment) influence the uptake; a careful 
analysis and interpretation of the discrepancy of the predicted and measured BCFs is 
necessary. 
Half of the fish BCF models clearly over-predict BCFs (Meylan, TGD, Dimitrov, Figure 1). 
A possible reason for the overestimation is due to the method used to measure 
bioconcentration. For example, many studies included in this work have analyzed the 
bioconcentration using radiolabelled chemicals measuring the total radioactivity. 
Generally, this method is very efficient in terms of laboratory effort but it is not suitable 
for distinguishing between the uptake of any metabolites and parent compounds. 
Therefore, the differences between the predicted and measured BCFs may be partially 
explained by the radioactivity measurements used to evaluate the BCF that do not 
distinguish the parent chemicals from their metabolites leading to a possible over-
prediction scenario. An increase in BCF prediction model performance was observed for 
the Meylan et al. (1999) and TGD (1996) models when acids and zwitterions are 
considered on their own, with a maximum of 50.9% of the predicted BCFs being within 
a factor of 10 of measured data for both these models. They are the only two models 
that estimate a fairly satisfactory threshold (50% of the BCFs are predicted by the 
model), confirming the hypothesis that for some models a better prediction occurs 
when acids and bases are considered separately.                                                                                                                                                      
These two models use the parameter LogKow as the sole descriptor in the simple linear 
regression equations proposed. Because of the simplicity of the two models, the 
difference in the prediction of BCFs is likely due to the different degree of 
hydrophobicity of the chemicals included in this study. While some compounds are 
highly hydrophobic, (for e.g. Eltrombopag, LogKow 6.15), others are very hydrophilic such 
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as Atenolol (LogKow of -0.03). However, this could just explain in part why some 
compounds are better predicted by the models than others.  
The Arnot and Gobas (2003) model was able to predict 49.2% of bases and zwitterions 
BCFs to within a factor of 10 of experimental values. Whilst this is the best performing 
model for the bases and zwitterions class, it was unable to estimate at least 50% of the 
measured BCFs. The original model accounts for the uptake rate of the chemical via the 
gills and the elimination of the parent compounds through metabolic transformation. 
Hence, we believe that possible differences between the predicted and measured BCFs 
could be explained partially by different detoxification and biotransformation processes 
of the different fish species included in this work. Evidence suggests that different 
compounds are metabolized to a different extent; for example, fluoxetine is completely 
metabolized to norfluoxetine (Nakamura et al., 2008a). Besides, it is well known that 
biotransformation influences the internal concentration of the parent compounds and 
metabolites, resulting in some cases of a higher internal concentration of the 
metabolites than their parent compounds (Ashauer et al., 2012). Therefore, this 
parameter is the most uncertain because it is very dependent on the metabolic process 
of the species.                                                                                   
Moreover, previous studies have demonstrated that one of the major passive uptake 
routes of xenobiotics is at fish’ gills (Erickson et al., 2006). However, a new theory has 
been presented by some authors regarding the permeability of ionisable chemicals in 
biological membranes (Dobson and Kell, 2008). They account for the active transport of 
ionisable compounds at the fish’ gills with either facilitated diffusion or carrier-mediated 
transport through the membranes. Thus, differences of BCFs could be partially explained 
by the fact that uptake is not only occurring through the passive adsorption of the 
neutral fraction of the compound, but, by the possibility that ionisable chemicals are 
transported across the bio-membrane by specific carriers (Sugano et al., 2010; Miller et 
al., 2015; Richmond et al., 2016). For example, it has been shown that two members of 
a solute carrier family (SLC), isolated from the fish’ gills of Rainbow trout, might act as 
principally responsible for the uptake of ionic and non-ionic drugs (Cooper et al., 2007; 
Fardel et al., 2012; Armitage et al., 2017).  
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However, whilst this is a plausible explanation for the discrepancies in predicted and 
measured BCFs presented in this study, this is a new hypothesis that needs be further 
investigated considering a wider range of ionisable chemicals in order to be validated.  
The Fu et al., (2009) model is the only model that was able to better predict BCFs when 
all the chemicals are considered together (43.9%, Table 2.2), while the Dimitrov et al., 
(2005) has a similar prediction for acids, bases and zwitterions and also for acids and 
zwitterions (39%, Table 2.2). The differences in the BCF prediction from the two models 
can be explained by exploring the input parameters, namely Kow and the water content 
which are the main descriptors of the Dimitrov et al., (2005) model and LogDow (pH-
corrected octanol-water partition coefficient) in the Fu et al., (2009) model. The LogDow 
is considered to be a better parameter for estimating the uptake of ionisable chemicals 
because it accounts for the pH, the dissociation constant (pKa), the valency of a 
compound and the Kow (Kah and Brown, 2008). For the Dimitrov et al., (2005) model, a 
physicochemical parameter (Kow) and a species-specific biological trait (water content) 
have been proposed in analyzing the bioconcentration factor. The Water Content is 
considered an important biological trait when assessing the bioconcentration (Rubach 
et al., 2012) based on the theory that a chemical is partitioned between the lipid and 
the aqueous phase of an organism. However, there is a scarcity in data regarding the 
specific water content of the species investigated. In order to test the model, if such 
information for the specific fish species could not be found in the literature, the class or 
phylum’s value of that species was recorded. This could be a critical point leading to the 
shift of the BCFs below the 0.1 line. In this case, this biological parameter is not so 
precise because it is not referred to the specific fish species. Besides, due to a difficulty 
to find this data, we suggest that more specific biological traits should be provided in 
the future, in particular when assessing the bioconcentration of xenobiotics organic 
chemicals across different species.  
The final model evaluated is the Chiou et al., (1977) model. The results show that BCFs 
are unable to be predicted within a factor of 10 of experimental values using this model 
and the general trend is an overprediction of the modeled BCFs (between 5 and 7 log 
units) compared to the experimental data.  
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Invertebrates models 
The invertebrates models evaluated in this work include the Karlsson et al., (2013) model 
and the Meredith-Williams et al., (2012) model. The former predicts lower than 20% of 
the modelled BCFs to within an order of magnitude of experimental values for both acids 
and bases. It considers biological traits, chemical, and environmental properties in order 
to describe the entire uptake process of ionisable compounds into a sediment-dwelling 
worm Lumbriculus variegatus. Due to the problem of data availability for biological 
traits, the same issue occurs with the Dimitrov et al., (2005). Most of the biological traits 
were not provided and in order to test the model, we relied on the literature. Scarce 
data are available about the internal pH or the water content of invertebrates, thus, 
when no data were available, we had to rely on biological traits of the class or phylum 
of the considered species. In this way, the deviation from the best-fit line and factor 10 
of the model may be in part due to the imprecision of the biological traits.                                                                                                                                         
On the other hand, the latter predicts more bases than acids; 38.4% to 20.8% 
respectively. It is the only model showing a clear underestimation of the BCFs, due in 
part to a negative estimation of the LogDlipw for some chemicals such as Atenolol or 
Sulfadiazine. 
2.4 Conclusions 
The present study has demonstrated that the uptake of ionisable compounds could not 
be reliably predicted by the current BCF models. The majority of the selected models 
under-predict BCFs while others over-predict BCF. Two models (Meylan et al., 1999 and 
TGD 1996) estimate 50% of the BCF data to within an order of magnitude of 
experimental values, while the remaining models demonstrated a low accuracy in 
predicting BCFs. The poor predictive accuracy of the models was observed also by the 
performance of the Nash-Sutcliffe Efficacy test and all models showed negative values.  
The different performance between the eight bioconcentration models could be 
partially explained by the wide variety of physicochemical properties, test conditions, 
the method to measure the BCF and the different input descriptors not fully suitable for 
describing the mechanism of uptake of ionisable compounds. In addition, the models 
showed an improved prediction when the acids, bases, and zwitterions were considered 
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separately. Based on these findings, we suggest considering these charged species 
separately in developing and proposing a new uptake predictive model. Ultimately, of 
eight models, only two invertebrate models have been evaluated in this work and this 
clearly shows the gap of data and thus invertebrates’ models available in the open 
literature compared to fish species. Further work should be addressed to develop more 
invertebrates BCF models, in particular for estimating the uptake of ionisable chemicals. 
It could be useful to focus on more than one biological trait, environmental and 
physicochemical parameters.    
Therefore, the next chapter will focus on assessing the key role of an environmental 
factor, pH, on the uptake of APIs that possess diverse physicochemical characteristics 
into the sediment-dwelling worm L. variegatus.  
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Chapter 3. Influence of pH on the uptake of ionisable active 
pharmaceutical ingredients (APIs) into the sediment-dwelling worm (L. 
variegatus) 
3.1 Introduction 
Previous studies have explored the uptake and depuration of APIs into non-target 
organisms such as earthworms (Carter et al., 2016), plants (Riemenschneider et al., 
2017; Santiago et al., 2016; Carter et al., 2015), fishes (Chen et al., 2017; Zhao et al., 
2017; Valdés et al., 2016; Du et al., 2016) and invertebrates (Karlsson et al., 2016; Miller 
et al., 2015; Meredith-Williams et al., 2012). 
For example, Karlsson et al., (2016) investigated the uptake of selected ionisable APIs 
into the benthic invertebrate Lumbriculus variegatus. Differences in uptake among the 
pharmaceuticals were observed which are believed to be due to differences in 
physicochemical properties of the study compounds and sediment properties. 
Differences in bioconcentration have also been assessed by Meredith-Williams et al., 
(2012) in two non-target invertebrates: the freshwater shrimp Gammarus pulex and the 
aquatic insect Notonecta Glauca. They found that the different bioaccumulative degree 
of each API was explained by the influence of water chemistry (for example pH), 
physicochemical properties of the compound (for example pKa) and different biological 
traits such as respiration and locomotion of the two organisms.  
Mechanism of ionisation. Most of the APIs that are in use are ionisable at pH ranges 
found in natural aquatic systems (Franco et al., 2010). Depending on the pH of the 
system, these compounds can be found in the neutral or ionized form as weak acids, 
bases or zwitterions. The fraction of the neutral and the ionized form of the chemical 
depends directly on the pKa and the pH of the medium can be calculated using the 
Henderson-Hasselbalch ( Henderson, 1908) equation: 
 
                                                                  αion = αneutral × 10i(pH-pKa)                              Equation  1  
                   
where αion is the ionic fraction of the compound, αneutral is the neutral fraction and I is 1 
for acids and -1 for bases.  
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Generally, ionized APIs are believed to be less bioaccumulative compared to their 
neutral counterpart (Rendal et al., 2011a) because they are more polar and they do not 
easily cross the plasma membrane which is comprised of fatty acids and phospholipids.  
Previous studies have analyzed the influence of pH on the toxicity and bioconcentration 
(BCF) of ionisable APIs. For example, a study by Nichols et al., (2015) examined the 
accumulation of the weak base diphenhydramine in fathead minnows at pH values of 
6.7, 7.7 and 8.7. They measured an increase in toxicity and bioconcentration with an 
increase in the water pH. Another study conducted by Anskjaer et al., (2013) measured 
the toxicity and bioconcentration of the weak acid sulfadiazine in the invertebrate 
Daphnia magna at pH values of 6, 7.5 and 8.5 respectively. In this case, the lower pHs 
led to higher toxicity and bioconcentration due to the fact that the majority of the 
compound exists in its neutral state at the lower pH values. Opposite results were found 
by Ding et al., (2016) who exposed Daphnia magna to two basic pharmaceuticals 
roxithromycin and propranolol at two different pH conditions (pH 8 and 9) and higher 
uptake was observed at higher pH exposure. Lastly, Rendal et al., (2011b) found that 
Daphnia magna and the algae Salix viminalis showed higher sensitivity to and uptake of 
pharmaceuticals at higher pH values of 8 and 9 than pH 6 and 7. Even though an 
increasing number of studies are available in the literature regarding the uptake of 
ionisable compounds in non-target aquatic species such as fish, pH-related invertebrate 
uptake studies are very limited, in particular for sediment-dwelling organisms. Because 
the pH of rivers naturally may range between 3 to 10 (Bundschuh et al., 2017), large 
differences may be expected in the ionization state of many APIs in natural waters which 
could have a large effect on the internal concentrations of these compounds in 
organisms. Recently, a model that accounts for the pH and the pKa of the chemical has 
been proposed for assessing the uptake of ionisable APIs in the sediment-dwelling worm 
L. variegatus (Karlsson et al, 2017). In this study, supporting the development of the 
model, a 37-fold difference in uptake for fluoxetine and 47-fold for diclofenac was 
observed in a water pH ranging between 5.5 and 8.5. This study was the first attempt of 
its kind in understanding the role of physicochemical and environmental properties in 
measuring the uptake of ionisable APIs in sediment-dwelling invertebrates but the 
approach was limited to only three APIs. Additional data on the effect of pH on the 
uptake of ionisable APIs in sediment-dwelling organisms are therefore needed. Also, 
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studies with better characterisation of pH effects than the previous studies are essential 
for a more comprehensive environmental assessment of the risks posed by APIs in the 
environment.   
Therefore, in this chapter, the uptake and depuration of four APIs were evaluated across 
pH values ranging from 5.5-9. Three of the APIs, amitriptyline, ketoconazole, 
norfluoxetine, are weak bases and the fourth API, diclofenac, is a weak acid. These 
pharmaceuticals were selected based on the literature and represent a diversity of 
physicochemical properties. The broad range of pHs was chosen in order to have each 
API fully and partially ionized. The aim of the study was to quantify the absorption and 
excretion of these emerging contaminants in sediment-dwelling invertebrates in order 
to gain more insight and understanding into how these APIs, which have different 
physicochemical properties, are taken up by the worms at different pH values. 
 
3.2 Material and methods 
3.2.1 Test chemicals 
The antimycotic, ketoconazole (CAS 65277-42-1), and anti-inflammatory, diclofenac 
(CAS 15307-86-5), were purchased from American Radiolabeled Chemicals, Inc. (UK). 
The two antidepressants amitriptyline (CAS 64-17-5) and norfluoxetine (CAS 65277-42-
1) were obtained from Merck & Co (New Jersey, USA) and from Sanofi (Paris, France). 
Test chemicals were all labeled with 14-C and they were selected to represent different 
physicochemical properties. Specific properties and activity data for each API are 
provided in Table (1.2) in Chapter 1. Stock solutions were prepared in ethanol and stored 
at -20  ̊C. The dosing stocks were prepared in either ethanol or artificial pond water 
(APW) (Naylor et al., 1989). Ethanol, acetate, 3-(N-morpholino)propane sulfonic acid 
(MOPS, CAS 1132-61-2), N-Cyclohexyl-2-aminoethanesulfonic acid (CHES, CAS 103-47-
9), tris(hydroxymethyl)aminomethane (TRIS, CAS 77-86-1) buffers, hydrochloric acid and 
sodium hydroxide were obtained from Sigma Aldrich (https://www.sigmaaldrich.com), 
Soluene-350 and Hionic Fluor were purchased from PerkinElmer 
(http://www.perkinelmer.com) and Ecoscint A from National Diagnostics  
(https://www.nationaldiagnostics.com).  
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3.2.2 Lumbriculus variegatus cultivation 
Lumbriculus variegatus were obtained from Blades Biological Ltd (Kent, UK) and reared 
in a 30 L glass aquarium. The aquarium contained artificial pond water with shredded 
unbleached tissue paper strips. The culture was maintained at a constant control 
temperature of 25 ± 2 ̊C with a light/dark cycle of 16h/8h. The organisms were fed with 
groundfish flakes (Tetramin, Tetra Werke) once a week.  
 
3.2.3 Uptake and depuration studies at multiple pHs   
The uptake and depuration experiments were carried out following the method of 
(Ashauer et al., 2010), consisting of a 24-hour uptake phase followed by 24-hour 
depuration phase. Worms were acclimatized to the pH test conditions for 24 hours prior 
to the beginning of the exposure. The APW was buffered at four pH values: 5.5, 7, 8 and 
9 using 0.1 mol/L of acetate, MOPS, TRIS and CHES buffers. For the uptake phase, 
animals were exposed in groups of 3 worms in 20 mL of APW at concentrations of 10 
µg/L (for the amitriptyline experiments 10 mL was used). The uptake phase included two 
sampling times (12 and 24 hours) and there were six replicates per sampling time point. 
An additional 12 groups of three animals were exposed for use in the depuration phase. 
After 24 hours of uptake, these worms were transferred to new beakers containing new 
APW without the test pharmaceutical with samples then being taken 12 and 24 h later. 
Six stability beakers (= APW only spiked with the APIs) and six control beakers (= beakers 
containing worms without the API) were also set up. To keep the pH stable additional 
uptake and depuration experiments were carried out increasing the amount of APW 
from 10 mL to 20 mL. Due to the high variability of pH throughout the experiments, an 
increase of the APW was necessary in order to keep the pH constant. The entire 
experiments were performed in the dark to avoid photodegradation of the APIs and 
exposure was performed at a constant temperature of 25 ± 2  ̊C. pH measurements were 
taken every 12 hours using a Mettler Toledo 51343104 InLab pH probe.  
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At each sampling time, 1 mL of test media was taken into a 20 ml scintillation vial to 
determine the remaining concentration of the API. 10 mL of Ecoscint A was added and 
the vials were ready to be analyzed. Likewise, worms were sampled, gently rinsed in 
deionized water, dried using filter paper and then transferred to a pre-weighed 
scintillation vial to measure the wet weight (g). Then, 2 mL of Soluene-350 was added 
and the vials were left overnight in order to allow the worms to be solubilized. Before 
analysis, 10 mL of Hionic Fluor was added. Internal concentrations and water 
concentrations of each API were analyzed using Liquid Scintillation Counting (HIDEX 300 
SL). Samples were counted for 5 minutes three times and counts were corrected for 
background activity by using blank controls. Counting efficiency and color quenching 
were corrected using the external standard ratio method. 
 
3.2.4 Estimation of uptake and depuration rate constant and bioconcentration factor 
The model used to derive the uptake and depuration rate constants was a first-order 
one compartment toxicokinetic model (Equation 1), programmed in the software 
OpenModel, (University of Nottingham, http://openmodel.info/ downloaded 5th May 
2017).  
 
                       dCint(t)/ dt= kin x Cwater(t) – kout x Cint(t)                                                                                1 
 
Where Cint is the organism internal concentrations (pmol/g wet weight), Cwater is the 
water concentration of the API (pmol/mL), kin and kout are the uptake (mL x g wet weight 
h-1) and depuration rate constant (h-1) and t is time (hours).  
Measured internal and water concentrations were used as input data to derive the 
uptake and depuration constants kin and kout. A detailed description of the model code 
is provided in the Appendix B. First, least-squares optimization with the Levenberg-
Marquardt algorithm was applied using the experimental data. Then, Monte-Carlo 
Markov-Chain (MCMC) with the Metropolis-Hastings algorithm was used to 
parameterize the model. 95 % confidence intervals were plotted along with the fit model 
curve. The bioconcentration factor (BCF) (Kg/L) was estimated by setting the water 
concentration (Cwater) equal to 1 and by running the model until a steady state was 
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reached. The formula used for calculating the BCF (L/Kg) at steady state is given in 
Equation 2: 
                                                                   BCF =  
Kin
Kout
                                                                              2 
 
3.2.5 Statistical analysis  
One-way ANOVA test was performed with Graphpad Prism (www.graphpadprism.com) 
in the stability beakers. The analysis was done to verify whether the aqueous 
concentrations of the level of radioactivity changed overtime during the exposure. Prior 
to the ANOVA test, the Shapiro-Wilk test was performed to test for normality.   
 
3.3 Results and discussion 
3.3.1 Measured concentrations in the stability beakers 
The analysis of the aqueous concentrations of the APIs in the stability beakers confirms 
that the level of radioactivity in solution was stable throughout the experiments for all 
the pH ranges meaning that there was no sorption of the test chemicals to the beakers 
(Figures 3.1, 3.2, 3.3, 3.4). Overall, the pH was stable for all the compounds remaining 
within the ± 0.3 units of the starting pH value.   
At some pH ranges, (for e.g. ketoconazole pH 8 and 9 and norfluoxetine pH 5.5) a slight 
decrease in the concentrations of the compound was observed during the first 12 h from 
the beginning of the experiment (p < 0.0001). A possible explanation may be that a 
biotransformation process has occurred, however, the use of radiolabelled APIs does 
not distinguish between the parent compound and the transformation products, 
therefore, we assumed that the measured compound throughout the test was the 
parent compound. The same trend was observed for diclofenac at pH 9 (p < 0.05). 
Diclofenac has been reported to be photosensitive and degradable through photolysis 
and biotransformation (Koumaki et al., 2015; Koumaki, et al., 2017). For example, 
diclofenac has been exposed to natural sunlight and a half-life of 1.7 h was found (Poiger 
et al., 2001). However, in this study, the experiments were conducted in the dark and 
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the photodegradation was therefore expected to be very limited. The concentration of 
the 14-C diclofenac in water was reported by Karlsson et al., (2016) where the authors 
analyzed the API over 48-h exposure. They observed stable radioactivity in the beakers 
containing the API and water only. Once pharmaceuticals end up in the water, their 
dissipation could be explained by other processes such as changes in pH and 
biodegradation. A study conducted by Baena-Nogueras et al., (2017) analyzed the fate 
of several PPCPs including diclofenac and amitriptyline and their removal from the water 
column. Photodegradation, hydrolysis and biodegradation were the processes that the 
authors investigated. Different results were found: diclofenac was highly degraded by 
the light but there were no significant changes in its removal with pH changes. This 
confirms the results of this study where the 14-C activity of diclofenac was stable at 
different pH ranges. Amitriptyline was not removed by any of the above mention 
processes (Baena-Nogueras et al., 2017). Another study evaluated the 
photodegradation of amitriptyline and its major metabolite in water and no 
photodegradation occurred in deionized water but an increase of the photodegradation 
was observed at higher pH in deoxygenated solution (Chen et al., 2017). However, in our 
experiments, the beakers were not deoxygenated and stable radioactivity of 
amitriptyline was observed.  
Regarding norfluoxetine, previous fate studies have mainly been conducted on the 
parent compound fluoxetine. For instance, Yin et al., (2017) evaluated the effects of 
hydrolysis and photodegradation on fluoxetine. They exposed fluoxetine to different pH 
values (from 2 to 10) over a year under dark and light conditions to assess the long-term 
effects of dissipation by the water chemistry and photodegradation. Fluoxetine was 
found to be persistent under both conditions (light and darkness), in particular, under 
dark conditions with a half-life of 858-13905 days at all the pH values. These half-life 
values show that the compound is hardly degradable under alkaline and acidic 
conditions and it is not photosensitive. Similar to the experiments of our study, the 
radioactivity of its primary metabolite norfluoxetine was stable at all pH values from 5.5 
to 9 and it was exposed to very limited light. Therefore, we conclude that hydrolysis and 
photolysis are negligible and do not account for the removal of this compound in water.  
The radioactivity of ketoconazole was found to be stable for the whole duration of the 
exposure at the different pH ranges. Only a slight decrease of the radioactivity was 
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observed at higher pHs such as 8 and 9 within the first 12 h (Figure 3) (p < 0.0001) in 
which a potential transformation process may have occurred. Limited studies about the 
fate of ketoconazole in the water column were found, and to the best of our knowledge, 
this is the first attempt to measure the stability of this azole fungicide in the water under 
acidic, alkaline and dark conditions. 
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Figure 3. 1. Mean and standard deviations of concentrations in water (pmol/mL, orange 
points) and pH of the stability beakers (violet squares) for amitriptyline at pH 5.5, 7, 8 and 9 
over 48 hours. Concentrations are based on measured activity and it is assumed this is the 
parent compound.  
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Figure 3. 2. Mean and standard deviations of concentrations in water (pmol/mL, orange 
points) and pH of the stability beakers (violet squares) for diclofenac at pH 5.5, 7, 8 and 9 over 
48 hours. Concentrations are based on measured activity and it is assumed this is the parent 
compound. 
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Figure 3. 3. Mean and standard deviations of concentrations in water (pmol/mL, orange 
points) and pH of the stability beakers (violet squares) for norfluoxetine at pH 5.5, 7, 8 and 9 
over 48 hours. Concentrations are based on measured activity and it is assumed this is the 
parent compound. 
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Figure 3. 4. Mean and standard deviations of concentrations in water (pmol/mL, orange 
points) and pH of the stability beakers (violet squares) for ketoconazole at pH 5.5, 7, 8 and 9 
over 48 hours. Concentrations are based on measured activity and it is assumed this is the 
parent compound. 
 
3.3.2 Uptake and depuration studies in Lumbriculus variegatus at multiple pHs  
3.3.3 pH variability in uptake and depuration experiments.  
The pH values of the exposure beakers were monitored throughout the experiments 
(Fig. 3.5). Different buffers were used to keep the pH constant for 48 hours as mentioned 
in the Material and Methods section. All the pH values remained within ± 0.3 pH units 
of the starting pH value per each time point except amitriptyline pH 5.5 treatment. In 
fact, during the exposure of amitriptyline, changes of pH by up to 0.5 log units were 
observed every 12 h (Figure 3.5, top left). Because the uptake of ionisable APIs is very 
sensitive to variations of pH, a drift of 0.5 log units could change the ionisation state of 
the molecule and thus influence the accumulation of the compound. Thus, to keep the 
pH stable, the addition of a few drops of 0.1 mol/L NaOH or HCl every 12 hours was 
necessary (Rendal et al., 2012). 
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Figure 3. 5. pH measurements over 48-h of exposure and 95% confidence intervals of the APW 
buffered for the uptake and depuration experiments of amitriptyline, ketoconazole, diclofenac 
and norfluoxetine. 
 
3.3.4 Uptake and depuration exposures.  
No mortality of the organisms was observed in the treatment beakers and the growth 
dilution of the worms was minimized due to the short duration of the uptake and 
depuration experiments. The radioactive concentration of the compounds in the water 
was measured (Figures 3.7, 3.9, 3.11, 3.13). During the uptake phase, a decrease of the 
radioactivity in the exposure beakers was observed which is likely due to the uptake of 
the APIs by the worms. The opposite occurred during the depuration phase when the 
worms were placed in the new beaker without radioactivity. 
The first order one-compartment toxicokinetic model was fitted to the measured 
internal concentration data for all the APIs (Figures 3.6, 3.8, 3.10, 3.12). Diverse results 
were observed depending on the compound and they will be discussed separately in the 
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following sections. The raw dataset of water concentrations, internal concentrations, 
and mass of the worms of each API are listed in Appendix B.  
For amitriptyline, the model successfully fitted the uptake and depuration data for all 
the pH treatments with most of the data fitted within the 95% confidence intervals.  
Overall, a rapid uptake followed by a rapid depuration was observed, however, at higher 
pHs the worms did not depurate amitriptyline, particularly at pH 9 where a shallow 
depuration curve was seen (Figure 3.6).   
Regarding ketoconazole, the model fitted the measured uptake and depuration data 
although, for the pH 7 experiment, the model slightly underestimated the 48-h 
depuration data (Figure 3.10). Also, a rapid uptake followed by a rapid depuration was 
seen.  
The last base evaluated in this study was norfluoxetine. The model successfully fitted 
the uptake and depuration data and rapid uptake by the worms was observed for all the 
pH treatments (Figure 3.12). However, during the depuration phase, the worms slightly 
depurated the compound at pH 7 and 8 but they did not depurate norfluoxetine at the 
most extreme pHs of 5.5 and 9.    
The only weak acid analyzed was diclofenac. The uptake of diclofenac showed a rapid 
increase of the 14-C activity of the target analyte for 24 hours, as well as a rapid 
depuration when the worms were transferred in the new medium (Figure 3.8). 
Generally, the model fitted the measured internal concentrations data but it slightly 
underestimated the 48-h depuration data of pH 8 and 9 experiments.  
 
The results of the uptake, depuration rates and the BCFs are shown in Table 3.1. The Kin 
ranged from 0.365 (mL × g-1 × h-1) of diclofenac pH 9 to 43.88 (mL × g-1 × h-1)  of 
norfluoxetine pH 9, while the Kout ranged from 1 × 10-7 (h-1) of norfluoxetine pH 5.5 to 
0.0014 (h-1) of norfluoxetine pH 8. Also, at pH 5.5, the BCF values ranged from 93.04 
(mL/g) to 1.06 × 107  (mL/g) and increased in the order of ketoconazole < amitriptyline < 
diclofenac < norfluoxetine. For the pH 7 tests, the BCF values ranged form 81.42 to 870 
(mL/g) and increased in the order of diclofenac < ketoconazole < amitriptyline < 
norfluoxetine. At pH 8, the BCF values ranged from 13.75 to 2902 (mL/g) and increased 
in the order of diclofenac < ketoconazole < amitriptyline < norfluoxetine. At pH 9, the 
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BCF values ranged from 3.78 to  1.11 × 104 (mL/g)  and increased in the same order as 
pH 8.   
Overall, the BCF increased with the increase of the water pH for the three bases and 
increased with a decrease of the water pH for diclofenac. In fact, it is worth noticing that 
a similar pattern of uptake among the three basic pharmaceuticals can be observed: 
higher uptake occurred at higher pH when the neutral fraction increased with an 
increase of the pH. For example, in a range of pH between 5.5 and 9, the neutral fraction 
of amitriptyline increased from 0 % to 30 %. For ketoconazole from 15 % to 99 % and for 
norfluoxetine from 0 % to 60 %. Likewise, the BCFs increased with an increase of pH (e.g. 
amitriptyline: 146 (pH 5.5) < 391 (pH 7) < 653 (pH 8) < 2284 (pH 9); ketoconazole: 93.04 
(pH 5.5) < 100.9 (pH 7) < 101.1 (pH 8) < 211.4 (pH 9). This trend was not be observed for 
norfluoxetine because the largest BCFs were calculated for pH 5.5 and 9, respectively 
1.06 × 107 and 1.11 × 104  mL/g.  
On the other hand, for diclofenac, an opposite uptake trend was observed compared to 
the basic APIs: higher internal concentrations occurred at lower pHs and increased in 
the order of 3.78 (pH 9) < 13.75 (pH 8) < 81.42 (pH 7) < 353.4 (pH 5.5). 
 
The results of this study demonstrate that L. variegatus can accumulate quantifiable 
concentrations of human active pharmaceutical ingredients and that the uptake of these 
APIs is pH-dependent. For example, for amitriptyline and ketoconazole, the BCFs 
calculated differed by approximately a factor of 15 and 2 between the highest and the 
lowest pH.  
On the other hand, for the acidic diclofenac: the BCF values differed by approximately a 
factor of 93 between pH 5.5 and 9 with a change in the fraction of ionisation of the 
compound by only 2-3 %. Results from a previous study reported the BCF of diclofenac 
to be 623, 30 and 8 in L. variegatus at three different pHs (5.5, 7 and 8.5) (Karlsson et 
al., unpublished) which are close to the values measured in this study. Also, the same 
uptake trend was seen: higher internal concentrations were observed at lower pHs 
when the compound increased its neutrality. Diclofenac has been inserted in the 
European watch list of priority substances as it has been demonstrated to alter fish 
feeding and behaviour (Nassef et al., 2010) and affects fish kidney and gill integrity 
(Hoeger et al., 2005). However, few studies have investigated the role of pH on 
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diclofenac uptake and effects in smaller organisms such as aquatic invertebrates. For 
instance, diclofenac was measured in two marine bivalves Mytilus galloprovincialis and 
Ruditapes philippinarum exposed to the API at low pH values. The reduction of pH 
affected biomarker responses of the organisms showing a significant decrease of COX 
activity which involves alterations in reproduction and osmoregulation (Munari et al., 
2018). Furthermore, the pH-dependent toxicity of diclofenac (EC50) has been assessed 
on Daphnia magna at three pH ranges of 6, 7.5 and 9 and the results showed lower 
toxicity at higher pH (Boström and Berglund, 2015).  
Regarding norfluoxetine, no studies on the mechanism of uptake of fluoxetine and its 
metabolite norfluoxetine into sediment-dwelling invertebrates have been studied so far. 
However, fluoxetine has been investigated at the sediment pH of 7.7 in lumbricids and 
a 48-h BASF of 0.33 L/Kg was found (Karlsson et al., 2016). In our study, much higher 
BCFs were derived.  
Norfluoxetine uptake has been also well documented in fish species (Brooks et al., 2005; 
Chu and Metcalfe, 2007; Gelsleichter and Szabo, 2013). It has been detected in the 
different body parts of fish, including: liver, brain and muscle tissues where 
norfluoxetine has been detected at higher concentrations than the parent compound 
fluoxetine. Also, norfluoxetine has been found to be more hydrophobic tending to 
accumulate to a greater extent than fluoxetine eliciting the same effects (Gelsleichter 
and Szabo, 2013). Norfluoxetine has a pKa value of 10.01 and the same trend of uptake 
(higher uptake at higher pH) as mentioned in the literature for basic compounds was 
seen. However, this trend was noticed for the experiments conducted at pH 7 and 8 
while significantly high BCF values were derived at pH 5.5 and 9. These high values are 
most likely due to a non-existent depuration of the compound by the worms. An almost 
non-existent depuration by the worms was also reported by Karlsson et al., 
(unpublished). Studies of the uptake of amitriptyline in non-target invertebrates are 
limited but, there has been a study that analyzed the bioaccumulation of amitriptyline 
into a freshwater mussel (de Solla et al., 2016). The BAF value calculated was 6028 L/Kg 
which is much higher than the value derived in this study at the highest pH. The 
explanation could be that the authors calculated the BAF which consists of the analysis 
of the uptake of the chemical from both the surrounding medium and the diet; whereas 
in our study, the exposure from the surrounding medium only was considered. Thus, a 
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possible underestimation of the accumulation of this highly prescribed antidepressant 
in our study could have been reported. Another study investigated the bioconcentration 
of amitriptyline in a freshwater mussel Lampsilis siliquoidea and a BCF value of 253 L/Kg 
at pH 8.3 was found (Gilroy et al., 2017). The value is the same order of magnitude with 
the value reported in our study, but, we derived a higher BCF of 653 L/Kg at the same 
pH range.  
Generally, there is not much information available in the literature about the 
accumulation of amitriptyline in the invertebrates compared to fish species, particularly 
regarding sediment-dwelling invertebrates. Therefore, comparisons of our results with 
other studies are very difficult due to the fact the only studies available reported 
bioconcentration/bioaccumulation values at a single pH. In this study, we highlighted 
how pH influences the uptake confirming the general rule that the neutral fraction of a 
molecule is more bioaccumulative when compared to the ionic fraction. Therefore, we 
suggest further investigation of amitriptyline in other non-target invertebrate species, 
more specifically at different pH values. In this way, we will be able to effectively 
compare the data in order to have a more understandable picture of the environmental 
risk. 
The last compound evaluated in this study was ketoconazole. Very little research has 
been conducted on the uptake in both fish species and invertebrates. Recently, a study 
investigated the toxicokinetic of some azole fungicides including ketoconazole in 
Gammarus pulex and the BAF calculated was 9.2 L/Kg at the exposure concentrations of 
100 µg/L (Rösch et al., 2016). The result is much lower compared to the BCF obtained in 
our study that ranged between 93.04 to 211.4 L/Kg at the exposure concentration of 10 
µg/L. However, the study did not mention the tested pH which is very important to 
consider when evaluating the toxicokinetic of ionic compounds such as ketoconazole. 
Also, the difference in the BCF among the two species could be due to the different 
species traits that has been suggested by different studies in the literature (Meredith-
Williams et al., 2012; Rico and Van den Brink, 2015; Sidney et al., 2016). For example, 
the two organisms possess different habitats and metabolism. To mention some, the 
shrimp inhabits the water column mainly, while the worm is normally submerged in the 
sediment and therefore subjected to exposure from the overlying water, the pore water 
between the sediment particles and the chemicals bounded to the sediment.  
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In addition, based on its pKa (6.5), the neutrality of ketoconazole increased by 84 % 
between the lowest and the highest pH. Hence, this compound should show the most 
extreme changes in BCF compared to the other basic APIs. However, this does not seem 
the case because the BCF differed by only a factor of 2. For instance, in comparison, the 
BCF of amitriptyline differed by 15 times between pH 5.5 and 9 with an increase of the 
neutral fraction by only 30 %. This slight difference in BCF of ketoconazole could be 
explained by the hydrophobicity of the molecule compared to the other bases. The 
correlation between the bioconcentration and hydrophobicity has been well established 
in the literature (Mackay, 1982; Mackay and Fraser, 2000). Ketoconazole possesses a 
logKow of 3.78 and therefore should not be expected to be as much bioaccumulative as 
norfluoxetine (logKow = 4.16) and amitriptyline (logKow = 4.92).  
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Figure 3. 6. Uptake (0-24-h) and depuration (24-48-h) graphs of amitriptyline at multiple pHs in 
L. variegatus. Red dots represent the internal measured concentrations (pmol/g wet weight). 
The thick line is the model fit of the toxikokinetic model and the dotted lines are 95% 
prediction intervals of the model. The concentrations are based on measured activity and it is 
assumed it is the parent compound.   
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Figure 3. 7. Exposure water concentrations (pmol/mL) and 95% confidence intervals of 
amitriptyline at multiple pHs over 48 hours in L. variegatus. The concentrations are based on 
measured activity and it is assumed it is the parent compound.   
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Figure 3. 8.  Uptake (0-24-h) and depuration (24-48-h) graphs of diclofenac at multiple pHs in L. 
variegatus. Red dots represent the internal measured concentrations (pmol/g wet weight). The 
thick line is the model fit of the toxicokinetic model and the dotted lines are 95% prediction 
intervals of the model. The concentrations are based on measured activity and it is assumed it 
is the parent compound.   
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Figure 3. 9. Exposure water concentrations (pmol/mL) and 95% confidence intervals of 
diclofenac at multiple pHs over 48 hours. The concentrations are based on measured activity 
and it is assumed it is the parent compound.   
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Figure 3. 10.  Uptake (0-24-h) and depuration (24-48-h) graphs of ketoconazole at multiple pHs 
in L. variegatus. Red dots represent the internal measured concentrations (pmol/g wet 
weight). The thick line is the model fit of the toxicokinetic model and the dotted lines are 95% 
prediction intervals of the model. The concentrations are based on measured activity and it is 
assumed it is the parent compound.   
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Figure 3. 11. Exposure water concentrations (pmol/mL) and 95% confidence intervals of 
ketoconazole at multiple pHs over 48 hours. The concentrations are based on measured 
activity and it is assumed it is the parent compound.   
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Figure 3. 12. Uptake (0-24-h) and depuration (24-48-h) graphs of norfluoxetine at multiple pHs 
in L. variegatus. Red dots represent the internal measured concentrations (pmol/g wet 
weight). The thick line is the model fit of the toxicokinetic model and the dotted lines are 95% 
prediction intervals of the model. The concentrations are based on measured activity and it is 
assumed it is the parent compound.   
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Figure 3. 13. Exposure water concentrations (pmol/mL) and 95% confidence intervals of 
norfluoxetine at multiple pHs over 48 hours. The concentrations are based on measured 
activity and it is assumed it is the parent compound.   
 
 
 
API pH fneutral (%) Kin (mL g-1 wet weight h-1), 
mean + SD 
Kout (h-1), mean + SD BCF (mL/g wet weight), 
mean + LCI, UCI 
Amitriptyline 5.5 ± 0.3 0 7.27 ± 0.54 0.0498 ± 0.00544 146 (135-166.7) 
Amitriptyline 7 ± 0.3 0.3 19.55 ± 0.84 0.0456 ± 0.0029 391.4 (367.4- 
432.9) 
Amitriptyline 8 ± 0.3 4 20.83 ± 0.78 0.0320 ± 0.0022 653 (623.1-700) 
Amitriptyline 9 ± 0.3 30 27.39 ± 1.36 0.0119 ± 0.0020 2284 (2151-2497) 
Diclofenac  5.5 ± 0.3  97 14.48 ± 0.94 0.041 ± 0.0041 353.4 (326-399) 
Diclofenac 7 ± 0.3 98 6.30 ± 0.56 0.076 ± 0.0089 81.42 (71.0-101.3) 
Diclofenac 8 ± 0.3 99 1.647 ± 0.14 0.12 ± 0.0121 13.75 (12.38-
16.16) 
Diclofenac 9 ± 0.3 100 0.365 ± 0.03 0.096 ± 0.009 3.78 (3.31-4.27) 
Ketoconazole 5.5 ± 0.3 15 4.41 ± 0.40 0.0048 ± 0.0065 93.04 (83.4-110.1) 
Ketoconazole 7 ± 0.3 76 5.11 ± 0.24 0.0051 ± 0.0034 100.9 (95.2-111.3) 
Ketoconazole 8 ± 0.3 97 5.11 ± 0.25 0.0051 ± 0.0035 101.1 (95.7-110.2) 
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Table 3. 1. Mean of uptake and depuration constants (kin and kout) with standard deviations 
and mean values of BCF estimated with lower confidence interval (LCI) and upper confidence 
interval (UCI) at different pH ranges. 
 
3.3.5 General considerations  
The mechanism of uptake and depuration of APIs into sediment-dwelling invertebrates 
is poorly understood. In our study, we assumed that the main uptake pathway of the 
APIs was via the skin only through passive adsorption and that only the parent 
compound was taken up. However, inside the body, a compound is metabolized and the 
degree of metabolization depends on the physicochemical characteristics of each 
pharmaceutical such as water solubility and the organism chosen to test. In our study, 
due to the analytical method limitations, possible metabolites were not detected. 
Accounting for biotransformation products leads to a better estimation of uptake and 
depuration rates (kin and kout). In addition, metabolites have sometimes been found to 
have a greater bioaccumulation factor compared to the parent compounds (Ashauer et 
al., 2012; (Miller et al., 2017) and they could partially explain the difference in uptake of 
the four APIs into the worms. Therefore, in this study, the LSC measurements should to 
be interpreted carefully because they can under or over-estimate the total BCF due to 
the analysis of the parent compound only. More research about the possible metabolic 
pathways and metabolites resulting from the bioconcentration of APIs in non-target 
invertebrates is needed. Measuring the metabolites in non-target organisms is 
important in order to have accurate measurements of BCFs and better understand 
whether the toxicity is due to the parent compounds or the metabolites.   
 
Ketoconazole 9 ± 0.3 99 5.80 ± 0.20  0.0027 ± 0.0018 211.4 (202.6-
225.9) 
Norfluoxetine 5.5 ± 0.3 0 1.06 ± 0.005 1 × 10-7± 0.001 1.06 × 107(1 × 107-
1.19 × 107) 
Norfluoxetine 7 ± 0.3 2 14.46 ± 0.77 0.0017 ± 0.0027  870.4 (817.7-
958.9) 
Norfluoxetine 8 ± 0.3 14 39.61 ± 2.09 0.0014 ± 0.0023 2902 (2724-3209) 
Norfluoxetine 9 ± 0.3 61 43.88 ± 2.29 0.004 ± 0.0018  1.11 × 104 (1.04 × 
104-1.25 × 104) 
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3.4 Conclusions 
This study clearly demonstrated the key role of environmental parameters such as pH in 
characterizing uptake of ionisable pharmaceuticals at a laboratory scale covering a 
broad range of pH from 5.5 to 9. Amitriptyline and ketoconazole were found to be 
increasingly bioaccumulative at high pH, except norfluoxetine for which the highest BCF 
was measured at pH 5.5 and pH 9. The opposite was observed for diclofenac. Exposing 
the organisms to each API in water only, produced valuable insights into our 
understanding of the internal exposure of inveretebrates to APIs and possible potential 
toxic effects that those chemicals may pose to non-target organisms. Thus, we strongly 
recommend particular attention to pH when assessing the uptake of ionisable 
compounds into non-target organisms.  
In this study, the role of metabolism was not investigated due to the measurement of 
the concentrations by the LSC which cannot distinguish between the parent and the 
metabolic compounds. In this way, a possible under or overestimation of the BCF could 
occur. Therefore, it is advisable to consider and analyse the biotransformation products 
for better estimating BCFs.  
Finally, it is important to recognize that the present study evaluated uptake and 
depuration of only four compounds, three weak bases and one weak acid and more 
work is needed with a wider range of APIs in order to generate more quantitative data 
for a better evaluation of the risk that ionisable pharmaceuticals may cause to aquatic 
organisms. 
L. variegatus lives mainly submerged in the sediment compartment where it burrows in 
the top layer. To further investigate the processes that influence the uptake of the 
ionisable APIs into sediment-dwelling invertebrates, a better understanding of the fate 
and mobility of these APIs in the sediment compartment is necessary. Thus, in the next 
chapter, experiments to understand the sorption behaviour of these APIs in different 
sediments will be presented.  
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Chapter 4. Sorption of ionisable active pharmaceuticals in four different 
types of sediments 
4.1 Introduction 
In the previous Chapter, the importance of pH in assessing the uptake of ionisable APIs 
into sediment-dwelling invertebrates was described. However, to fully understand the 
different pathways of uptake of ionisable APIs, the fate and the sorption behavior of 
these compounds have to be assessed. Therefore, in this Chapter, the degree of sorption 
and the mechanisms that influence the sorption of APIs onto sediment particles will be 
presented.  
 
Knowledge of the sorption behvaiour of an API is essential in understanding the 
persistence of sediment-associated chemicals because it gives an indication of the 
mobility and the bioavailability of these chemicals between different compartments, for 
example, the water-sediment compartment. In addition, the bioavailable fraction of 
chemicals is important in determining the uptake and toxicity to non-target organisms. 
Once a chemical ends up in the sediment compartment, it could bind to the sediment 
particles being less available in the water column, but, still elicits negative effects to the 
sediment-dwelling organisms that are exposed via sediment particles (for example 
through ingestion of the particles) and the pore water (=interstitial water between the 
sediment particles) (Maund et al., 2002). In the surface water, pharmaceuticals may 
undergo several natural processes such as biodegradation, volatilization, hydrolysis, 
photo-degradation and sorption onto the solid matrix (Martínez-Hernández et al., 
2014a; Baena-Nogueras et al., 2017; Koumaki et al., 2017b). For instance, the fate of 
four anti-inflammatories including diclofenac was investigated in the water-sediment 
system and it was found that biotic processes such as biodegradation were the main 
processes of removal of the compound from the water-sediment phases. Baena-
Nogueras et al., (2017) studied the disappearance of many PPCPs by hydrolysis, changes 
in pH, photodegradation and biodegradation and found that while some compounds 
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were susceptible to these processes, some chemicals (carbamazepine and amitriptyline) 
were more persistent.  
For new chemicals that have to be authorized, sediment toxicity data are necessary. 
When experimental data are lacking, the Equilibrium Partition (EqP) proposed by Di Toro 
et al., (1991) is used by regulators as the first screening for sediment quality criteria. It 
provides useful data in assessing the contamination of sediment-associated chemicals. 
For neutral chemicals, the EqP states that in an equilibrated sediment system, the 
chemical sorbed to the sediment organic carbon is in equilibrium with the pore water, 
thus, the exposure of this chemical toward benthic organisms is the same regardless of 
the exposure pathway and can be predicted based on the Koc (= organic carbon-
normalized sorption coefficient) of the compound (Fig. 4.1). The EqP also demonstrated 
that water-only exposure is equal to the sediment-pore water exposure by assuming 
that the chemical activity in each system is at the equilibrium.  
 
 
Figure 4. 1. Equilibrium partitioning illustrated by di Toro et al., (1991) 
 
Typically, the sorption behavior of chemicals is described by several sorption coefficients 
such as (Kd) and the Freundlich coefficient (Kf). They describe the distribution of a 
chemical between the water and the solid phase. These sorption coefficients differ 
between different soils/sediments depending on the chemical and the sorbent; and, for 
non-polar chemicals, it has been demonstrated that the main mechanism of sorption is 
through hydrophobic interactions with the organic content of the sediment (Karickhoff 
et al., 1979; Chiou et al., 1979; Karickhoff, 1981). Therefore, Koc is often estimated with 
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linear regression analysis by using chemical descriptors, such as the LogKow , that reflects 
the hydrophobicity of the molecule (Sabljić et al., 1995; Doucette, 2003).  
Unlike neutral chemicals for which the hydrophobic interactions with the organic matter 
are the main mechanism of sorption (Delle Site, 2001); for ionisable chemicals, the 
differences in the sorption are more likely due to other mechanisms and the interactions 
between the pharmaceuticals’ physicochemical properties (LogKow, pKa) and the 
properties of the sediments (pH, cation exchange capacity, texture) (Kodešová et al., 
2015). 
Research exploring the sorption of ionisable pharmaceuticals in the sediment 
compartment has recently increased (Stein et al., 2008; Martínez-Hernández et al., 
2014; Styszko, 2016;  Al-Khazrajy and Boxall, 2016; Kiecak et al., 2019). 
For example, Styszko, (2016) investigated the sorption of several pharmaceuticals both 
acids and bases in three different sediments and found that the main mechanisms of 
interactions between the APIs and the sediments were the hydrophobic and 
electrostatic interactions. Another study by ( Al-Khazrajy and Boxall, (2016) assessed the 
sorption of five ionisable pharmaceuticals (1 acid and 4 bases) in ten types of sediments. 
The authors explored the possible sorption mechanisms involved for each compound 
and the main predictors that were likely to play a key role in determining the sorption. 
Both physicochemical and environmental predictors were identified such as LogDow, clay 
content, CEC and the organic content of the sediments. Their results also found that the 
main mechanisms of sorption for the four basic APIs were hydrophobic, electrochemical 
and hydrogen bonding interactions. The cation exchange was observed as the possible 
mechanism of sorption for the acidic compound.  
The information reported in the abovementioned studies showed the diverse and 
complex processes involved in the sorption of ionisable pharmaceuticals for which the 
hydrophobic interactions are not the only mechanism of sorption as for neutrals. While 
the study of  Al-Khazrajy and Boxall, (2016) is one of the latest in explaining some of 
these interactions, much work is needed to better understand the mobility and 
persistence of these APIs in the sediments.  
 
Some studies have proposed predictive models for estimating the Koc of neutral organic 
chemicals (Burkhard, 2000; Kipka and di Toro, 2011); however, few models have been 
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proposed for ionisable chemicals. For example, Franco and Trapp, (2008) proposed a 
model for estimating the Koc in the soil for both bases and acids separately. Specifically, 
the model accounts for the LogKow and the pKa of the chemicals which are essential 
parameters to predict sorption. However, our knowledge about the sorption processes 
that drive the partitioning of ionisable chemicals between water and sediment is still 
very limited.  
Therefore, the aim of this study was to explore the sorption behavior of two bases 
(amitriptyline and norfluoxetine) and one acid (diclofenac) in four different types of 
sediment and evaluate the influence of sediment properties on pharmaceutical 
sorption. Ketoconazole was not included in this study due to the dissipation of the API 
in the aqueous phase during the shaking.  
With this study, we aim to bring new information about the partitioning behavior of 
ionisable pharmaceuticals in sediments and consequently the mobility and the available 
fraction of these chemicals that could be taken up by sediment-dwelling organisms. In 
addition, a separate test of biodegradation for diclofenac in the sediments was 
conducted to establish whether the dissipation of the API was due to the sorption and 
not to the activity of the microorganisms. Ultimately, an evaluation of predictive 
sorption models, proposed in the literature for ionisable compounds, was carried out 
using the resulting data.   
 
4.2 Materials and methods 
4.2.1 Chemicals and reagents  
Diclofenac (CAS 15307-86-5) was purchased from American Radiolabelled Chemicals, 
Inc. (UK); amitriptyline (CAS 64-17-5) was obtained from Merck & Co (New Jersey, USA) 
and norfluoxetine (CAS 57226-68-3) was obtained from Sanofi (Paris, France). Test 
chemicals were all 14-C labelled and they were selected to represent different 
physicochemical properties (see Table 1.2 in Chapter 1). Stock solutions were prepared 
in ethanol and stored at -20  ̊C. Calcium chloride was obtained from Sigma Aldrich (UK). 
Centrifuge PTFE tubes were purchased from Oak Ridge by Nalgene Nunc International.  
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4.2.2 Sediments sampling and characterization 
Four sediments were collected in different rivers of England: Millington Beck (Millington, 
53.967063,-0.718046), River Dove (Barnsley, 53.527113,-1.445819), Farndale Brook 
(Yorkshire Moors, 54.370489,-0.968043) and River Foss (Earswick, 54.007509,-
1.060050). The sediments were sampled and sieved through a 2 mm sieve and stored at 
4 ºC. The sediments were then dried at 25 ± 1 °C. The chosen locations were selected 
based on previous information about the sediment properties from other studies and 
the accessibility to the site. The characterization of the sediments was carried out by the 
Forest Research (https://www.forestresearch.gov.uk/, Surrey, UK) for the following 
properties: pH (ISO 10390), Total Organic Carbon (TOC) (ISO 10694), Cation Exchange 
Capacity (CEC) (ISO 11260) (1994) and texture (Table 4.1). 
4.2.3 Sorption studies 
Sorption studies were carried out following the OECD guideline 106 “Adsorption-
Desorption using a batch Equilibrium method” (OECD, 2000). The study consisted of an 
intial preliminary study in order to determine: 
 
• the best solution/sediment ratio; 
• the equilibration time and the amount of each API absorbed to the sediment at 
equilibrium; 
• the stability of the chemical and potential absorption to the test vessels.  
 
The main study was then performed to generate the sorption isotherms and to obtain 
the sorption coefficient of the tested APIs in the four sediments.  
In the preliminary experiments, different sediment/solution ratios were tested for each 
API and sediment. Air-dried sediment (0.2 g, 0.4 g, 0.5 g and 1 g) was placed into test 
tubes and mixed with 3 mL, 5 mL and 40 mL of 0.01M of CaCl2 overnight before spiking 
the pharmaceutical. Solution/ratios of 1:1, 1:5, 1:40 1:80, 1:100 and 1:200 were chosen. 
After 24 hours of shaking, chemicals were spiked at a concentration of 10 µg/L and the 
tubes were placed on the shaker in the control chamber at 20 ºC ± 2 for 24 hours, 48 
hours and 72 hours to assess the optimum time that is required for the API to reach an 
equilibrium between the sediment and the solution. Norfluoxetine studies were done 
 79 
 
at 4  ̊C using glass jars. The use of the glass jars was necessary due to the absorption of 
the API of over 30 % to the surface of the PTFE tubes during the experiments to observe 
the stability of the compound. Duplicate tubes per each sediment, time and 
solution/ratio were chosen. Controls containing 0.01M of CaCl2 and the test chemical 
were added to check the stability of the compounds and possible adsorption to the test 
vessels. To avoid photolysis, the entire test was run in the dark and the test tubes kept 
in a sealed container. The velocity of the shaker was set at 250 rpm. 
At sampling, 1.5 mL of the supernatant was collected and pipetted into a 
microcentrifuge tube (VWR) and centrifuge for 5 minutes at 3500 rpm using a Micro Star 
12 microcentrifuge (VWR). Then, 1 mL of the supernatant was collected for analysis and 
mixed with 10 mL of Ecoscint A (NationalDiagnostics). The measurements were 
conducted with a Liquid Scintillation Counter (LSC) from HIDEX 300SL. Samples were 
analyzed three times for 5 minutes and corrected for background activity using blank 
controls. The counting efficiency and color quenching were corrected using the external 
standard ratio method.   
 
4.2.4 Main study 
The main study was performed in order to determine the sorption coefficient of each 
API in the four sediments. The same conditions described above were used and are 
summarized in Table 4.2. Five different concentrations were chosen in order to generate 
the sorption isotherms and triplicates test tubes were used along with controls and one 
blank per sediment. The measurements of the samples were carried out using the same 
methodology as described above. Sorption isotherms were fitted to derive Kd using 
either the linear isotherm method and Kf (Freundlich coefficient) using the Freundlich 
isotherm methods.  
The mass of the API absorbed to the sediment was determined by calculating the 
difference in concentration between the initial (Ci) and the concentration in solution at 
sampling time (Caq) (Equation 1) 
 
                                                 Cs= (Ci –Caq) × V / ms                                                Equation  1 
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V is the volume in the test tubes (L), Ci is the initial concentration of the compound; Caq 
is the concentration of the API in the aqueous solution at the end of the sorption test 
and ms is the mass of the sediment (Kg).  
Then, the sorption isotherms were derived by using the linear and the Freundlich 
coefficients, respectively Kd and Kf.  
In addition, the organic carbon-normalized sorption coefficient (KOC) was calculated by 
using the Kd value as shown in the following Equation 2: 
 
                                                       Koc = Kd / ƒOC × 100                                           Equation   2 
Where ƒOC is the fraction of the organic content (%).  
4.2.5 Biodegradation experiments 
Diclofenac is known to be biodegradable (Koumaki et al., 2017b), thus, in order to check 
whether its dissipation was due to sorption and not to the biodegradation, an additional 
equilibrium time experiment of diclofenac was carried out using sterilized sediments. 
Triplicates of sediments were autoclaved at 121 °C for 45 minutes (Dodgen et al., 2014). 
During the sterilization process, some main characteristics of the sediments such as pH 
and Total carbon (TC) may have been changed. Therefore, triplicates of sterilized 
sediments were analyzed to determine their total carbon and pH and the results 
compared to the unsterilised air-dried sediments. The pH was assessed following the 
ISO 10390:2005, using a 1: 5 v/v of sediment and 0.01M of CaCl2. The determination of 
the TC was carried out by the C/N analyzer (Vario Macro Elementar). Statistical analysis 
using a Kruskal-Wallis test was performed to compare the samples.  
4.2.6 Evaluation of predictive models 
The model developed by Franco & Trapp, (2008) was evaluated. The model predicts the 
LogKoc of chemicals and we calculated the Koc for each API and sediment for acids 
(Equation 3) and bases (Equation 4) separately.  
 
LogKoC = Log[ϕn × (100.54 × logKow + 1.11 )]+ [ϕion × (100.11 × logKow + 1.54 )]      Equation    3 
LogKoC = Log[ϕn × (100.37× logKow+ 1.70 )]+ [ϕion × (10pka 0.65 × logKow + ƒ0.14)]    Equation   4 
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Where: LogKow is the octanol-water partition coefficient; pKa is the dissociation constant; 
ƒ is the diffusion limiting factor and it is calculated as Kow / (Kow + 1); ϕn and ϕion are the 
fraction of the neutral and ionised part of the chemical and they were calculated using 
Equation 5 and 6 below: 
 
                                          ϕn = 1/  1 + 10a (pH -pKa)                                                   Equation  5 
                                                 ϕion = 1 – ϕn                                                            Equation  6 
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Properties Millington Barnsley Moors Earswick 
Silt (%) 54 24 12 4 
Sand (%) 23 58 78 91 
Clay (%) 23 18 10 5 
pH (H2O) 7.31 7.52 6.43 7.78 
TOC (%) 6.576 14.260 0.787 0.782 
CEC (cmol+/Kg) 28.772 26.257 5.312 6.221 
Tot Al3+ (mg/Kg) 1 1 2 0 
Tot Fe2+ (mg/Kg) 1 0 0 0 
Tot Ca2+ (mg/Kg) 5482 3064 728 1083 
Tot K+ (mg/Kg) 131 115 47 50 
Tot Mg2+ (mg/Kg) 95 223 146 63 
Tot Na+ (mg/Kg) 38 1662 18 19 
Tot Mn2+ (mg/Kg) 31 440 71 24 
Table 4. 1. Properties of the four sediments used in the sorption studies.  
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Table 4. 2. Summary of the laboratory conditions for the sorption study (OECD 106) of the three pharmaceuticals.
         
         
         
         
Compound Experiment 
concentrations 
(ug/L) 
Equilibrium 
time (h) 
Temperature 
(  ̊C) 
Millington 
solution/ratio 
(w/vol) 
Earswick 
solution/ratio 
(w/vol) 
Moors 
solution/ratio 
(w/vol) 
Barnsley 
solution/ratio 
(w/vol) 
Test 
vessels 
Amitriptyline 2, 5, 8, 11, 15 24 and 48 
for Moors 
20 1:200 1:40 1:100 1:200 centrifuge 
PTFE tubes 
Norfluoxetine 2, 5, 8, 11, 15 24 4 1:200 1:40 1:80 1:200 glass jars 
Diclofenac 2, 5, 8, 11, 15 24 20 1:5 1:1 1:5 1:5 centrifuge 
PTFE 
tubes 
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4.3 Results and discussion 
4.3.1 Preliminary studies 
In accordance with the OECD guideline 106, preliminary equilibrium time experiments 
were carried out for 48-h for diclofenac and 72-h for amitriptyline and norfluoxetine 
(Fig. 4.2). The three compounds reached the equilibrium between the sediment and the 
water within 24-h from the beginning of the test with the exception of amitriptyline in 
the Moors sediment. In this latter case, the API reached equilibrium within 48-h (Table 
4.2).   
In addition, a slight decrease in the sorption was noticed for diclofenac in the Barnsley 
sediment after 24-h. A possible explanation for the decline could be due to 
biodegradation. The sorption studies were carried out with air-dried sediments in order 
to maintain the sediment’ properties. Hence, the decreased sorption of diclofenac 
during the test was probably due to the activity of the microorganisms present in the 
sediment. Different studies have demonstrated the dissipation of diclofenac via 
biodegradation by the microbial community of the water/sediment systems (Kunkel and 
Radke, 2008; Koumaki et al., 2017). Therefore, an additional equilibrium test using 
autoclaved sediments was carried out to evaluate whether the presence of the 
microorganisms could be the factor responsible for the decrease in the sorption of the 
compound (Fig. 4.3). For this purpose, the sediments were autoclaved at 121 °C for 45 
minutes and the main sediments’ properties such as pH and Total Carbon were assessed 
by comparing the results with air-dried sediments (Figures C.1 and C.2). As can be seen, 
pH and Total Carbon showed no significant difference between the sediments treated 
in the autoclave and the sediments dried at 25 °C (0.1 < p-value < 0.8). By evaluating the 
sorption capacity of diclofenac in the autoclaved sediments (Fig. 4.3) and comparing the 
results with the air-dried sediments (Fig. 4.2), diclofenac was concluded to be stable and 
therefore we concluded that the activity of the microorganisms was negligible.  
The optimum sediment/solution ratios are shown in Table 4.2. The ratios were chosen 
based on the criteria set up by the OECD 106 for which the sorption of the test substance 
should be preferably above 50 % and the concentration of the test substance in the 
water phase should be detectable by the analytical method.      
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Figure 4. 2. Sorption behaviour of the three APIs using air-dried sediments over 48-h for 
diclofenac and 72-h for amitriptyline and norfluoxetine.  
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Figure 4. 3. Sorption behaviour of diclofenac using autoclaved sediments over 72-h. 
 
4.3.2 Main studies 
Along with the sediment beakers, the stability of each API was monitored throughout 
the duration of the test by measuring the controls. For all the APIs, the final 
concentration was measured and compared with the initial spiked concentrations. For 
diclofenac more than 95 % (µ = 96.4, σ = 2.5) of the remaining API was detected in the 
water;  for amitriptyline more than 90 % (µ = 92.5, σ = 4.7) and for norfluoxetine more 
95 % (µ = 96, σ = 4) was detected in the water phase after 24 h suggesting low 
degradation or absorption of the pharmaceuticals on the surface of the test tubes. 
 
The Kf and the Koc coefficients were obtained by plotting the Linear and the Freundlich 
isotherms ( Figure 4.4 and 4.5). The Linear (R2 = 0.678-0.995) and the Freundlich models 
(R2 = 0.542-0.998) all adequately described the sorption of the three APIs at the 5 
different concentrations (Table 4.3). The lowest R2 calculated was for diclofenac in the 
Earswick sediment, 0.678 and 0.542 respectively for the two isotherms. Also, the 1/n 
parameter was reported (Table 4.3). This parameter shows the linearity of the model 
when the slope (n) is > 1; however, the n ranged between 0.462 and 0.826 
demonstrating the non-linearity of the sorption isotherm with the data.   
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Figure 4. 4. Linear isotherms of the selected APIs in the sediments. Initial concentration ranged 
between 2 to 15 µg/L. Points represent the mean of three replicates. 
 
 
-1.5 -1.0 -0.5 0.0 0.5 1.0
1
2
3
4
Amitriptyline
Log Caq (g/L)
L
o
g
 C
s
 (

g
/K
g
)
-1.5 -1.0 -0.5 0.0 0.5 1.0
1
2
3
4
Norfluoxetine
Log Caq (g/L)
-1.0 -0.5 0.0 0.5 1.0
0.5
1.0
1.5
2.0
Diclofenac
Log Caq (g/L)
Moors
Barnsley
Millington
Earswick
Freundlich equation
 
Figure 4. 5. Freundlich isotherms of the selected APIs in the four sediments. Initial 
concentration ranged between 2 to 15 µg/L. Points represent the mean of three replicates. 
 
 
The Kf and Koc of diclofenac, amitriptyline, and norfluoxetine are shown in Figure 4.6. 
The sorption coefficient (Kf) for Moors sediment increased in the following order 
diclofenac < norfluoxetine < amitriptyline; for Millington, Barnsley and Earswick in the 
order of diclofenac < amitriptyline < norfluoxetine. The Kf value ranged from 2.07 (L/Kg) 
for diclofenac to 1681.12 (L/Kg) for norfluoxetine.  
Regarding the KOC, it increased in the order diclofenac < amitriptyline < norfluoxetine in 
the four sediments and it ranged from 41.8 (L/Kg) for diclofenac to 48131 (L/Kg) for 
norfluoxetine. A table that summarizes all the values is provided in Table 4.3. The pH of 
the sorption experiments was recorded (Fig. C.3) and this was found to be slightly acidic 
for Moors (5.52-6.16) while slightly alkaline for the rest of the sediments (6.87-7.62). 
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Figure 4. 6. Logarithmic Kf and Koc values of the three APIs in the four types of sediments. The 
bars represent the mean of three replicates and the error bars represent the standard 
deviations. 
 
 
 
Table 4. 3. Comparisons of the Kd and Koc measured for pharmaceuticals in the different 
sediments.  
 
 
Sediment Compound Linear Freundlich 
Kd L kg-1 
(±SD) 
Koc (±SD) 
 
R2 KF 
µg 1-1/n 
(cm3 ) 1/n 
g-1 
1/n R2 
Moors Amitriptyline 243.5(±12.9) 30946.6(±1668.8) 0.756 510.4 0.641 0.952 
Diclofenac 5.46(±0.9) 694.7(±118.6) 0.99 14.4 0.751 0.944 
Norfluoxetine 378.7(±48.2) 48131(±6124.9) 0.994 498.7 0.774 0.998 
Millington Amitriptyline 848.3(±131.2) 12901(±1996) 0.934 1315.2 0.741 0.989 
Diclofenac 11.1(±0.6) 169.2(±10.0) 0.985 22.7 0.569 0.995 
Norfluoxetine 1318.5(±5) 20050(±489) 0.983 1673.01 0.826 0.978 
Barnsley Amitriptyline 833.7(±9.4) 5846.5(±66.4) 0.936 1489.4 0.529 0.994 
Diclofenac  5.96(±1.05) 41.8(±7.4) 0.985 9.75 0.798 0.997 
Norfluoxetine 1348.3(±24.3) 9455.1(±376.9) 0.995 1681.1 0.703 0.996 
Earswick Amitriptyline 49.7(±2.5) 6365(±328.1) 0.972 86.4 0.7934 0.992 
Diclofenac 0.47(±0.09) 60.3(±11.3) 0.678 2.07 0.462 0.542 
Norfluoxetine 87.5(±5.3) 11191(±688.9) 0.962 169.2 0.682 0.993 
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Comparing the results with the literature, the Kd and Kf values of amitriptyline in our 
study are approximately in the same range of the values reported by Al-Khazrajy & 
Boxall, (2016a) which were 8.78- 247.9 and 39.81-950.9 (L/Kg) respectively.  
For norfluoxetine, sorption studies were only found for fluoxetine which is the parent 
compound. For example, Kwon and Armbrust, (2008) analysed the sorption behaviour 
of five selective serotonin reuptake inhibitors (SSRIs) including fluoxetine in two 
sediments. The authors reported high Kd and Kf values ranging from 785-1304 and 229-
419 (L/Kg), close to those reported in our study (Kd 87.51-1348; Kf 169-1681, L/Kg).  
On the other hand, sorption coefficients of diclofenac were much lower compared to 
the two bases amitriptyline and norfluoxetine. Even though diclofenac has a predicted 
LogKow of 4.51, from previously reported studies where the sorption behavior of 
diclofenac has been characterized in sandy sediments, Kf values were reported to be low, 
ranging from 0.81 to 7.81 (L/Kg) (Scheytt et al., 2005). Similar findings have been 
reported by Le Guet et al., (2018) where low sorption coefficients (Kd and Kf) have been 
measured in the sediment: 9.9 and 7.5 (L/Kg) respectively.   
 
The differences in pharmaceuticals sorption behavior are likely due to the different 
sediments properties and their interaction with the physicochemical properties of the 
pharmaceuticals. 
For example, the highest Kf value for amitriptyline was observed for Millington and 
Barnsley sediments, 1315.2 and 1489.4 (L/Kg) respectively. In contrast, lower Kf values 
for Moors (510.4, L/Kg) and Earswick (86.34, L/Kg) were seen for these compounds. 
Differences in the sorption behavior of amitriptyline in Millington and Barnsley 
sediments compared to Moors and Earswick are likely due to the high organic content 
of the first two sediments. Al-Khazrajy and Boxall, (2016) previously suggested that 
hydrophobic interaction with the organic matter is the main mechanism of sorption for 
amitriptyline. In addition, they measured a sorption coefficient of 186.21 (L/Kg) for the 
Millington site while in this study, a higher sorption coefficient was measured. 
Differences in the measurements may be due to the different sampling season of the 
sediments which could potentially slightly change the environmental properties of the 
sampled sediment. In addition, a second mechanism of sorption was suggested between 
the cationic form of the API and the sediment through cation exchange interactions (Al-
Khazrajy and Boxall; 2016; Bagnis et al., 2018).  
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The sorption behavior of norfluoxetine is similar to amitriptyline with Millington and 
Barnsley sediments having the greatest Kf values as well as Koc. Both APIs are bases 
possessing similar LogKow values (4.92 for amitriptyline and 4.16 for norfluoxetine) 
suggesting a potential strong hydrophobic interaction with the organic content present 
in the sediments.  
 
For norfluoxetine, in the Earswick sediment, the influence of pH might partially explain 
the low sorption behavior of the two bases. For example, a sorption study of three basic 
antimicrobial agents on two types of soils found low sorption coefficients at high pH (ter 
Laak et al., 2006). Here, low Kf values in Earswick sediments were observed (86.34 L/Kg 
for amitriptyline and 169.28 L/Kg for norfluoxetine) where the pH measured of the 
sediment was alkaline (7.78). The influence of pH in determining the sorption behavior 
of fluoxetine was explained also by Kwon and Armbrust, (2008). The authors found a 
strong correlation between the pH and the sorption of five SSRIs, including fluoxetine, 
in two sediments and three soils. They suggested that a possible ionic binding between 
the positive API and the sediment could explain the mechanism of sorption.  
In the Moors sediment, the Kf values of the two basic compounds was almost equal (e.g. 
510.4 L/Kg for amitriptyline and 498.74 L/Kg for norfluoxetine). At the experimental pH 
(6.09-7.69), both the APIs were 100% ionic due to their pKa values; which means that 
they were present in their cationic form and a possible interaction between the positive 
functional group and the sediment may have occurred. In fact, previous studies 
highlighted the contribution of the amine groups on the possible mechanism of sorption 
of the positively charged compounds (Martínez-Hernández et al., 2014b; Bagnis et al., 
2018). 
 
Significant variation in sorption on the four sediments was observed also for diclofenac. 
The Kf coefficient increased in the following order: Earswick < Barnsley < Moors < 
Millington.  The reason may be due to the presence of the anionic form of the API in the 
sediment-water solutions during the batch sorption experiments. In fact, diclofenac has 
a pKa of 3.9 and the majority of the compound is negatively charged in the pH range of 
the experiments (6.09-7.69). Thus, a possible electrostatic repulsion by the anions 
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present on the sediments surface may partially explain the low sorption behavior of this 
compound (Scheytt et al., 2005; Krascsenits and Hiller, 2008).  
4.3.3 Evaluation of predictive models 
The evaluation of the Franco and Trapp, (2008) model for estimating the Koc resulted in 
different prediction scenarios (Fig. 4.7). For amitriptyline a slight under-prediction for 
the Millington sediment was observed as well as the Moors sediment with the measured 
data being two times higher than the predicted values. In the Earswick sediment, a slight 
over-prediction is seen but it is worth noting that for the Barnsley sediment almost equal 
results between the predictions and the observed data were found. Regarding 
norfluoxetine, the model under-predicted the measured data for the Moors and 
Millington sediments, whereas, good predictions for the Eraswick and Barnsley 
sediments were observed. On the contrary, for diclofenac generally Koc predictions 
higher than the measured values were observed.  
 
The same model has been evaluated by Al-Khazrajy and Boxall, (2016) and the authors 
found that the model generally overestimated the sorption of the bases and under-
estimated the sorption of the acids. The scenario of our study showed the opposite 
results. The model was able to predict quite well the bases but not the acidic diclofenac. 
The estimation of the Koc for acids included in the model the LogKow as the sole 
descriptor. This descriptor is important for neutral compounds for which hydrophobic 
partitioning with the organic matter has been recognized but it may not be appropriate 
for ionisable acids for which the best predictor for estimating sorption was found to be 
the LogD (=pH-corrected octanol-water partition coefficient) (Kah and Brown, 2007).  
On the other hand, the model worked quite well for the bases and especially for 
amitriptyline. The slight under-prediction observed in our study for norfluoxetine was 
observed also by Karlsson et al., (2013). In order to predict the sorption of basic 
compounds, the model accounts for the logKow and the pKa of the chemical. These two 
parameters as the only predictors for estimating the sorption of basic compounds may 
not be enough; in fact, it is well known that additional sorption processes such as cation 
exchange are an important mechanism of interaction that should be accounted 
(Schaffer et al., 2012).  
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Figure 4. 7. Comparison of the predictive and measured data for estimating the Koc using the 
Franco and Trapp, (2008) model for the study APIs in four sediments. 
 
4.4 Conclusions 
The dissipation of emerging environmental contaminants in surface water and 
sediments is due to different processes such as photodegradation, volatilization, 
biodegradation and sorption. In the present study, some of these processes were 
evaluated such as sorption of three APIs in the sediment compartment and the sorption 
coefficients Kf and Koc were derived. The biodegradation experiment was limited to 
diclofenac only. Comparing the sorption results, differences between the sorption 
coefficients for the three APIs were seen. These differences are likely due to the 
interaction of the sediment properties (e.g. organic content, pH, etc.) with the 
physicochemical properties of the APIs (pKa and LogKow).  
In general, this study showed that the sorption behavior of two basic APIs amitriptyline 
and norfluoxetine on two sediments containing high organic content (Millington and 
Barnsley) was driven mainly by the interaction with the organic content. Conversely, for 
Earswick, the sorption behavior could be explained by the pH of the sediment, while 
Moors by the interaction of the positive charges of the two APIs with the surface of the 
sediments. 
For diclofenac that is acidic at the testing pHs, the interaction between the anionic 
particles on the surface of the sediments and the anionic API could describe the 
mechanism of sorption. 
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Lastly, a predictive model for estimating the Koc of ionisable chemicals was evaluated 
that it resulted in quite satisfactory predictions for the basic compounds and in 
particular for amitriptyline.  
Furthermore, the study highlighted the complexity in describing the processes that drive 
the sorption of APIs in sediments and more research is needed with more 
pharmaceuticals to fully understand what influence the sorption of ionisable 
compounds.  
 
The experiments of this Chapter highlighted the distribution of the studied APIs to four 
different types of sediments possessing diverse properties. Knowing the fraction of the 
API that is bound to the sediment is essential in order to assess the free fraction of the 
compound that is more likely to be taken up by non-target organisms such as the worm 
Lumbriculus variegatus that lives in this compartment. Therefore, in the next Chapter, 
these sediments will be used to investigate the sediments’ properties that may influence 
the uptake of ionisable APIs into the sediment-dwelling worm L. variegatus.  
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Chapter 5. Influence of sediment properties on the uptake of ionisable 
APIs into the sediment-dwelling invertebrate Lumbriculus variegatus 
5.1 Introduction 
In the previous Chapters, the fate of the APIs in the study sediments and the uptake into 
sediment-dwelling worms from the water column were assessed. This chapter builds 
upon the findings of the previous chapters to explore the uptake of APIs from sediment 
into lumbricids. 
In the past decade, different classes of pharmaceuticals have been frequently detected 
in sediments (Vazquez-Roig et al., 2010; Silva et al., 2011; Al-Khazrajy and Boxall, 2017).   
Once a chemical is bound to the sediment particles, it could be taken up into benthic 
invertebrates. Consequently, sediments are both a sink and a source of pharmaceuticals, 
settling on the bottom of the water column of rivers and lakes and then potentially 
moving into sediment-dwelling organisms (Liebig et al., 2005; Henderson et al., 2010; 
Camacho-Muñoz et al., 2013). The three main routes of exposure to sediment-dwelling 
invertebrates such as Lumbriculus variegatus are: from the sediment particles 
themselves; the water overlying the sediment and the interstitial water present 
between the sediment particles (Gilroy et al., 2012). Therefore, concerns over the 
impact of sediment-associated chemicals on benthic organisms have started to be 
assessed (Dussault et al., 2008; Egeler et al., 2010; Lucero et al., 2015; Nieto et al., 
2017a). Different responses have been investigated such as reductions in growth, 
emergence, survival as well as oxidative stresses such as increased damage to the DNA 
(Lucero et al., 2015). For example, recently a study conducted by Nieto et al., (2017) on 
Chironomus riparius with two APIs (diclofenac and carbamazepine) found that the 
midges showed a decrease in growth and changes in sex ratio after 10 days of exposure 
at relatively low concentrations of the two chemicals (30 µg/g).  
The combination between chemical and sediment properties and organisms traits is 
important in determining the uptake into benthic invertebrates (Leppänen and 
Kukkonen, 2000; Mäenpää et al., 2008; Slootweg et al., 2010; Meredith-Williams et al., 
2012; Du et al., 2015; Karlsson et al.,  2016). For instance, sediment properties are 
important for determining the bioavailability of many pollutants because they regulate 
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their fate and presence in the water-sediment column, consequently, they affect the 
bioaccumulation potential to non-target organisms living in this column. For example, 
the organic carbon and pH of sediment have been recognized as important 
environmental properties in regulating the sorption and retention of APIs in the 
sediment systems (Al-Khazrajy and Boxall, 2016). Another study by Maënpaä¨ et al.,  
(2003) exposed C. riparius and L. variegatus to three pesticides spiked in four sediments 
and found an inverse relationship between the bioconcentration factor of the pesticides 
and the organic matter of the sediments suggesting that the organic material had a 
pronounced effect on the bioavailability of the chemicals potentially accumulated by the 
organisms. Also, the authors suggested that other sediment properties such as texture 
affected the accumulation of the chemicals in the organisms.  
Previous studies have demonstrated that the uptake of chemicals could differ among 
different test organisms due to different biological traits (e.g. different habitat, 
ingestion, metabolism and sediment contact) (Meredith-Williams et al., 2012; Rubach 
et al., 2010; Rubach et al., 2012; Sidney et al., 2016; Carter et al., 2016a). For example, 
Meredith-Williams et al., (2012) evaluated the difference in the bioconcentration factor 
(BCF) of a range of pharmaceuticals in freshwater invertebrates: the shrimp Gammarus 
pulex, the insect Notonecta glauca and the snail Planobarius corneus. The observed 
differences in the BCFs between the species were likely due to the diverse biological 
traits such as the mode of respiration and habitat. Furthermore, Sidney et al., (2016) 
exposed four freshwater benthic invertebrates (C. riparius, H. Azteca, L. variegatus and 
S. corneum) to polychlorinated biphenyls (PCBs) in sediments and found that the species 
traits explained differences in bioaccumulation among the organisms. For instance, H. 
Azteca was found to have the greatest BSAF probably due to the habitat. H. Azteca lives 
mainly in the water column and the authors suggested that the shrimp was primarily 
exposed to the contaminants present in the water compared to the other organisms 
that lived in the sediment such as L. variegatus. 
The idea of combining physicochemical properties of the APIs and environmental 
parameters is essential in understanding how APIs are taken up by non-target organisms 
and to what extent they may elicit adverse effects on them. Research exploring the 
combination of these properties has increased lately. However, our current knowledge 
regarding the uptake of pharmaceuticals from the sediment compartment is still very 
limited in particular for ionisable APIs. Recently some research has assessed the uptake 
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of ionisable APIs into sediment-dwelling worms (Karlsson et al., 2016; Karlsson et al., 
2017). Experiments involving exposure of lumbricids to diclofenac, fluoxetine and 
triclosan revealed that the worms accumulated the APIs to a different extent due to the 
ionisation of the compounds and their hydrophobicity (Karlsson et al., 2016). In the 
second study, the authors proposed a novel modelling approach to estimate the internal 
concentrations of ionisable APIs from sediment studies. They exposed the worms to 
different environmentally relevant concentrations of diclofenac, fluoxetine and triclosan 
at pH values ranging from 5.5 to 8.5. The model accounts for the ionized and unionized 
species of the chemical and it assumes that the exposure of the worms to the chemicals 
derived from the pore water. This is based on the EqP theory for which,  at equilibrium, 
the pore water exposure of chemicals bound to the sediments is assumed to provide the 
same exposure as the water-only exposure (Di Toro et al., 1991). The authors observed 
47 and 37-fold difference in the internal concentrations of the lumbricids at the highest 
and lowest pH for these two compounds.  
However, the study did not consider other environmental properties of the sediments 
that could influence the uptake such as the organic carbon. The last two mentioned 
studies have attempted to cover the gap between sediment uptake studies, particularly 
with sediment dwellers and ionisable APIs for which our knowledge is still very limited 
compared to fish species and other aquatic invertebrates. In respect to other aquatic 
invertebrates such as Daphnia magna or Gammarus pulex, there are not much data 
available in the literature regarding the uptake of ionisable APIs into L. variegatus. 
Exploring the effects of sediment characteristics that could potentially influence the 
accumulation of APIs in the worms will allow us to better estimate the internal exposure 
and thus the toxicity that these chemicals may have to the organisms and ultimately 
provide a better interpretation of the sediment bioaccumulation experiments.  
Benthic organisms such as L. variegatus are important organisms dwelling in the 
sediment and Lumbriculus is one of the most common species used in bioaccumulation 
laboratory tests to assess xenobiotics (Maënpaä¨ et al., 2003). Besides, oligochaetes are 
the prey of fishes thus, a trophic transfer could occur. They have been also found to 
bioaccumulate pharmaceuticals to a greater extent than higher trophic species in the 
food chain (Lagesson et al., 2016).  
Therefore, the main aim of this study was to evaluate the uptake and the depuration of 
three ionisable APIs (amitriptyline, norfluoxetine and diclofenac) in the sediment-
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dwelling worm L. variegatus and to understand the degree of influence of sediment 
properties along with the physicochemical characteristics in determining the uptake. 
The results will give valuable insight in describing the difference in bioaccumulation of 
three ionic APIs in small invertebrates inhabiting the sediment. In addition, the results 
will bring new data for a better evaluation of the risk of benthic invertebrates.   
 
5.2 Material and methods 
5.2.1 Test organisms 
L. variegatus were cultured as described in Chapter 3. One week before the beginning 
of the test, the organisms were transferred to small aquaria containing sediment 
(approx. 4 cm) and the APW for the acclimatization. The sediment was the same used 
to run the sorption experiments.  
 
5.2.2 Test sediments 
The sediments chosen for the experiments were the Moors and Barnsley sediments 
which were sampled from different locations in England.  Their properties are fully 
described in Chapter 4.   
 
5.2.3 Test chemicals 
Radiolabelled 14-C amitriptyline (CAS 64-17-5), 14-C diclofenac (CAS 15307-86-5) and 
14-C norfluoxetine (CAS 65277-42-1) were obtained from different suppliers as 
described in Chapter 3. All the radiochemicals were dissolved in ethanol and stored at -
20 °C while the dosing stocks were prepared in APW the day before the beginning of the 
test in order to avoid any degradation of the compound.  
PTFE centrifuge tubes were purchased from Oak Ridge by Nalgene Nunc International. 
Soluene-350 and Hionic Fluor were purchased from PerkinElmer 
(http://www.perkinelmer.com) and Ecoscint A from National Diagnostics  
(https://www.nationaldiagnostics.com). The solvents used in the extraction methods 
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were: methanol (HPLC grade, purity ≥99.9%); acetonitrile (≥ 99.9%); HLPC water and 
H3PO4 (ACS reagent, ≥ 85%) were all purchased from Sigma Aldrich (UK). 
pH measurements were taken every 12 hours using a Mettler Toledo 51343104 InLab pH 
probe.  
 
5.2.4 Evaluation of extraction methods for the test compounds from sediment 
A range of potential solvents were assessed for the suitability for extracting the test 
materials from sediments. The six solvents chosen for evaluation of their suitability for 
use in extractions were: MeOH, ACN, 7:3 (v/v) ACN/H2O; 0.1% H3PO4 MeOH, 0.1% H3PO4 
ACN and 0.1% H3PO4 7:3 (v/v) ACN/H2O. For each assessment, triplicate PTFE tubes 
containing 3 g dw of sediment were spiked with approximately 0.010 MBq of each API. 
The tubes were then shaken in the dark for an hour to properly mixed the API with the 
sediment at 300 rpm. After that, the ethanol was left to evaporate for an hour and the 
extractions were then carried out. Test solvent (10 ml) was added to the tubes which 
were then left to shake in the dark for 1 h at 300 rpm. The samples were then centrifuged 
for 10 minutes at 2500 rpm and the solvent removed. The procedure was repeated twice 
and the solvent phases were pooled prior to the analysis. 
Analysis of the extracts was carried out by LSC with 1 ml of the sample being taken and 
mixed with 10 ml of Ecoscint A (National Diagnostic).  
Ultimately, the solvent extraction method that had the best recovery for each API and 
sediment was validated using triplicates samples at three concentrations of 0.075 µg/g, 
0.15 µg/g and 0.225 µg/g.  
 
5.2.5 Toxicokinetic experiments 
Toxicokinetic experiments followed the same design as used by Karlsson et al., (2016). 
Briefly, the system consisted of 3 g dw of sediment and 15 ml of APW. Each API was 
spiked into the sediment to give a final concentration of 10 µg/g in the water phase. 
Vessels were then left to allow the test chemical to equilibrate between the overlying 
water and the sediment by shaking overnight at 300 rpm. After the equilibration time, 
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the tubes were positioned upright and the sediment was left to settle before adding the 
worms.  
Twelve tubes containing 3 worms each were used during the uptake phase and six of 
these were sampled at 12 h and the remainders at 24 h. A further 12 tubes were set up 
to explore the depuration of the test chemical. Worms were exposed in these to the test 
chemical for 24 h after which time they were transferred to new tubes containing 
sediment. Six of these tubes were removed at 36 h after the start of the study and the 
remaining tubes were removed at 48 h. 
Stability beakers without the worms and sediment controls (= tubes containing 
sediment, APW and worms with no API) were also prepared.  
Exposures were performed at 20 °C in the dark to avoid photodegradation of the API. 
pH was measured with a Mettler Toledo 51343104 InLab pH probe.  
At each time point, the worms were taken with a spatula and transferred in beakers 
containing 15 ml of APW for 6 h to purge their guts (Mount et al., 1999). After 6 h, they 
were rinsed in water, dried on a tissue, weighted on a balance to measure the dry weight 
and frozen at -20  °C.  
For the analysis, worms were dissolved in 2 ml of Soluene 350 (Perkin Elmer) overnight 
and then 10 ml of Ionic Fluor (Perkin Elmer) was added and the vials were ready to be 
analyzed by the LSC.  
 
After the removal of the organisms from the tubes, the overlying water and sediment 
were centrifuged for 10 minutes at 3000 rpm and 1 ml of the water was taken in order 
to analyze the concentration of the API freely dissolved in the water column. The water 
was mixed with 10 ml of Ecoscint A, the pH was measured and the remaining water in 
the test tubes was disposed of.  
Lastly, the sediment extraction was carried out by adding 10 ml of extraction solvent 
and shaking the tubes for 1 h at 300 rpm. Amitriptyline and norfluoxetine were extracted 
with 0.1 % H3PO4 7:3 ACN/H2O for both sediments, while diclofenac with 0.1 % H3PO4 
7:3 ACN/H2O for Moors and 7:3 ACN/H2O for Barnsley. The samples, after the shaking, 
were centrifuged for 5 minutes at 3000 rpm and the solvent was transferred to a glass 
vial. The operation was repeated twice and the solvents were pooled together. Again, 1 
ml of solvent was mixed with 10 ml of Ecoscint A for subsequent analysis by LSC.  
 95 
 
5.2.6 Pore water analysis 
A separate test was carried out to determine the concentrations of each API in the 
sediment pore water of the system. Three test tubes containing 3 g dw of sediment and 
15 ml of APW spiked at 10 µg/L of each API were prepared. The tubes were left to shake 
for 24 h in the dark at 300 rpm. At the end of the shaking, the sediment was transferred 
into disposable syringes containing 1 cm of glass wool at the bottom (Fig. 5.1). The 
syringes, contained in 50 ml Falcon tubes, were then centrifuged for 40 minutes twice 
and 500 µl of the extracted water  was collected and pipetted into a 2 ml Eppendorf 
tubes. The Eppendorf tubes were centrifuged for 5 minutes and 300 µl of pore water 
was collected for analysis. The pH was measured using a Mettler Toledo 51343160 
InLab micro pH probe (Fig. 5.1). Lastly, the pore water was mixed with 10 ml of Ecoscint 
A and ready for analysis.  
 
        
Figure 5. 1. Pore water pH analysis (left figure) and Falcon tubes containing the syringes with 
3g of the sediment ready for the extraction of the pore water (right figure). 
 
 
Concentrations of the test chemicals in the pore water were also estimated based on 
the following formula suggested by Karlsson et al., (2017): 
                     
              Cpw = Csed / {[Kd × (%sed / % water) × bulk density] +1}                         Equation 1 
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Where Cpw is the concentration of the chemical in the pore water (pmol/mL) and Csed is 
the concentration of the chemical in the sediment (pmol/g); Kd is the sorption 
coefficient; % water and % sediment are the % of moisture and sediment in the sediment 
samples.  
For the bulk density, three replicates of wet sediment were weighted up to 80 mL in 100 
mL beakers. The height and the diameter of the beaker were measured in order to 
obtain the radius and the ring density. The replicates were left in the over at 50 °C 
overnight and then the dry weight was measured.  
 
5.2.7 Lipid analysis 
Lipid content of the worms was measured following the method suggested by (Smedes, 
1999). Triplicates test tubes containing approximately 100 mg of organisms were 
weighed (wet weight) and placed in a vial dried. After that, the tubes were placed in the 
lyophilizer for 2 h and then dried in the oven at 50 °C overnight, following which the dry 
weight was determined. The worms were transferred into pre-weighed vials and ground 
with a glass rod. In order to extract the lipids from the worms, 1.6 ml of 2-propanol 
(Sigma Aldrich), 2 ml of cyclohexane (Sigma Aldrich) and 2.2 ml of de-ionized water were 
added as solvents. The tubes were vortexed for 30 seconds, sonicated in a water bath 
for 5 minutes and centrifuged for 5 minutes at 3000 rpm. The upper layer was removed 
and pipetted into a pre-weighted brown glass vial and then the extraction procedure 
was repeated twice. The combined extracts were evaporated under a gentle stream of 
nitrogen and finally weighed on the balance to determine the lipid content by adjusting 
the results using an external liposome (1,2 – distearoyl-sn-glycerol-3-phosphocholine) 
and cyclohexane as controls.  
 
5.2.8 Kinetic modelling analysis 
Mean concentrations and standard deviations of the six replicates tubes were calculated 
for each time point. The uptake rate constant (kin) and the depuration rate constant 
(kout) were derived using Open Model (University of Nottingham, 
http://openmodel.info/ downloaded 5th May 2017). The accumulation was assumed to 
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follow the first-order one- compartment toxicokinetic uptake described by the following 
formula:  
 
                                            dCint /dt = (Csed × kin ) – (Cint × kout )                                Equation 2 
 
Where Cint is the organism internal concentration (pmol/g wet weight), Csed is the water 
concentration of the analyte (pmol/g), kin and kout are the uptake (mL x g wet weight × h-
1) and depuration rate constant (h-1) and t is time (hours).  
The first order one-compartment toxicokinetic model is a reliable model that assumes a 
constant uptake and elimination per time. Therefore, the concentration of the 
compound into the body of an organism is proportional to the concentration in the 
water/sediment and the concentration of the compound eliminated is proportional to 
the concentration remained in the body.  
Also, the kinetic biota accumulation factor (BAFk) was calculated by setting the Csed equal 
to 1 and by running the model until the equilibrium was reached. The Marquardt 
algorithm was first applied in order to find the general fit values of the uptake and 
elimination rates values, then, the Monte Carlo along with the Metropolis-Hastings 
algorithm was applied by running the model for 10000 iterations to find the best fit 
values.   
The 95% confidence intervals around the fitted curves were derived (Ashauer et al., 
2010).                                   
The biota-sediment accumulation factor (BSAF) was calculated following the OECD 305 
by taking into account the lipid content of the worms and organic content of the 
sediment based on the formula below: 
  
                                              BSAF = BAFk × ƒOC / ƒlip                                              Equation 3 
 
Where ƒOC is the total organic content of the sediment (%) and ƒlip is the lipid fraction of 
the worms (% wet weight).  
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5.2.9 Statistical analysis 
Statistical analysis of the measured data was performed with Graphpad Prism 
(www.graphpad.com). For each API, differences of the concentrations over time in the 
stability vials containing sediment, water and the compound only were analyzed. Tests 
for normality were performed using the Shapiro-Wilk normality test. If the data passed 
the normality test, then, one-way ANOVA test was used to evaluate the differences in 
the concentrations between the treatment groups at 0 h, 24 h and 48 h.   
 
5.3 Results and discussion  
5.3.1 Evaluation of extraction solvents for the pharmaceuticals from the sediments 
Extraction efficiencies varied by solvent, pharmaceutical and sediment type (Table 5.1). 
For example, the extraction efficiency of amitriptyline ranged between 0.2% with 
acetonitrile and 63% using the acidified 0.1 % H3PO4 and 7:3 ACN/H2O. For diclofenac, 
efficiencies ranged between 3% with acetonitrile and 81% with 7:3 ACN/H2O and for 
norfluoxetine efficiencies were in a range of 2% using acetonitrile and 65% with 0.1% 
H3PO4 7:3 ACN/H2O (Table 5.1). Based on the preliminary studies, the solvents that 
resulted in the highest recoveries were used for the validation of the method and the 
results are shown in Table 5.2.  
 
 
 Amitriptyline 
M
o
o
rs
 
Extraction solvent t Mean recovery (%) 
MeOH 12 
ACN 0.2 
7:3 ACN/H2O 21 
0.1% H3PO4 MeOH 20 
0.1% H3PO4 ACN 3 
0.1% H3PO4 7:3 ACN/H2O 57 
B
ar
n
sl
ey
 MeOH 51 
ACN 13 
7:3 ACN/H2O 43 
0.1% H3PO4 MeOH 47 
0.1% H3PO4 ACN 20 
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0.1% H3PO4 7:3 ACN/H2O 63 
 Diclofenac 
M
o
o
rs
 
MeOH 11 
ACN 3 
7:3 ACN/H2O 76 
0.1% H3PO4 MeOH 40 
0.1% H3PO4 ACN 20 
0.1% H3PO4 7:3 ACN/H2O 77 
B
ar
n
sl
ey
 
MeOH 51 
ACN 10 
7:3 ACN/H2O 81 
0.1% H3PO4 MeOH 9 
0.1% H3PO4 ACN 22 
0.1% H3PO4 7:3 ACN/H2O 77 
 Norfluoxetine 
M
o
o
rs
 
MeOH 7 
ACN 2 
7:3 ACN/H2O 41 
0.1% H3PO4 MeOH 13 
0.1% H3PO4 ACN 5 
0.1% H3PO4 7:3 ACN/H2O 65 
B
ar
n
sl
ey
 
MeOH 20 
ACN 4 
7:3 ACN/H2O 51 
0.1% H3PO4 MeOH 21 
0.1% H3PO4 ACN 6 
0.1% H3PO4 7:3 ACN/H2O 58 
Table 5. 1. Preliminary recoveries of the study compounds from the sediments using different 
extraction methods. 
 
 
Table 5. 2. Recoveries of the test compounds from the sediments for the validation of the 
extractions. 
 
 Compound Extraction solvents Mean recovery 
(%) 
M
o
o
rs
 
Amitriptyline 0.1% H3PO4 7:3 ACN/H2O 62 (1.53) 
Diclofenac 0.1% H3PO4 7:3 ACN/H2O 81 (1.0) 
Norfluoxetine 0.1% H3PO4 7:3 ACN/H2O 72 (2.08) 
B
ar
n
sl
ey
 Amitriptyline  0.1% H3PO4 7:3 ACN/H2O 64 (6.35) 
Diclofenac 7:3 ACN/H2O 83 (3.5) 
Norfluoxetine 0.1% H3PO4 7:3 ACN/H2O 72 (1.0) 
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5.3.2 Lipid content of the organisms 
The average wet weight of the worms was 25 mg which corresponded to 10-11 worms 
per vial (2.5 mg/worm). The mean wet weight (%) was 1.5 and the mean dry weight of 
the lipid content (%) was 1.7. The recoveries using the external liposome and the 
cyclohexane as controls were 99%. The liposome used was 1,2 – distearoyl-sn-glycerol-
3-phosphocholine which is a major component of the biological membrane and its 
composition was found to be high in Oligochaetes (Bell et al., 1994).  
Assessing the lipid content of the worms is important because normally a positive 
correlation between bioconcentration and the lipid content of the organism is found; in 
particular for hydrophobic compounds that mainly partition into the lipid membrane of 
species (Mackay, 1982).  Other studies have measured the lipid content of L. variegatus; 
for example (Liebig et al., 2005) measured 8% dw. In their study, a higher dry weight of 
the worms than our measurements was reported and we believe that the difference in 
the lipid content of the worms depends on several factors such as the maturity of the 
organisms, the different suppliers and the different cultivation conditions.  
 
5.3.3 Uptake and depurations experiments 
Stability samples. The concentrations of the test APIs in the water phase and sediment 
and the pH of the overlying water in the vials without the worms were measured 
throughout the duration of the experiments (Figs. 5.2, 5.3, 5.4). The pH of the overlying 
water of the Moors sediment was slightly acidic (6.30-6.53) compared to the Barnsley 
sediment (7.14-8.15). Also, in both sediments, pH remained quite stable over the 
duration of the study. In the Moors sediments, concentrations of diclofenac remained 
stable (p-value > 0.05) while changes in the concentrations for the Barnsley sediments 
were observed (p-value < 0.05*). Regarding the two bases, amitriptyline and 
norfluoxetine, concentrations were stable in the Moors sediment (p-value > 0.05). 
Whereas, in Barnsley sediment, after 24-h, a decrease in the sediment concentrations 
was observed ( p-value < 0.001***).  
Looking at Figures 5.2 and 5.4, concentrations of amitriptyline and norfluoxetine were 
greater in the sediment than in the overlying water. For example, in the Moors 
sediment, the concentration of amitriptyline in the sediment compartment was 4-fold 
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higher than in the water column, as well as norfluoxetine. Regarding Barnsley, the same 
scenario as Moors was observed: the sediment concentrations of the two APIs were 3-
fold higher than the concentrations detected in the water.   
On the other hand, diclofenac seemed to be equally distributed between the sediment 
and the overlying water having half of the API adsorbed into the sediment and half 
dissolved in the aqueous phase.  
The factors affecting the dissipation of pharmaceuticals particularly in sediments have 
not been well studied yet.  For instance, the degradation of 6 pharmaceuticals including 
amitriptyline in 10 different types of sediments was investigated by Al-Khazrajy et al., 
(2018). Amitriptyline was found to be persistent across the sediment types with an 
average half-life of 62 days. In addition, the authors evaluated the effect of the microbial 
activity using sterile and non-sterile sediments and a higher half-life was found under 
sterile conditions suggesting that the microbes contribute largely to the dissipation of 
amitriptyline. In our study, non-sterile sediments were used thus, it is possible that the 
degradation of amitriptyline may be due to the presence of the microorganisms. Our 
aim was to maintain the properties of the sediment similar to the sediment that we 
sampled in the field but further studies should be done to investigate which main factors 
could contribute to the dissipation of amitriptyline enabling us to better understand the 
fate of this highly prescribed antidepressant in the sediment.  
Some data are available on the degradation of norfluoxetine in the sediment 
compartment. The fate of norfluoxetine and its parent compound, fluoxetine, was 
assessed by Kwon and Armbrust, (2006b) under different conditions to evaluate the 
possible influence of microbes, light and the water in the distribution of the API in the 
water-sediment column. According to the results, norfluoxetine rapidly adsorbed to the 
sediment and it was reported to be photolytically and hydrolytically stable and not 
degraded by the microbial activity. In our study, the test was performed in the dark and 
no contribution of the light was produced. Generally, the factors dominating the 
bioavailability and persistence of pharmaceuticals in sediments are unclear and little is 
known. Some attempts to explain the fate of these contaminants in the aquatic system 
are growing but due to the complexity of the diverse mechanisms that could be 
potentially involved, more research is needed.   
Data regarding the persistence of diclofenac are limited, however, the fate of the API 
has been assessed in water-sediment systems under high and low flow velocity of the 
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overlying water (Kunkel and Radke, 2008). The authors reported a DT50 of 8.5 days under 
low flow conditions. Another fate laboratory test performed on diclofenac in a sediment 
river system found that diclofenac was stable under all biotic and abiotic conditions 
(Koumaki et al., 2017). Similar to the findings of Koumaki et al., (2017) study, diclofenac 
was found to be quite stable in both sediments over 48-h and we can therefore exclude 
the influence of biotic as well as abiotic degradation processes in the test.     
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Figure 5. 2. Mean (±SD) of the measured water concentrations (blue dots), sediment 
concentrations (brown squares) and pH data (green triangles) of the stability beakers of 
amitriptyline in the two sediments. 
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Figure 5. 3. Mean (±SD) of the measured water concentrations (blue dots), sediment 
concentrations (brown squares) and pH data (green triangles) of the stability beakers of 
diclofenac in the two sediments. 
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Figure 5. 4. Mean (±SD) of the measured water concentrations (blue dots), sediment 
concentrations (brown squares) and pH data (green triangles) of the stability beakers of 
norfluoxetine in the two sediments.  
 
 
 
5.3.4 Toxicokinetic experiments 
 No mortality of the worms was observed during the experiments. The reproduction and 
growth of the organisms were limited by the short duration of the tests. The 14-C 
radioactivity of the three APIs was measured for the overlying water and sediment 
compartments. Also, the overlying water pH was monitored throughout the 
experiments and it tended to be alkaline for Barnsley (7.62- 8.15) and acidic for Moors 
(6.45-6.66). The concentrations in the sediment decreased over the 24-h of exposure 
possibly due to uptake of the API by the worms, whereas, the concentrations remained 
stable for the water phase.  
The first order one-compartment toxicokinetic model was fitted to the experimental 
data (Figs. 5.5, 5.6, 5.7). For most datasets, the model seems to fit well in particular for 
amitriptyline, whereas for diclofenac and norfluoxetine different scenarios were 
observed. Specifically, the model underestimated the uptake rates of diclofenac in 
Barnsley and the depuration rates of diclofenac in Moors while it underestimated the 
uptake rates of norfluoxetine in the Barnsley sediment. 
The kinetic BAFs, uptake, depuration rates and BSAFs of the three APIs are listed in Table 
5.3 below. The kinetic BAF increased in the following order norfluoxetine < amitriptyline 
< diclofenac in the Moors sediment and norfluoxetine < diclofenac < amitriptyline in the 
Barnsley sediment.  
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The biota-sediment bioaccumulation factor (BSAF) increased in the following order 
norfluoxetine < amitriptyline < diclofenac for Moors and norfluoxetine < diclofenac < 
amitriptyline for Barnsley. The BSAF ranged from 5 g/mL for norfluoxetine to 201 g/mL 
for amitriptyline in the Barnsley sediment and from 13 g/mL for norfluoxetine to 17.2 
g/mL for diclofenac in the Moors sediment.  
 
Even though bioaccumulation is an important endpoint as part of the risk assessment of 
chemicals, not many studies have been focussed on the sediment bioaccumulation of 
pharmaceuticals, particularly into invertebrates. However, one study conducted by 
Karlsson et al., (2016) reported the BSAF of diclofenac to be 0.57 L/Kg after 48-h of 
exposure into L. variegatus (Karlsson et al., 2016). In this study, the BSAFs derived were 
higher by two orders of magnitude; 10.6 g/mL and 17.2 g/mL for the Barnsley and Moors 
sediments respectively. Although the organism used in the experiments was the same, 
differences in bioconcentration could be explained by the influence of the different 
sediment properties such as pH and organic matter. In the toxicokinetic experiments of 
Karlsson et al., (2016), the pH was 7.67 and the organic carbon (OC) was 0.51 %. The two 
sediments chosen in our experiments possessed diverse properties (Barnsley pH = 7.52 
and OC = 14.26 %; Moors pH 6.43 and OC = 0.787 %). Thus, differences in the 
accumulation are likely to be due to the different environmental characteristics. Also, a 
possible transformation process could have occurred into the worms leading to more 
hydrophilic metabolites that are excreted faster than the parent compound. This could 
explain the underestimation of the depuration rates in the Moors sediment. However, 
no studies regarding the metabolic pathway of diclofenac into sediment-dwelling 
invertebrates have been found in the literature. The metabolic pathway of diclofenac 
has been reported in fish species and several metabolites have been identified through 
glucuronidation (Kallio et al., 2010; Lahti et al., 2011). Recently, experiments 
investigating the metabolic pathway of diclofenac in marine mussels were studied 
(Bonnefille et al., 2017; Świacka et al., 2019). Bonnefille et al., (2017) identified 13 
metabolites of diclofenac in the marine organism Mytilus galloprovincialis, including 4'-
hydroxy-diclofenac and 5-hydroxy-diclofenac that were found in another marine mussel 
(Mytilus trossulus) by Świacka et al., (2019).  
In the future experiments to detect the metabolites of APIs for invertebrates are 
necessary to have a better understanding of their influence in the uptake and 
 105 
 
depuration process for a better estimation of the internal exposure, hence, potential 
toxicity to non-target species.     
In addition, diclofenac is the only weak acid evaluated in this study. It possesses a pKa of 
3.9. In Chapter 3, the water-only uptake studies showed that at lower pH, diclofenac is 
accumulated more in the organisms. In this study, a higher BASF was observed for the 
Moors sediment compared to the Barnsley. Thus, we believe that the pH could be the 
property that may explain the accumulation differences of the worms among the two 
sediments.  
The internal concentration of diclofenac has been reported in other aquatic 
invertebrates such as Gammarus pulex (Miller et al., 2016). The authors estimated 
bioconcentration of 14 L/Kg after exposure of the gammarids to 48-h at 10 µg/L of the 
compound. In our study, the same exposure concentration was used and the results 
were in the same order of magnitude to that reported by  Miller et al., (2016). Slight 
differences in the uptake could be due to the different exposure time and species used 
in the toxicokinetic experiments, thus, different species traits such as locomotion, 
feeding habit, respiration (Ducrot et al., 2005; Sidney et al., 2016).    
 
For amitriptyline, to the best of our knowledge, no data regarding sediment 
bioaccumulation into invertebrates have been published yet. However, the 
bioconcentration of amitriptyline has been assessed into a gilt-head bream (Sparus 
aurata) at two concentrations of 2 µg/L and 10 µ/L (Ziarrusta et al., 2017). At the same 
concentrations used to expose the worms in our study (10 µg/L), the authors calculated 
a BCF 21 L/Kg which is slightly higher than the results reported in our study. They also 
noticed that amitriptyline was mainly accumulated in the brain which is not surprising 
as the brain should be its main target organ.  
Understanding the relationship between the sediment characteristics and the 
physicochemical properties that affect the accumulation of APIs into non-target 
organisms is complex and not well studied. However, below, a possible explanation for 
the observations of uptake of the APIs into L. variegatus is also given for the two bases. 
The two studied study sediments had very different characteristics: Barnsley had high 
organic content (14.26%) and high pH (7.56); while Moors had low organic content 
(0.787%) and low pH (6.43). In this way, the two chosen sediments allow comparisons 
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between the sediment characteristics, physicochemical properties of the compounds 
and bioaccumulation.  
Amitriptyline is a basic pharmaceutical (pKa = 9.4, LogKow = 4.92, see Chapter 1) and its 
fate in the sediment system depends on the speciation at the sediment pH. Based on 
the Henderson-Hasselbach equation, the API increases its neutrality with increasing pH. 
At pH 6.43 (the pH of Moors sediment), 0.11% of amitriptyline is in the neutral form, 
while at pH 7.52 (pH of the Barnsley sediment), 1.30% is in the neutral form. Based on 
our findings in Chapter 3, at high pH amitriptyline bioconcentration increases, and, 
similar results can be seen in this study when comparing the BSAFs of Barnsley and 
Moors (Table 5.3), i.e.: a higher BSAF of Barnsley was measured compared to Moors.  
Amitriptyline has been found to be highly adsorbed to sediments containing high organic 
content suggesting that the hydrophobic interactions with the neutral part of the API 
are its dominant sorption mechanism (Al-Khazrajy and Boxall, 2016). Whereas, in our 
study, even though amitriptyline has a high affinity with the organic content, the pH 
seemed to have influenced greater uptake into the worms. Therefore, it is very 
important to account for the pH of the study medium because it may explain the 
differences in the bioaccumulation between sediments.   
Norfluoxetine has not been well studied in invertebrate species yet, however, the 
uptake of fluoxetine and its major metabolite norfluoxetine has been investigated into 
a marine mussel Mytilus galloprovincialis (Silva et al., 2016). The organisms were 
exposed to fluoxetine for 15 days and the metabolic products such as norfluoxetine 
were analyzed too. The pseudo-BCF calculated for norfluoxetine was found to be higher 
than fluoxetine at 15 days of exposure (124 L/Kg and 155 L/Kg for fluoxetine and 
norfluoxetine respectively). A possible explanation could be the polarity of fluoxetine 
compared to norfluoxetine: norfluoxetine has been found being more accumulative and 
hydrophobic than its parent compound (Gelsleichter and Szabo, 2013). Similar results 
were reported by different authors who exposed different fish species to fluoxetine and 
norfluoxetine to investigate the distribution and accumulation into non-target species 
(Brooks et al., 2005; Nakamura et al., 2008a; Paterson and Metcalfe, 2008b). In this 
study, norfluoxetine only was detected and the accumulation factors analyzed for the 
two sediments were much lower than those reported in the above-mentioned study of  
Silva et al., (2016).  Differences in the uptake could be due to the different exposure 
conditions, concentrations, test duration and the biological traits of the test species.  
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Norfluoxetine is also a basic pharmaceutical (pKa = 10.01 and LogKow = 4.16) and it 
increases the neutrality from 0.42% at pH 6.43 to 5% at pH 7.52. In the Moors sediment, 
a rapid uptake followed by a rapid depuration was observed whereas in Barnsley 
sediment the model over-estimated the uptake and under-estimated depuration. Also, 
the BSAF reduced with increasing of the sediments' organic content. These results 
contradict the amitriptyline’ results, even if the two pharmaceuticals should show 
similar bioaccumulation patterns. In this case, the differences in the BSAFs of the two 
sediments could be explained by the different binding degree of the API to the organic 
material. We suggest that the bioavailability of norfluoxetine is due to the different 
power of binding to the organic material. Therefore, higher BSAF is observed for Moors 
sediment which contains relatively low organic content, consequently, a greater 
bioavailability of norfluoxetine in the pore water to be taken up by the organisms could 
explain the results. In addition, it has been suggested that sediments containing coarse 
particle size possess a higher degree of bioaccumulation than sediments having fine 
particle size (Maënpaä¨ et al., 2003). This observation could be applied to the sediments 
of our study; in fact, the particles analyzed for Moors showed a high percentage of sand 
(78%), see Chapter 4, and a high BSAF was measured supporting the theory stated 
above.   
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Figure 5. 5. Uptake and depuration of amitriptyline (right figure) in Moors and Barnsley 
sediments. Red dots represent the internal concentrations measured in the worms (pmol/g 
wet weight), the blue thick line represents the model fit curves and the dashed blue lines the 
95% confidence interval of the model fit. The left figure shows the water concentrations (blue 
dots in pmol/mL), sediment concentrations (brown squares, pmol/g) and pH measurements of 
the overlying water (green triangles). 
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Figure 5. 6. Uptake and depuration of diclofenac (right figure) in Moors and Barnsley 
sediments. Red dots represent the internal concentrations measured in the worms (pmol/g 
wet weight), the blue thick line represents the model fit curves and the dashed blue lines the 
95% confidence interval of the model fit. The left figure shows the water concentrations (blue 
dots in pmol/mL), sediment concentrations (brown squares, pmol/g) and pH measurements of 
the overlying water (green triangles). 
 110 
 
0 1 2 2 4 3 6 4 8
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
 M o o r s
T im e  (h )
In
t
e
r
n
a
l 
c
o
n
c
e
n
t
r
a
t
io
n
 (
p
m
o
l/
g
)
0 1 2 2 4 3 6 4 8
0 .0
2 .5
5 .0
7 .5
1 0 .0
1 2 .5
1 5 .0
1 7 .5
2 0 .0
2 2 .5
2 5 .0
W a te r  a n d  s e d im e n t
T im e  (h )
C
o
n
c
 (
p
m
o
l/
m
L
 o
r
 g
)
0 1 2 2 4 3 6 4 8
0
1 0 0
2 0 0
3 0 0
4 0 0
 B a rn s le y
T im e  (h )
In
t
e
r
n
a
l 
c
o
n
c
e
n
t
r
a
t
io
n
 (
p
m
o
l/
g
)
0 1 2 2 4 3 6 4 8
0 .0
2 .5
5 .0
7 .5
1 0 .0
1 2 .5
1 5 .0
1 7 .5
2 0 .0
W a te r  a n d  s e d im e n t
T im e  (h )
C
o
n
c
 (
p
m
o
l/
m
L
 o
r
 g
)
N o r f lu o x e t in e
 
Figure 5. 7. Uptake and depuration of norfluoxetine (right figure) in Moors and Barnsley 
sediments. Red dots represent the internal concentrations measured in the worms (pmol/g 
wet weight), the blue thick line represents the model fit curves and the dashed blue lines the 
95% confidence interval of the model fit. The left figure shows the water concentrations (blue 
dots in pmol/mL), sediment concentrations (brown squares, pmol/g) and pH measurements of 
the overlying water (green triangles). 
 
 
API Sediment pH  
overlying 
water 
pH  
sediment 
 
Kin 
(ml × g × h
-1
) 
Kout 
(h
-1
) 
BAFk  
(95% CI) 
(g/ml) 
BSAF 
(g/ml) 
Amitriptyline Moors 6.50  
(0.02) 
6.43 0.98 0.03 27.5 
(25.1- 31.73) 
14.4 
Amitriptyline Barnsley 7.77 
(0.04) 
7.52 1.54 0.07 21.24 
(18.6- 26.45) 
201.9 
Diclofenac  Moors 6.61 
(0.02) 
6.43 
 
4.115 0.12 32.73 
(30.54-
36.61) 
17.2 
Diclofenac Barnsley 7.96 
(0.06) 
7.52 
 
2.38 0.12 20.14 
(16.47-
27.17) 
10.6 
Norfluoxetine Moors 6.51 
(0.01) 
6.43 
 
1.57 0.06 24.76 13.0 
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Table 5. 3. Uptake and elimination rate constants, kinetic BAF and the sediment-biota 
accumulation factor (BASF) of L. variegatus exposed to the three API in the two sediments. 
 
 
5.3.5 Limitations  
In our study, we assumed that the radioactivity measured represented the parent 
compound only and either biotransformation products and metabolites were not 
quantified. This is mainly due to the limitation of the method, in particular, that the 
liquid scintillation counter detects the radioactivity without differentiates between 
parent compounds and metabolites. Thus, without considering the contribution of 
biotransformation products, an over or underestimation of the internal concentrations 
could occur. In fact, some studies have found higher internal concentrations of 
metabolites than parent compounds in invertebrates (Ashauer et al., 2012; Miller et al., 
2017).  
Lastly, we analyzed the total radioactivity absorbed through the skin and the respiratory 
system including the contribution of the diet. However, we did not consider the feeding 
route and the adsorption through the skin separately. In the future, further studies to 
understand the contribution of the uptake of sediment-associated APIs should be 
covered to evaluate whether it contributes significantly to the uptake. In the literature, 
contradictory results underlined a potentially significant difference in accumulation via 
food uptake. For example, in a study conducted by Karlsson et al., (2016) of two 
pharmaceuticals and one personal care product on L. variegatus they found a negligible 
contribution of the diet for diclofenac and fluoxetine but a considerable difference in 
the uptake of triclosan between feeding and non-feeding worms. Similar to these 
findings, Ashauer et al., (2010) assessed the food uptake of two pesticides attached to 
leaf discs on G. pulex and a food contribution of less than 2% was measured in assessing 
the whole bioaccumulation process leading the authors to conclude that the diet route 
was negligible.      
(21.07-
31.54) 
Norfluoxetine  Barnsley 8.01 
(0.09) 
7.52 0.96 0.10 9.48 
(7.17- 13.72) 
5.0 
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5.3.6 Pore water analysis 
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Figure 5. 8. Measured and predicted pore water concentrations of the three APIs in the two 
sediments. Bar charts represent the mean of three replicates with the standard deviations. 
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Figure 5. 9. pH measurements of the pore water of Moors and Barnsley sediments. Bar charts 
represent the mean of three replicates with the standard deviations. 
 
A significant difference between the estimated and measured pore water 
concentrations were observed (Fig. 5.8). Generally, for all the APIs in the two sediments 
very low predictions have been obtained using the formula suggested by Karlsson et al., 
(2017).  
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The estimated pore water concentrations were obtained by using the Kf values from the 
batch sorption experiments described in Chapter 4. Also, the bulk density was measured 
and it has been found to be 0.878 g/cm3 for Moors and 0.450 g/cm3 for Barnsley.  
  
Based on these findings, the Kf value may not be appropriate for the estimation of the 
pore water concentration. We believe that the different conditions and water chemistry 
of the batch sorption studies and the sediment uptake studies of this chapter could have 
influenced the underestimation of the predicted pore water concentrations.  
Pore water is an important parameter to consider because it could provide a better 
understanding of the route that contributes the most to the uptake of chemicals in 
sediment-dwelling worms (Di Toro et al., 1991; Leppänen and & Kukkonen, 1998). 
However, measuring the pore water of API in the laboratory is challenging and to our 
best knowledge, not many studies have measured it. For instance, Carter et al., (2016) 
measured the pore water concentrations of diclofenac, fluoxetine, and orlistat in 
different soil types and suggested that depending on the soil texture and the cation 
exchange capacity, the pore water concentrations of the compounds differed due to the 
soil characteristics and their interaction with the physicochemical properties of the 
chemicals.   
Also, pH measurements of the pore water samples were taken (Fig 5.9), and the results 
show Barnsley sediment to be more alkaline than Moors, similar to the findings of the 
uptake and depuration experiments. pH is an important parameter when assessing the 
uptake of ionisable chemicals from the sediment into worms (Karlsson et al., 2017). 
However, because of the lack of information about pore water concentrations and, in 
particular, pH, assessing the real risk that ionisable compounds may pose to benthic 
invertebrates is difficult. Therefore, we recommend more studies and data in order to 
establish a more reliable picture of which route is the main contributor to the uptake 
into benthic invertebrates. In this way, we will be able to evaluate the risk that APIs may 
pose to non-target organisms dwelling in the sediment compartment.  
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5.4 Conclusions 
Toxicokinetic constants and the kinetic BAFs and BSAFs were derived from worms 
exposed to contaminated sediment.  We demonstrated differences in bioaccumulation 
of the two basic APIs and one acid into L. variegatus and how uptake varies across two 
sediments possessing diverse properties. In addition, these experiments showed how 
sediment properties influence the bioavailability of the tested compounds.  Among 
other properties, the pH and the organic content seemed to be the main descriptors to 
have influenced the uptake to the organisms.  Also, the pore water concentrations were 
measured and compared to the predicted concentrations but a remarkable difference 
between the measured and predicted concentrations was found. We concluded that the 
Kf may not be appropriate in describing the pore water concentration of chemicals when 
assessing the uptake of sediment-dwelling invertebrates. However, analyzing entirely 
the mechanisms influencing the potential uptake into sediment-dwelling invertebrates 
is not simple due to the combination of environmental, physicochemical and biological 
factors that could be involved.  
Therefore, we suggest more research regarding this topic, in particular, with more 
sediments to have a clear picture of the possible parameters that have to be considered 
for modelling approaches.  
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Chapter 6. General discussion and conclusion 
6.1 Summary of the thesis and results  
New data on the fate, uptake and elimination of ionisable active pharmaceutical 
ingredients in benthic invertebrates have been presented and discussed in this Ph.D. 
thesis. In the past 20 years, more attention has been dedicated to evaluating the 
behaviour of ionisable APIs in non-target organisms.  
Bioaccumulation is a key criterion as part of the Environmental Risk Assessment process, 
therefore, many studies have been conducted on the uptake of pharmaceuticals in 
aquatic and terrestrial organisms like terrestrial earthworms (Carter et al., 2016; Parelho 
et al., 2018), aquatic invertebrates (Meredith-Williams et al., 2012; Ding et al., 2016), 
Hedgespeth et al., 2018), sediment organisms (Karlsson et al., 2016; Nieto et al., 2017a) 
and plants (Li et al., 2018; Kodešová et al., 2019).  
Although research regarding this topic is increasing, particularly assessing the uptake of 
APIs into aquatic invertebrates, the sediment compartment has not been well studied 
yet. Assessing the sediment uptake of ionisable APIs is important to understand the 
main routes of exposure of these chemicals into benthic invertebrates. Benthic species 
are key ecological organisms at the bottom of the food chain and prey of upper trophic 
organisms such as fishes. Thus, a potential biomagnification process could occur 
(Lagesson et al., 2016; Haddad et al., 2018). For example, Lagesson et al., (2016) 
evaluated the trophic transfer of pharmaceuticals from bottom to top predators in the 
aquatic food web. The organisms chosen for the experiments were a fish species 
(common perch) and four invertebrates from different habitats and with different diets 
such as Zygoptera, Ephemeroptera, the waterlouse Asellus aquaticus and the snail 
Planorbidae. The authors found a higher accumulation of the APIs into the benthic 
species (Asellus aquaticus and the snail Planorbidae) than the fish. They suggested that 
the diet could explain the differences in the accumulation among species. The snail and 
the waterlouse feed on periphyton which has been found to accumulate 
pharmaceuticals (Du et al., 2015). However, these studies did not consider 
environmental properties such as the pH that could influence the uptake among the 
different species.  
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Also, not many studies into understanding the trophic transfer of contaminants from 
prey to a predator have been proposed yet, specifically studies with L. variegatus. 
Further research on the trophic transfer of APIs in the aquatic food web is therefore 
needed, including sediment-dwelling worms. In this way, we will be able to understand 
the role of these organisms and the environmental properties that could affect the 
bioavailability of the APIs and ultimately the uptake and toxicity.     
 
The studies of this Ph.D. thesis, therefore, have started to explore the fate and the 
uptake of ionisable APIs into sediment-dwelling invertebrates. Laboratory experiments 
have been conducted in order to elucidate which physicochemical properties and 
sediment characteristics are important to consider for assessing the bioconcentration 
and the risk that these chemicals may pose to benthic worms. The main findings of the 
thesis will be briefly summarized in the following paragraphs.  
 
6.2 Main findings of the experimental chapters 
Bioconcentration models available from the literature to calculate the BCF were 
evaluated (Chapter 2). The BCF models selected for this study included six developed 
specifically for fish species and two for invertebrates. The predicted and measured BCF 
were compared to evaluate whether the chosen models could suitably predict the BCF. 
We observed that all the models showed a low accuracy in predicting BCFs resulting in 
both over or under-estimation compared to measured values.  
The evaluation of current BCF models was important in order to give a broad 
understanding of which physicochemical properties of chemicals, environmental 
parameters, and biological traits could be essential for a more accurate estimation of 
the bioconcentration. We believe that the differences between measured and predicted 
BCF estimations were due to different factors such as the different test conditions of the 
studies, different duration of the exposure and the different analytical methods used for 
the estimation of BCF. For example, for the fish species, the conditions of the 
experiments varied between the different studies. The majority of the tests performed 
the “flow-through” experimental design as recommended by the OECD 305, however, 
some studies performed static, semi-static or renewal experiments (Wang and Gardinali, 
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2013). The exposure concentrations and the duration could also explain the differences 
in the estimated BCF: for example, some studies analyzed the bioconcentration into fish 
species over shorter periods of time (7 days) (Wang and Gardinali, 2013) than others (42 
days) (Steinbach et al., 2016). Also, some studies evaluated the contribution of dietary 
uptake whereas others assessed adsorption through the skin only. Similar variability is 
seen in tests with with different studied involving: different duration of the test, 
different concentrations of the API spiked, different environmental conditions (water-
only exposure or sediment exposure) and species traits such (Rubach et al., 2012) and 
different measurements and reporting. For example, some studies reported the lipid 
content as wet weight and other as dry weight. Variability in the BCF can be attributable 
to the different lipid content measured among the organisms. Ultimately, the analytical 
method could lead to uncertainties in the estimation of the BCF. If the study used 
radiolabelled compounds, variability in determining the BCF could arise due to the fact 
that with that method is impossible to distinguish between the parent compound and 
metabolites. Therefore an overestimation could happen (Arnot and Gobas, 2006).  
 
In general, the main findings in Chapter 2 underlined the need to improve BCF models 
for invertebrates. In fact, only two models were evaluated due to the fact that not many 
are available in the literature, that have specifically been developed for sediment-
dwelling invertebrates. These models are necessary to predict the risk that ionisable 
APIs may pose to lower trophic organisms. Also, Chapter 2 showed a general overview 
of the difficulty in estimating the BCF using in-silico models.  
 
In Chapter 3, water-only uptake studies were carried out. The main objective was to test 
the effect of the water pH on the uptake of ionisable APIs into sediment-dwelling worms. 
Depending on the degree of ionisation and the pH of the test medium, a compound can 
be fully or partially ionized and, consequently, its degree of bioaccumulation can vary. 
For instance, it is well known that the neutral part of a chemical is more bioaccumulative 
than the ionized counterpart (Anskjaer et al., 2013).  
Therefore, in order to test this hypothesis, the worms were exposed to environmentally 
relevant pH ranges between 5.5 and 9 in APW. Kinetic uptake and depuration rate 
constants and the BCF were derived (Table 6.1). Different uptake patterns were 
observed for weak bases and acids separately. For bases (amitriptyline, norfluoxetine 
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and ketoconazole), uptake increased with the increase in pH. Other studies have shown 
similar findings. For example, Bittner et al., (2019) found that neutral species of basic 
antihistamines were taken up at a higher rate than the ionized species resulting in higher 
toxicity in Zebrafish. The same authors found that β-blockers such as metoprolol and 
propranolol were accumulated at higher pHs in embryos of zebrafish resulting in more 
toxic (Bittner et al., 2018).  
On the other hand, the BCF calculated for acidic compounds like diclofenac, showed an 
opposite uptake trend: higher uptake occurring at lower pH values. The results are 
consistent with other studies found in the literature. For example, the influence of the 
pH on the toxicity of triclosan to the microalgae Chlorella ellipsoidea exposed at different 
pHs showed that the compound, which is a weak acid, was more toxic at lower pH when 
present at its undissociated form (Khatikarn et al., 2018).  
 
These results clearly demonstrated the importance of water pH in determining the 
uptake and toxicity of ionisable organic chemicals. This is also important for regulatory 
purposes. For instance, when evaluating the potential bioaccumulation capacity of a 
chemical for the PBT assessment, more attention should be directed to the pH at which 
the substance is tested (Matthies et al., 2016). For example, it could be useful to test the 
uptake of the molecule at the pH for which the molecule is expected to be more 
bioaccumulative. Moreover, based on the threshold values of the bioconcentration 
criteria for the chemical risk assessment, a substance is considered bioaccumulative (B) 
when the BCF > 2000 L/Kg and very bioaccumulative (vB) at BCF values > 5000 L/Kg. 
Therefore, amitriptyline at pH 9 and norfluoxetine at pH 8 would be classified as 
bioaccumulative and norfluoxetine at pH 5.5 and 9 as very bioaccumulative (EMA, 2018). 
 
Because the tested organism is a sediment-dwelling species, the exposure of APIs from 
contaminated sediment has to be assessed. Hence, sorption studies were performed 
(Chapter 4) to understand the degree of sorption of these ionisable APIs to sediments 
and the available fraction freely dissolved in the water. For this purpose, batch 
equilibrium sorption studies were carried out with four sediments (Moors, Barnsley, 
Millington and Earswick). The sediments were selected based on their different 
properties such as different organic content, pH, CEC and texture. The sorption 
coefficients of amitriptyline, norfluoxetine and diclofenac increased in the order 
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diclofenac < norfluoxetine < amitriptyline in Moors sediment and diclofenac < 
amitriptyline < norfluoxetine in Barnsley, Millington and Earswick sediments. KOC values 
varied greatly depending on the compound and the sediment. Diclofenac showed 
remarkably low sorption coefficients for the four sediments compared to the two bases. 
The KOC ranged between 2.07 Kg/L in Earswick and 22.75 Kg/L in Millington. The sorption 
of diclofenac was measured in three sediments and low sorption coefficients were 
observed ranging from 4.5 Kg/L to 19.6 Kg/L as well (Styszko, 2016). Recently a study by 
Le Guet et al., (2018) investigated the influence of the humic substances of sediments 
on the sorption behaviour of acidic and basic pharmaceuticals including diclofenac and 
found that humic substances facilitated the sorption of diclofenac onto the sediment, 
therefore an increase of the sorption was observed. In our study, the humic substances 
were not determined and we suggest to include this analysis in future sorption 
experiments to further evaluate the influence that humic substance may have on other 
pharmaceuticals.  
Higher sorption coefficients were derived for the two bases amitriptyline and 
norfluoxetine. Amitriptyline was found to be highly absorbed to the two sediments 
possessing high TOC such as Millington and Barnsley. The same sorption behaviour was 
observed for norfluoxetine. Also, the contribution of the inorganic and organic 
components of different sediment types have been investigated by (Yamamoto et al., 
2018) and the authors found that the organic matter contributed the most in the 
adsorption of the basic APIs.  
We concluded that the hydrophobic interactions between the sediment and the 
hydrophobicity of the two compounds were the main factors contributing to the 
sorption across the sediments.   
Other processes potentially involved in the sorption of the bases and acids have been 
suggested by other authors. For example, for bases, cation exchange capacity was 
suggested being an important process of sorption to understand the mobility of the 
compounds in different sediments (Yamamoto et al., 2009; Al-Khazrajy and Boxall, 
2016). For acids, electrostatic repulsion between the sorbent and the sorbate could 
possible explain the low sorption behaviour (Kah et al., 2017). A similar mechanism of 
sorption behaviour for diclofenac has been described on different river sediments by 
(Svahn and Björklund, 2015).   
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In Chapter 5, the uptake of the three ionisable APIs from sediment was investigated. The 
main objective was to combine the information derived from the previous chapters and 
have a comprehensive picture of the main sediment properties that influence the 
uptake of ionisable APIs into benthic worms. For this purpose, two sediments, Moors 
and Barnsley were selected in order to have sediment with high and low organic content 
and pH. Kinetic uptake, depuration rate constants and the kinetic bioaccumulation 
factor (BAFk) were derived along with the biota-sediment accumulation factor (BSAF). 
Table 6.2 gives an overview of the sorption coefficients and the uptake parameters 
collected from Chapters 4 and 5. Different considerations regarding the possible factors 
influencing the uptake of the organisms will be argued. 
For amitriptyline, a considerable higher BSAF was measured for Barnsley sediment than 
Moors. This might be due to the fact that the Barnsley sediment had a higher pH. Thus, 
the accumulative power of the compound increased with the increasing of the sediment 
pH. However, this was not the case of norfluoxetine where we found that the BSAF 
decreased with the increasing of the organic content of the sediments. As shown in 
Table 6.2, the BSAF was higher in the Moors sediment, which contained low organic 
content than Barnsley. Hence, we believe that in the Moors sediment, norfluoxetine was 
more freely bioavailable to be taken up by the worms and consequently more 
bioaccumulative.  
Regarding diclofenac, higher BASF was found for the Moors sediment than Barnsley. 
Here again, the results are in agreement with chapter 3 where greater uptake of 
diclofenac was observed at lower pH values.  
Assessing the uptake of sediment-associated chemicals is not easy due to the diverse 
composition of the sediment, the fate of the chemicals between the water and the 
sediment phase and the different physicochemical properties of the chemicals. The 
influence of sediment characteristics on the bioaccumulation of chemicals into L. 
variegatus has been argued by other authors who exposed the organisms to pesticides,  
(Mäenpää et al., 2008) polycyclic aromatic hydrocarbons (Sheedy et al., 1998) and 
pharmaceuticals (Liebig et al., 2005). Different sediment characteristics were suggested 
to influence the bioavailability of sediment-associated chemicals; for example, the 
bioaccumulation of sediment-associated herbicides in L. variegatus was investigated 
and the results showed that the bioaccumulation into the organisms was greater in the 
organisms exposed in the sediment containing less organic matter, thus, in the sediment 
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with the higher bioavailability of the compound to be taken up by the worms 
(Maënpaä¨et al., 2003). The pH has been found to affect the uptake into the worms by 
a recent study published by Karlsson et al., (2017) where differences in the uptake into 
the worms was observed between the higher pH (8.5) value and the lower pH value (5.5) 
of diclofenac and fluoxetine.  
However, although L. variegatus is used a standard test organism for sediment toxicity 
tests (Egeler et al., 2010; Gilroy et al., 2012); uptake studies from the sediments of 
ionisable pharmaceuticals are still very limited and the study conducted in Chapter 5 is 
one of its kind in trying to interpret the influence of sediment characteristics on the 
bioaccumulation of ionisable sediment-bound pharmaceuticals. 
Pore water concentrations of the APIs are another important source of uptake for 
benthic organisms (Leppänen and & Kukkonen, 1998; Sidney et al., 2016). In our study, 
the pore water concentrations were estimated with a separate test from the sediment 
uptake experiments. The concentrations were compared to the predicted 
concentrations using a formula suggested by Karlsson et al., (2017) and we noticed a 
remarkable difference between predicted and measured values. Pore water is an 
important exposure route, however, due to the difficulty of obtaining the data, the 
manipulation and the method extraction that could change the original matrix. The pore 
water should be analyzed in combination with the other exposure routes that could 
influence more the availability of sediment-associated chemicals (Chapman et al., 2002). 
Therefore, we suggest a reliable method to estimate the pore water for bioaccumulation 
study in order to understand to what extent the pore water contributes largely to the 
uptake of APIs into the sediment-dwelling worms.   
 
In conclusion, our experimental findings produced knowledge on the fate and the 
uptake of ionisable pharmaceuticals in the water-sediment compartment. We 
attempted to explain some environmental properties such as the pH and its influence 
on the uptake into the worms, the sorption behaviour of the APIs and the interactions 
that these APIs, possessing different physicochemical properties, had with some 
sediment characteristics toward the organisms.  
Recently, a novel modelling uptake approach has been proposed to reliably estimate 
internal concentrations of ionisable APIs to the sediment-dwelling worm L. variegatus 
(Karlsson et al., 2017).  
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In the next section, this model will be applied in order to test the applicability of this 
approach with the experimental data generated in this thesis and the wider implications 
will be discussed.   
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Table 6. 1. Summary of the BCFs at the different pHs of the four APIs measured in Chapter 3. 
 
 
 
 
 
 
 
Compound BCF (L/Kg) pH 5.5 BCF (L/Kg) pH 7 BCF (L/Kg) pH 8  BCF (L/Kg) pH 9 
Amitriptyline  146 391 653 2284 
Diclofenac 353 81 13 3.78 
Norfluoxetine 1.06 × 107 870 2902 1.11 × 104 
Ketoconazole 93 100 101 211 
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Table 6. 2. Summary of the sorption coefficients and the uptake parameters for the three APIs measured in Chapter 4 and 5. 
 
 
 
 
 Compound KF 
(mg/Kg) × (mg/L) 
KOC 
L/Kg 
pH sediment BAFK 
(g/mL) 
BSAF 
(g sediment/g worms lipid 
content) 
 
Moors 
Amitriptyline 510.4  30946.6 6.43 27.5 14.4 
Diclofenac 14.43 694.7 6.43 32.73 17.2 
Norfluoxetine 498.75 48131 6.43 24.76 13.0 
 
Barnsley 
Amitriptyline 1489.4 5846.5 7.52 21.24 201.9 
Diclofenac 9.75 41.8 7.52 20.14 10.6 
Norfluoxetine 1681.12 9455.1 7.52 9.48 5.0 
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6.3 Applicability of the experimental data to a novel pH-dependent 
uptake modelling approach 
The model proposed by Karlsson et al., (2017) was developed to estimate the uptake 
of sediment-associated ionisable compounds to benthic invertebrates. The model is 
based on the first-order one-compartment toxicokinetic model where the uptake 
rates of the ionized (kin-ion) and unionized part of the molecule (kin-neu) and the 
depuration rate (kout) have to be derived by using the experimental data of the water-
only uptake studies (Chapter 3). These rates are shown in Table 6.3. First, to obtain 
these parameters, the fraction of ionisation of the chemical (ʄion) has to be estimated 
based on the pH and the pKa by using the equation of Henderson-Hasselbach. Then, 
the ionic uptake rate and depuration rate were derived by using the experimental 
data from the water-only uptake studies where each molecule was fully dissociated. 
For example, for amitriptyline and norfluoxetine at pH 5.5, 100% of the molecules 
are dissociated. For diclofenac, the dissociated uptake rate at pH 9 was derived first 
as at this pH value, the molecule is 100% unionized. Then, the data of the test with 
the most deviating pH were used to derive the other uptake rate. 
Ultimately, we evaluated whether it was possible to estimate the internal 
concentrations into the worms (Figs. 6.1, 6.2, 6.3) by using the overlying water 
concentrations from the sediment-uptake studies (Chapter 5).  
The goodness of fit between the modelled and measured internal concentrations was 
calculated using the Nash Sutcliffe value. If the value > 0, the fit is considered 
acceptable; if the value < 0, the fit is unacceptable.  
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 amitriptyiline norfluoxetine diclofenac 
Measured water pH  
Water pH at 5.5 4.52-7.11 5.51-5.69 5.39-6.46 
Water pH at 9 8.28-9.34 8.83-9.20 8.52-9.22 
Ƒion used for the modelling 
Water pH at 5.5 1 1 0.025 
Water pH at 9 0.70 0.40 0 
Rate constants derived by the model 
Kin-neu (L × Kg-1 × h-1) 229.5 66.2 0.37 
Kin-ion (L × Kg-1 × h-1) 8.0 1.066 995 
Kout (h-1) 0.096 1 × 10-7 0.097 
Table 6. 3. Water conditions, fraction of ionisation and the derived uptake and depurations 
constants of the three APIs by using the model proposed by Karlsson et al., (2017).  
 
 
Figure 6. 1. Model evaluation of amitriptyline in sediment-exposed Lumbriculus variegatus. 
The red dots represent the internal concentrations measured in the worms (pmol/g wet 
weight). The blue thick line represents the model fit curves and the dashed blue lines the 
95% confidence interval of the model fit. 
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Figure 6. 2. Model evaluation of diclofenac in sediment-exposed Lumbriculus variegatus. 
The red dots represent the internal concentrations measured in the worms (pmol/g wet 
weight). The blue thick line represents the model fit curves and the dashed blue lines the 
95% confidence interval of the model fit. 
 
 
Figure 6. 3. Model evaluation of norfluoxetine in sediment-exposed Lumbriculus variegatus. 
The red dots represent the internal concentrations measured in the worms (pmol/g wet 
weight). The blue thick line represents the model fit curves and the dashed blue lines the 
95% confidence interval of the model fit. 
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pH amitriptyline norfluoxetine diclofenac 
9  -13.7 0.22 0.65 
7.52  -1.8 -1.0 -0.11 
6.43  -6.4 -1.9 -0.12 
5.5  0.93 0.83 -0.13 
 
Table 6. 4.  Nash Sutcliffe values for the model fit at the different pH values. The pH values 
5.5 and 9 were analyzed from the water-only uptake tests (chapter 3). The pH values 7.52 
and 6.43 were analyzed from the sediment uptake tests (chapter 5).  
 
Even though the Nash Sutcliffe values are slightly negative (Table 6.4), comparisons 
of the model predictions with the measured internal concentrations into the worms 
showed that the model worked quite well for diclofenac and norfluoxetine. In fact, 
for diclofenac, the approach underpredicted the actual accumulation by a factor of 2 
in Moors sediment but a reasonably good fit was found for Barnsley sediment. For 
norfluoxetine, the model underestimated the uptake data by a factor of 4 for the 
Moors sediment but a good fit for the depuration data was seen. However, 
amitriptyline results showed a remarkable underprediction for both sediments. 
These results may be explained by the sediment ingestion of the worms which was 
not investigated in this work. A previous study by Karlsson et al., (2016) 
demonstrated the importance of the dietary uptake when comparing worms without 
the head and worms with the head. In the future, additional experiments with these 
compounds and the worms should be done to further understand the contribution 
of the ingestion of sediment particles. For example, using the method suggested by 
Karlsson et al., (2016) it would be possible to better understand whether the particle 
ingestion is a major contribution to the uptake into the worms. 
Although there is a mismatch between model predictions and measured 
observations of amitriptyline, the results of diclofenac and norfluoxetine are quite 
promising. In fact, with this approach, it is possible to predict the internal exposure 
to an acceptable degree of accuracy based on the concentrations of the API in the 
overlying water, the degree of ionisation and the water pH.  
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Diclofenac was also used in the model development by Karlsson et al., (2017). The 
authors found that the comparisons between modelled predictions and measured 
data were less than a factor of 5. Similar results were reported for fluoxetine. Better 
predictions were observed for our results. However, in our study, we employed the 
model using the overlying water concentrations of the chemicals instead of the pore 
water concentrations as they suggested. Also, the different sediment characteristics 
may have contributed to those differences.   
We tested the general applicability of the model with new data and sediments and 
the results seem quite promising. With this approach, it was possible to estimate the 
internal concentrations in the organisms with reasonably good predictions. In the 
future, we suggest to further explore the model with more molecules and sediments.   
6.4 Implication for the Environmental Risk Assessment 
Overall, the research presented in this thesis shows that APIs are taken up by non-
target organisms and therefore they could potentially cause adverse effects to them.  
Bioconcentration is an essential parameter included in the PTB assessment of the 
European Medicine Agency (EMA) guidelines for medicinal products. However, 
experimental bioconcentration tests are required for fish species only and no tests 
with lower trophic species are considered. For this purpose, the OECD guideline 305 
is recommended; however, the number of fish required, the time in the laboratory 
and the cost of the equipment is demanding. Therefore, the use of models to predict 
the bioconcentration has been proposed to overcome the use of the OECD 
guidelines. Some of them have been evaluated in Chapter 2. These models attempted 
to combine physicochemical, environmental parameters and biological traits to 
better estimate the accumulation of APIs in fishes and few in invertebrates. However, 
the majority of the model failed in predicting the BCF. 
Recently, new modelling approaches have been proposed such as machine learning 
methods to extend the classical linear regression QSAR models and still trying to 
substitute the use of animals used to experimentally determined the BCF/BAF of a 
chemical. For example, machine learning methods were employed to predict the BCF 
in fish species by using classification trees and random forest on over 700 chemicals 
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(Strempel et al., 2013). The authors found a good prediction of bioaccumulation and 
with this novel approach they were able to understand also which physicochemical 
descriptors play a key role in determining the BCF in fish species. For instance, they 
found that the main important descriptors were the LogD (octanol-water partitioning 
distribution), the LogBioHL (logarithmic of the degradation kinetic by 
biotransformation half-life) and TPSA (polarity by topological polar surface area). 
More recently, the applicability of machine learning techniques has been extended 
to invertebrates (Miller et al., 2019). In this latter study, the authors applied machine 
learning models to one fish species (Ciprinis carpio) and a freshwater invertebrate 
(Gammarus pulex). Here again, they found good prediction performance and they 
also listed important descriptors such as MW (molecular weight), LogD, TPSA 
(topological polar surface area) and nN (numbers of nitrogens). The use of these new 
models is complex but advantageous. In fact, they can reliably estimate BCF, they 
specifically indicate the most important descriptors for a certain organism and they 
offer a rapid alternative to the linear relationship models-based.  
In addition, these models could be integrated into the European guidelines and 
ultimately could be expanded to other species such as in this case to oligochaete. In 
fact, due to the lack of the data available for invertebrate species in the literature 
and the need of these data for regulators, the potential applicability of these novel 
approaches could offer an alternative due to their flexibility and the relatively low 
cost for first screening in the PTB assessment.    
 
Risk assessment 
 
In the European regulations such as the European Medicine Agency (EMA), the PTB 
assessment is included and in the case of substances possessing the logKow > 4.5, the 
ECHA guideline should be followed for testing the bioaccumulation potential of 
substances in fish species and other aquatic organisms such as invertebrates (ECHA, 
2017).  
In Chapter 3, the role of the pH on the uptake of ionisable substances was 
investigated. The Bioconcentration factor (BCF) was observed to vary remarkably 
between the lowest pH value (pH =5.5) and the highest pH value (pH =9) for all the 
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APIs, Table 1. These changes are likely to affect the toxicity on benthic organisms and 
studies in the literature have demonstrated the relationship between the pH and 
toxicity to non-target species (Nakamura et al., 2008b; Anskjaer et al., 2013; Boström 
and Berglund, 2015). For example, recently, Scott et al., (2019) evaluated the 
influence of pH on the fish species Fundulus grandis of three weak bases 
pharmaceuticals, carbamazepine, diltiazem, and diphenhydramine, at two pH values 
(8.3 and 6.7). They found a significant difference between the bioconcentration of 
the APIs into the fish between the two pH values suggesting the pH as a key 
parameter to consider when assessing the uptake of ionisable chemicals.    
Therefore, for standard toxicity tests suggested by the European guidelines, we 
suggest that careful attention should be pointed to the pH values at which the 
organisms are exposed to the substance that it elicits the greatest uptake and 
therefore toxicity. Otherwise, an under or an over-estimation of the risk could occur.  
The data reported in Chapter 5 could be useful to interpret the transfer of the APIs 
to higher trophic levels and therefore assess the risk of secondary poisoning to 
predators such as fish species that feed on lumbricids in their diet (Diepens et al., 
2014).  
In this chapter, we evaluated a new modelling approach that predicts the uptake of 
ionisable compounds into benthic invertebrates. The model is the first of its kind in 
trying to combine physicochemical properties and sediment characteristics for 
estimating the uptake into benthic invertebrates. The approach that we used was 
slightly different from the approach illustrated by the authors. However, the model 
worked quite well for some compounds (diclofenac and norfluoxetine). With this 
method, it was possible to predict the internal exposure within a factor of 2 for 
diclofenac and within a factor of 4 for norfluoxetine. We suggest that further 
improvement of the model should be done with more sediments. This could help in 
understanding if other sediment properties are involved in the uptake and, in a 
longer-term, the model could be an important tool in generating data on the uptake 
of ionisable compounds in other aquatic invertebrates.    
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6.5 Recommendations for future work 
The research presented in this PhD thesis produced new insights into the uptake and 
fate of ionisable APIs into a sediment-dwelling worm L. variegatus.   
Nevertheless, some areas of research need to be expanded and some questions have 
to be addressed in the future. In the following paragraphs, these questions will be 
briefly discussed.  
1. In the current studies, a single species was used in order to have a clear 
picture of the relationship between physicochemical properties of the 
compounds (pKa) and environmental properties (pH, OC). Although the range 
of molecules tested was limited, in the future, the species traits could be 
included in the analysis. In this way, we suggest additional species could be 
used enabling to evaluate the difference in uptake in different invertebrates 
(Rubach et al., 2012). For example, we suggest organisms that live in the 
water column only such as Hyalella Azteca or Gammarus pulex that have a 
different feeding habit and habitat. Another species that could be used is 
Daphnia magna which is easy to cultivate as the above mention organisms 
and for which there are available data in the literature. Also, the insect 
Chironomus riparius could be tested to evaluate other species traits such as 
mode of respiration.    
2. The two main pathways of uptake of chemicals into benthic invertebrates are 
via the skin and the diet (Lappänen and & Kukkonen, 1998). It would be 
interesting to assess the diet exposure. Work is needed on a broader range 
of molecules to really understand relationships between properties and 
dietary uptake. This work is fundamental and it might be needed to 
understand the relationship that we can then integrate into models. 
3. The experimental tests in this work used radiolabelled compounds and due 
to instrument limitations, we assumed the fate and uptake of the parent 
compounds only. The analysis of the metabolites has been omitted. 
Therefore, another future work would be the investigation of the 
transformation products of the chosen APIs by employing new techniques 
such as the TOF-MS.  
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4. This research demonstrated that linear regression models proposed in the 
literature failed in estimating the BCF. For benthic invertebrates that are 
submerged in the sediment, the environmental properties like pH and TOC 
have to be accounted for along with physicochemical properties as pKa. The 
model proposed by Karlsson et al., (2017) tried to link these factors but, 
because of the complexity of the uptake, a refinement of the model is 
needed. A possible solution could be the novel machine learning techniques 
that are rapid and cost-effective in determining the BCF and illustrating which 
factors are important to take into considerations. However, the need of data 
to run the models is necessary. For example, more BCF data on lumbricids on 
a large range of molecules would be required where these substances are 
tested at more than one pH value in order to estimate the bioconcentration 
at different pH ranges. Also, other physicochemical data could be selected 
such as the pKa. For ionisable chemicals, it is an important parameter to take 
into consideration and few experimental measurements of the pKa are 
available in the literature and the majority of the studies use estimated tools. 
If the pKa could be measured, it would be a more reliable data.   
5. In our research, the pore water concentrations were not measured along 
with the uptake experiments from sediments over time. This was due to the 
difficulty of properly handling the samples in the laboratory and the potential 
loss of part of the sediment. We also found a large difference between 
measured and predicted pore water concentrations. Thus, future work could 
be the development of an analytical method able to measure the pore water 
in the exposure beakers to better comprehend the contribution of the pore 
water as another route of exposure.   
6. It would be worth assessing the impact that these compounds may have on 
the lumbricids. With this thesis, we demonstrated that the worms 
accumulate the APIs, hence, the internal concentrations could be linked with 
the effects. For example, the effects of ionisable compounds have been 
demonstrated in the literature on several invertebrate species (Nieto et al., 
2017b; Liu et al., 2017; Nkoom et al., 2019) and information on L. variegatus 
is needed to better understand the toxicity. 
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Appendices 
Appendix A – Supporting Data for Chapter Two 
 
Evaluation of models for estimating the bioconcentration factor of 
ionisable compounds 
 
 
Name CAS 
number 
Class LogKow Reference pKa Reference 
2,4-DB (4-(2,4-
dichlorophenoxy
)butyric acid 
 
94-82-6 
 
 
Herbicide 
 
3.6 
 
EPI Suite 
 
7.8 
(Kishino and 
Kobayashi, 
1995) 
Atenolol 29122-68-
7 
 
β-blocker -0.03 EPI Suite 9.6 (Steinbach et 
al., 2014) 
5-Fluorouracil 51-21-8 
 
Anti-
cancer 
-0.81 EPI Suite 8.0
2 
DrugBank 
Asenapine 
maleate 
85650-56-
2 
 
Antipsyc
otic 
4.77 EPI Suite 8.6 iPiE database 
Asunaprevir  630420-
16-5 
 
Anti-
hepatitis 
C 
3.42 iPiE 
database 
4.8 iPiE database 
Beclabuvir 
Hydrochloride 
958002-
36-3 
 
Antiviral 6.11 EPI Suite 4.6/
6.8 
iPiE database 
Bentazone 25057-89-
0 
 
Herbicide 2.34 EPI Suite 3.3 (Maënpaä¨ et 
al., 2003) 
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Buprenorphine 
524885-
79-7 
 
 
Analgesic 
 
3.11 
iPiE 
database 
 
8.3 
iPiE database 
 
Carvedilol 
 
72956-09-
3 
 
 
β-blocker 
 
3.05 
Williams 
et al., 
2012 
 
8 
(Meredith-
Williams et 
al., 2012) 
Ceritinib 1032900-
25-6 
 
Anticanc
er 
5.1 EPI Suite 10.
5 
ACD I lab 
Chloramphenicol 
 
56-75-7 
 
Antibiotic 0.92 EPI Suite 8.6 Karlsson et 
al., 2015 
 
Dabrafenib 
mesylate 
1195768-
06-9 
 
 
Anticanc
er 
3.93 iPiE 
database 
6.6 iPiE database 
Daclatasvir 
Dihydrochloride 
 
1009119-
65-6 
 
Antiviral 4.67 iPiE 
database 
4.9/
5.6 
iPiE database 
Dasanatib 302962-
49-8  
 
Anticanc
er 
1.1 EPI Suite 3.1/
6.8 
iPiE database 
Diphenhydramin
e 
 
58-73-1 
 
Anti-
histamin
e 
3.11 EPI Suite 9 Nichlos et al., 
2015 
Diazepam 439-14-5 
 
Sedative 2.7 EPI Suite 3.4 DrugBank 
 
Diltiazem 
 
42399-41-
7 
 
Calcium 
channel 
blocker 
 
 
2.79 
 
EPI Suite 
 
7.7 
 
SRC, 2004 
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Diclofenac 
 
15307-86-
5 
 
Nonstero
idal anti-
inflamma
tory drug 
 
 
4.02 
 
EPI Suite 
 
4.1 
 
SPARC 
 
Diclofenac 
sodium 
 
15307-79-
6 
 
Nonstero
idal anti-
inflamma
tory drug 
 
 
4.02 
 
EPI Suite 
 
3.9 
 
iPiE database 
Eltrombopag 496775-
61-2 
 
Antitrom
bosis 
 
6.15 EPI Suite 1.7/
5.9 
iPiE database 
 
Fluoxetine 
54910-89-
3 
 
 
Anti-
depressa
nt 
 
4.65 
 
EPI Suite 
 
10.
01 
Nakamura et 
al., 2008 
 
Formoterol 
73573-87-
2 
 
β-
antagonis
t 
 
1.4 
 
EPI Suite 
 
9.8
1 
 
DrugBank 
 
 
Ibuprofen 
15687-27-
1 
 
Nonstero
idal anti-
inflamma
tory drug 
 
3.79 EPI Suite 4.4 Syracuse 
Research 
Corporation 
Ioxynil 1689-83-4 
 
Herbicide 3.94 EPI Suite 3.9
6 
Tomlin, 1994. 
Imipramine 50-49-7 
 
Anti-
depressa
nt  
5.01 EPI Suite 9.2 DrugBank 
 
Lapanitib 
388082-
78-9 
 
 
Anticanc
er 
 
5.29 
 
EPI Suite 
 
5.7 
 
ACD I lab  
 
Metoprolol 
 37350-58-
6 
 
 
β-blocker 
 
1.69 
 
EPI Suite  
 
9.6
8 
Escher et al., 
2017 
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Mirtazapine 61337-67-
5 
 
Antidepr
essant 
2.78 iPiE 
database 
7 iPiE database 
Moclobemide 71320-77-
9 
 
Antidepr
essant 
1.16 EPI Suite 6.2 IPCS InCHEM 
database 
Naproxen 22204-53-
1 
 
Anti-
inflamma
tory 
3.36 Karlsson 
et al., 
2015 
4.5 Karlsson et 
al., 2015 
 
Nilotinib 
hydrochloride 
 
923288-
90-8 
 
 
Anticanc
er 
 
3.6  
iPiE 
database 
 
2.5/
4.2 
iPiE database 
Norfluoxetine 54910-89-
3 
 
Anti-
depressa
nt 
4.65 EPI Suite 9.8 DrugBank 
Pentachlorophe
nol 
87-86-5 
 
Insecticid
e 
4.74 EPI Suite 4.7
4 
Ashauer et al., 
2006 
 
Posaconazole 
171228-
49-2 
 
 
Antifung
al 
 
2.59 
iPiE 
database 
 
3.6/
4.6 
iPiE database 
Propanolol 13013-17-
7 
 
β-blocker 2.6 EPI Suite 9.5
3 
Ding et al., 
2016  
Ranitidine 66357-35-
5 
 
Anti-
histamin
e 
0.29 EPI Suite  8.0
8 
DrugBank 
Roxithromycin 
 
80214-83-
1 
 
Antibiotic  2.75 EPI Suite 8.8 Ding et al., 
2016 
Salicylic acid  69-72-7 
 
Anti-acne 
product 
2.30 Karlsson 
et al., 
2015 
3.1 Karlsson et 
al., 2015 
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Sulfadiazine 68-35-9 
 
Anti-
bacterial 
-0.09 Anskjær 
et al., 
2013 
6.5 Anskjær et al., 
2013 
 
Telcagepant 
781649-
09-0 
 
 
Antinfla
mmatory 
 
 
3.44 
 
EPI Suite 
 
4.2 
 
ACD I lab 
Terbutaline 46719-29-
3 
 
β-
antagonis
t 
0.67 EPI Suite 9.7
6 
DrugBank 
Triclosan 
 
3380-34-5 
 
Anti-
bacterial 
5.42 Karlsson 
et al., 
2015 
8.1  SPARC 
 
Table A. 1. List of the chemicals and their physicochemical characteristics recorded in the 
database for estimating the BCF. 
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Table A. 2. Specific biological traits of both fish and invertebrate species’ order or class 
obtained from the open literature. 
 
Organisms Water content (%) Lipid weight (%) wet 
weight 
Internal pH 
Fish species 
Japanese medaka 85.2 4.3 7.5 
Mosquito fish 65.97 1.56 7.5 
Oncorhynchus mykiss 76.3 2 7.3 
Fathed minnow 65.97 2.9 7.5 
Lepomis macrochirus 71.3 4.02 7.5 
Invertebrate species 
Gammarus pulex 80 1.34 8 
Lumbriculus 
variegatus 
62.8 1.2 8 
Daphnia magna 97.8 0.94 8.44 
Notonecta glauca 72.26 3.81 7.5 
Planobarius corneus 76 2 7 
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Figure A. 1. Models evaluated exploring the relationships of predicted BCF and measured 
BCF data for acids and zwitterions. 
 
 
 141 
 
 
Figure A. 2. Models evaluated exploring the relationships of predicted BCF and measured 
BCF data for bases and zwitterions. 
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Appendix B – Supporting Data for Chapter Three  
 
Influence of pH on the uptake of ionisable active pharmaceuticals 
ingredients (APIs) into the sediment-dwelling worm (L. variegatus) 
 
Model code 
The toxicokinetic model used is an OpenModel available from the University of 
Nottingham (https://www.nottingham.ac.uk/environmental-
modelling/OpenModel.htm).  
Initial: 
• Cint = 0 
 
Main: 
• Cwater = Water.Cwater(t) 
• Cint.rate = kinx Cw – koutx Cint 
 
Indipendent variable options: 
• Symbol: t 
• Start: 0 
• Stop: 48 
• Output steplength: 1. 
 
ODE Options: 
• Method: Euler; 
• Steptlength options: automatic. 
 
Automatic Steplength: 
• Error facto: 0.01 
• Min steplength: 1E-12. 
 
Merit function options: 
• Squared deviations 
• No weights 
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Settings for the Markov Chain Monte Carlo method 
• Stopping rule: fixed iterations 
• Fixed iterations: 10000 
• No improvement steps: 1000 
• Threshold no improvement: 0.01 
• Maximum errors: 1000 
• Maximum steps: 10000 
• Proposing distribution: adapting proposal. 
 
Data for the model 
 
The dataset consists of concentration of the water (pmol/ml), concentrations in the 
worms (pmol/g wet weight) over time (hours) and mass of the worms (g).  
 
Amitriptyline pH 5.5  
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass of the 
worms(g) 
0 39.15 12 2482.6 0.038 
12 26.54 12 2483.6 0.028 
24 22.09 12 1827.3 0.043 
24.1 2.00 12 2097.3 0.034 
36 6.33 12 2351.6 0.031 
48 6.75 12 2851.9 0.037 
  24 2607.1 0.023 
  24 3333.1 0.026 
  24 2239.2 0.043 
  24 2260.7 0.051 
  24 2208.6 0.035 
  24 2705.8 0.043 
  36 1720.3 0.039 
  36 1196.1 0.046 
  36 1514.1 0.020 
  36 1425.7 0.037 
 144 
 
  36 1279.3 0.03 
  36 1957.2 0.03 
  48 2604.9 0.025 
  48 2615.9 0.029 
  48 1360.2 0.023 
  48 1697.6 0.048 
  48 1344.5 0.032 
  48 1352.5 0.029 
 
 
Amitriptyline pH 7 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass of the 
worms(g) 
0 33.19 12 5782.0 0.022 
12 19.71 12 4594.7 0.027 
24 19.05 12 4633.1 0.025 
24.1 0.25 12 3841.6 0.034 
36 5.21 12 4433.0 0.025 
48 6.26 12 4812.8 0.025 
  24 5652.8 0.021 
  24 3983.5 0.030 
  24 5711.1 0.024 
  24 5916.5 0.020 
  24 6918.8 0.019 
  24 7528.5 0.014 
  36 3539.9 0.025 
  36 3763.6 0.021 
  36 3007.7 0.014 
  36 4160.4 0.016 
  36 3951.1 0.024 
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  36 3761.6 0.015 
  48 3181.1 0.017 
  48 4726.1 0.018 
  48 2677.1 0.021 
  48 3267.1 0.020 
  48 3567.1 0.021 
  48 3945.4 0.022 
 
Amitriptyline pH 8 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass of the 
worms(g) 
0 37.93 12 5612.3 0.022 
12 21.21 12 7193.8 0.021 
24 17.94 12 7185.4 0.017 
24.1 1.29 12 6244.0 0.021 
36 4.14 12 5698.5 0.024 
48 7.13 12 6086.8 0.020 
  24 9758.8 0.015 
  24 7286.5 0.023 
  24 7715.8 0.022 
  24 6234.7 0.026 
  24 7847.4 0.021 
  24 7877.3 0.025 
  36 6331.1 0.020 
  36 6431.6 0.019 
  36 7451.7 0.014 
  36 6604.0 0.017 
  36 5232.6 0.026 
  36 6080.4 0.023 
  48 5679.8 0.018 
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  48 5343.6 0.020 
  48 6083.0 0.015 
  48 5606.6 0.013 
  48 3662.6 0.029 
  48 6086.4 0.019 
 
Amitriptyline pH 9 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass of the 
worms(g) 
0 40.01 12 8680.6 0.027 
12 8.48 12 8584.8 0.033 
24 3.65 12 7225.0 0.034 
24.1 0.28 12 10072.3 0.025 
36 2.00 12 7536.2 0.038 
48 2.37 12 7445.0 0.036 
  24 7409.0 0.043 
  24 6894.7 0.050 
  24 5948.8 0.059 
  24 8769.0 0.036 
  24 10160.3 0.031 
  24 7424.6 0.037 
  36 8675.2 0.040 
  36 8486.2 0.038 
  36 7762.2 0.045 
  36 5769.3 0.055 
  36 9022.4 0.037 
  36 7515.9 0.044 
  48 6370.5 0.048 
  48 8714.0 0.034 
  48 7130.4 0.046 
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  48 8534.7 0.036 
  48 7409.8 0.045 
  48 7322.8 0.038 
 
Diclofenac pH 5.5 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass of the 
worms(g) 
0 45.73 12 5486.84 0.026 
12 21.67 12 3629.91 0.035 
24 23.13 12 4106.37 0.051 
24.1 1.02 12 3588.33 0.043 
36 4.03 12 4810.00 0.030 
48 6.17 12 3289.78 0.035 
  24 7437.7 0.030 
  24 5023.2 0.032 
  24 5568.8 0.026 
  24 6283.2 0.031 
  24 7842.8 0.023 
  24 5407.2 0.033 
  36 2785.6 0.035 
  36 4264.0 0.035 
  36 4264.0 0.042 
  36 2319.3 0.025 
  36 5743.8 0.024 
  36 2497.7 0.027 
  48 3550.1 0.023 
  48 2900.9 0.028 
  48 2842.8 0.019 
  48 2842.8 0.035 
  48 3887.6 0.032 
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  48 3641.7 0.035 
 
Diclofenac pH 7 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass of the 
worms(g) 
0 33.20 12 1263.08 0.043 
12 30.05 12 1521.15 0.047 
24 28.73 12 1340.73 0.034 
24.1 1.20 12 1698.06 0.041 
36 3.47 12 905.49 0.042 
48 4.68 12 1815.83 0.033 
  24 2063.9 0.036 
  24 2011.2 0.043 
  24 3282.0 0.028 
  24 1357.4 0.042 
  24 2025.2 0.036 
  24 2509.1 0.036 
  36 716.9 0.03 
  36 970.7 0.039 
  36 970.7 0.023 
  36 569.6 0.041 
  36 766.3 0.051 
  36 633.6 0.056 
  48 572.8 0.024 
  48 767.6 0.033 
  48 1205.4 0.039 
  48 1205.4 0.018 
  48 304.1 0.036 
  48 547.0 0.022 
 
Diclofenac pH 8 
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Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass of the 
worms(g) 
0 34.07 12 427.6 0.036 
12 28.70 12 272.9 0.032 
24 28.12 12 324.2 0.041 
24.1 3.06 12 454.3 0.037 
36 3.41 12 359.2 0.037 
48 2.92 12 391.5 0.045 
  24 293.5 0.041 
  24 324.6 0.041 
  24 302.7 0.042 
  24 374.5 0.050 
  24 297.9 0.036 
  24 300.9 0.037 
  36 171.3 0.048 
  36 121.2 0.052 
  36 129.4 0.043 
  36 126.0 0.029 
  36 138.1 0.028 
  36 145.2 0.034 
  48 68.2 0.041 
  48 130.3 0.029 
  48 138.7 0.031 
  48 145.5 0.034 
  48 105.6 0.034 
  48 125.8 0.037 
 
 
Diclofenac pH 9 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass of the 
worms(g) 
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0 45.60 12 124.3 0.033 
12 28.33 12 110.6 0.055 
24 32.62 12 135.04 0.036 
24.1 1.70 12 92.69 0.040 
36 1.70 12 108.81 0.043 
48 2.94 12 91.06 0.045 
  24 96.27 0.052 
  24 111.22 0.048 
  24 70.1 0.034 
  24 82.2 0.036 
  24 74.0 0.032 
  24 101.0 0.035 
  36 32.0 0.021 
  36 45.4 0.037 
  36 47.3 0.028 
  36 37.9 0.031 
  36 52.9 0.043 
  36 36.7 0.034 
  48 30.1 0.031 
  48 37.4 0.037 
  48 32.6 0.031 
  48 43.8 0.040 
  48 37.3 0.027 
  48 29.8 0.043 
 
Ketoconazole pH 5.5 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass of the 
worms(g) 
0 14.55 12 422.61 0.023 
12 12.44 12 345.42 0.018 
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24 11.83 12 588.06 0.027 
24.1 0.28 12 812.39 0.022 
36 0.18 12 563.80 0.023 
48 0.40 12 755.09 0.028 
  24 830.16 0.027 
  24 916.25 0.031 
  24 579.05 0.026 
  24 762.30 0.033 
  24 811.56 0.034 
  24 445.38 0.026 
  36 383.68 0.031 
  36 361.07 0.030 
  36 646.43 0.033 
  36 553.20 0.028 
  36 489.71 0.036 
  36 200.56 0.025 
  48 379.69 0.029 
  48 379.69 0.030 
  48 440.63 0.026 
  48 286.11 0.031 
  48 422.61 0.027 
  48 345.42 0.025 
 
 
 
 
Ketoconazole pH 7 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass pf the 
worms(g) 
0 16.08 12 1584 0.026 
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12 14.25 12 1706 0.031 
24 14.39 12 1188 0.023 
24.1 0.43 12 1794 0.028 
36 0.98 12 1504 0.029 
48 2.02 12 1265 0.020 
  24 1688 0.031 
  24 1562 0.031 
  24 1632 0.027 
  24 1766 0.020 
  24 1578 0.031 
  24 1531 0.023 
  36 1047 0.019 
  36 847 0.025 
  36 847 0.028 
  36 1096 0.032 
  36 1046 0.032 
  36 973 0.025 
  48 818 0.023 
  48 1108 0.028 
  48 1021 0.021 
  48 1021 0.024 
  48 998 0.026 
  48 1199 0.024 
 
 
 
Ketoconazole pH 8 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass pf the 
worms(g) 
0 26.56 12 1021.61 0.014 
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12 15.05 12 824.42 0.013 
24 15.03 12 1013.65 0.013 
24.1 0.08 12 745.50 0.015 
36 0.04 12 1063.50 0.015 
48 0.17 12 634.50 0.015 
  24 1090.96 0.013 
  24 1201.61 0.014 
  24 1291.32 0.017 
  24 1228.39 0.014 
  24 1254.27 0.017 
  24 1587.95 0.014 
  36 572.68 0.014 
  36 546.96 0.014 
  36 546.96 0.02 
  36 512.68 0.01 
  36 705.75 0.012 
  36 455.63 0.014 
  48 565.78 0.016 
  48 393.28 0.016 
  48 519.26 0.017 
  48 519.26 0.017 
  48 308.04 0.014 
  48 441.25 0.018 
 
 
 
Ketoconazole pH 9 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass pf the 
worms(g) 
0 33.61 12 1698.52 0.032 
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12 14.39 12 1681.92 0.043 
24 14.33 12 1512.13 0.034 
24.1 0.12 12 1110.24 0.031 
36 0.52 12 1256.93 0.022 
48 0.26 12 1231.63 0.023 
  24 1977.58 0.028 
  24 1606.88 0.028 
  24 1994.11 0.025 
  24 1731.63 0.026 
  24 1897.72 0.034 
  24 1937.95 0.033 
  36 1674.19 0.040 
  36 1311.22 0.035 
  36 1311.22 0.027 
  36 1234.17 0.030 
  36 1053.07 0.022 
  36 1233.75 0.03 
  48 1257.34 0.031 
  48 1139.70 0.025 
  48 935.95 0.032 
  48 935.95 0.029 
  48 1114.25 0.030 
  48 994.25 0.030 
 
 
 
Norfluoxetine pH 5.5 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass pf the 
worms(g) 
0 47.40 12 397.7 0.025 
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12 30.06 12 367.1 0.026 
24 30.38 12 408.5 0.023 
24.1 0.79 12 399.1 0.018 
36 1.08 12 601.9 0.020 
48 0.99 12 394.2 0.025 
  24 887.8 0.022 
  24 865.3 0.026 
  24 644.1 0.028 
  24 816.7 0.022 
  24 895.3 0.021 
  24 1303.1 0.017 
  36 928.7 0.021 
  36 747.0 0.023 
  36 747.0 0.021 
  36 787.3 0.019 
  36 1032.3 0.026 
  36 766.5 0.022 
  48 1497.7 0.015 
  48 960.0 0.018 
  48 848.6 0.019 
  48 848.6 0.019 
  48 929.4 0.023 
  48 827.3 0.029 
 
 
 
Norfluoxetine pH 7 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass pf the 
worms(g) 
0 33.87 12 7762.6 0.015 
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12 31.31 12 7207.5 0.015 
24 30.17 12 6253.2 0.018 
24.1 0.51 12 6011.8 0.014 
36 0.92 12 6528.0 0.017 
48 1.24 12 5941.6 0.018 
  24 10137.3 0.013 
  24 8343.5 0.016 
  24 6099.3 0.019 
  24 6944.8 0.018 
  24 9135.3 0.014 
  24 9207.3 0.013 
  36 7049.2 0.018 
  36 6377.5 0.017 
  36 6968.7 0.015 
  36 5829.2 0.018 
  36 7331.8 0.016 
  36 7041.6 0.013 
  48 6546.1 0.016 
  48 6606.7 0.018 
  48 6667.3 0.02 
  48 6687.7 0.016 
  48 8334.3 0.017 
  48 8040.9 0.015 
 
 
 
Norfluoxetine pH 8 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass pf the 
worms(g) 
0 38.85 12 14859.4 0.017 
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12 23.73 12 16677.7 0.014 
24 19.99 12 15010.9 0.015 
24.1 0.40 12 15522.5 0.017 
36 1.20 12 13277.2 0.014 
48 1.93 12 18636.5 0.014 
  24 20595.3 0.017 
  24 21094.1 0.016 
  24 14135.1 0.018 
  24 19316.1 0.015 
  24 17470.0 0.021 
  24 22846.7 0.016 
  36 19762.2 0.013 
  36 14395.8 0.015 
  36 14395.8 0.011 
  36 28334.1 0.015 
  36 17765.9 0.020 
  36 18263.8 0.021 
  48 18931.5 0.017 
  48 15636.3 0.018 
  48 16435.4 0.013 
  48 16435.4 0.017 
  48 16099.7 0.017 
  48 15680.8 0.016 
 
 
Norfluoxetine pH 9 
Time (h) Cwater 
(pmol/ml) 
Time (h) Cint (pmol/g) Mass pf the 
worms(g) 
0 39.76 12 12956.7 0.032 
12 16.96 12 11155.0 0.035 
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24 13.08 12 24359.4 0.017 
24.1 0.26 12 13787.6 0.029 
36 0.56 12 17479.2 0.023 
48 1.50 12 13201.1 0.033 
  24 26298.7 0.016 
  24 18456.1 0.025 
  24 24974.7 0.02 
  24 20016.5 0.03 
  24 18651.9 0.027 
  24 24305.3 0.014 
  36 17711.8 0.026 
  36 19580.9 0.022 
  36 19580.9 0.023 
  36 18170.1 0.021 
  36 13537.4 0.021 
  36 19535.1 0.030 
  48 19077.4 0.022 
  48 28577.1 0.017 
  48 22168.0 0.017 
  48 22168.0 0.022 
  48 17164.8 0.023 
  48 24771.2 0.018 
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Mass balance calculations of 24 h uptake and 24 h depuration of the three APIs. 
  
 Timepoint 
(h) 
Tot mass of 
API in water 
(pmol) 
Tot mass of API in 
the worms (pmol) 
Tot mass of API in the 
whole system (pmol) 
% of spiked API  
 
 
 
 
 
Amitriptyline 
pH 5.5  
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
374.7 
416.7 
520.5 
422.3 
328.9 
449.4 
267.5 
301.4 
288.3 
288.7 
241.2 
278.8 
210.2 
261.5 
222.3 
225.0 
237.5 
0 
0 
0 
0 
0 
0 
94.34 
69.54 
78.57 
71.31 
72.90 
105.52 
59.96 
86.66 
96.29 
115.30 
77.30 
374.69 
416.74 
520.46 
422.32 
328.94 
449.41 
361.84 
370.90 
366.92 
360.00 
314.15 
384.33 
270.198 
348.18 
318.63 
340.33 
314.84 
100 
105.31 
119.02 
97.41 
79.72 
107.32 
96.57 
93.73 
83.91 
83.03 
76.13 
91.78 
72.11 
87.99 
72.86 
78.50 
76.30 
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24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
238.7 
84.0 
69.2 
64.5 
84.1 
64.7 
83.3 
82.4 
75.9 
52.4 
75.7 
68.3 
50.6 
 
116.35 
67.09 
55.02 
30.28 
52.75 
38.38 
58.72 
65.12 
75.86 
31.28 
81.48 
43.02 
39.22 
 
355.05 
151.051 
124.24 
94.83 
136.84 
103.09 
142.03 
147.53 
151.77 
83.64 
157.15 
111.30 
89.78 
 
84.78 
36.1 
29.7 
22.6 
32.7 
24.6 
33.9 
35.2 
36.2 
20.0 
37.5 
26.6 
21.4 
 
 
 
Amitriptyline 
pH 7 
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
374.1 
353.7 
334.6 
328.8 
313.8 
334.0 
232.5 
211.3 
183.8 
178.6 
191.1 
202.1 
194.4 
158.0 
0 
0 
0 
0 
0 
0 
130.29 
127.14 
118.91 
133.70 
113.91 
123.40 
121.79 
122.59 
374.13 
353.72 
334.56 
328.83 
313.82 
333.98 
362.76 
338.48 
302.68 
312.29 
305.04 
325.53 
316.14 
280.61 
100 
97.20 
94.47 
94.54 
92.03 
98.28 
96.96 
93.01 
85.47 
89.79 
89.45 
95.79 
84.50 
77.11 
 161 
 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
177.7 
207.3 
201.3 
222.0 
61.1 
52.9 
62.0 
55.8 
54.1 
42.6 
65.1 
61.2 
68.1 
62.0 
62.0 
57.0 
 
140.15 
121.41 
134.54 
108.48 
91.58 
82.12 
45.19 
69.65 
97.91 
59.50 
57.16 
88.15 
59.30 
68.42 
77.99 
89.88 
 
317.85 
328.74 
335.81 
330.50 
152.68 
135.01 
107.23 
125.49 
152.01 
102.07 
122.26 
149.31 
127.38 
130.44 
139.99 
146.91 
 
89.75 
94.52 
98.48 
97.25 
44.9 
39.7 
31.6 
36.9 
44.7 
30.0 
36.0 
43.9 
37.5 
38.4 
41.2 
43.2 
 
 
 
Amitriptyline 
pH 8 
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
327.4 
373.7 
399.1 
428.4 
445.6 
414.5 
210.7 
230.8 
204.4 
241.5 
238.5 
0 
0 
0 
0 
0 
0 
123.47 
151.07 
122.15 
131.12 
136.76 
327.38 
373.70 
399.12 
428.36 
445.63 
414.51 
334.16 
381.90 
326.59 
372.67 
375.30 
100 
106.61 
108.83 
112.10 
112.86 
104.12 
102.07 
108.95 
89.05 
97.52 
95.05 
 162 
 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
225.6 
193.3 
197.9 
190.8 
189.7 
184.9 
198.9 
41.8 
55.5 
57.1 
57.3 
55.1 
57.7 
73.9 
78.2 
75.5 
64.8 
75.2 
60.4 
 
121.74 
146.38 
167.59 
169.75 
162.10 
164.80 
196.93 
126.62 
122.20 
104.32 
112.27 
458.00 
139.85 
102.24 
106.87 
91.25 
72.89 
106.21 
115.64 
 
347.33 
339.647 
365.50 
360.60 
351.85 
349.68 
395.86 
168.455 
177.67 
161.41 
169.54 
513.15 
197.55 
176.13 
185.06 
166.77 
137.65 
181.42 
176.03 
 
87.24 
103.75 
104.27 
98.33 
92.07 
88.56 
99.43 
42.3 
44.6 
40.5 
42.6 
128.9 
49.6 
44.2 
46.5 
41.9 
34.6 
45.6 
44.2 
 
 
 
 
Amitriptyline 
pH 9 
0 
0 
0 
0 
0 
0 
12 
12 
474.9 
413.5 
177.9 
428.1 
378.9 
404.2 
131.8 
98.3 
0 
0 
0 
0 
0 
0 
234.37 
283.30 
474.90 
413.54 
177.93 
428.15 
378.91 
404.17 
366.15 
381.60 
100 
93.09 
50.06 
114.59 
101.13 
106.47 
77.10 
85.90 
 163 
 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
90.8 
127.9 
74.8 
51.5 
53.9 
35.8 
41.2 
49.1 
52.1 
52.8 
34.2 
27.2 
25.2 
29.2 
42.1 
28.1 
28.2 
51.0 
32.2 
38.2 
25.5 
30.1 
 
245.65 
251.81 
286.37 
268.02 
318.59 
344.73 
350.98 
315.68 
314.97 
274.71 
347.01 
322.48 
349.30 
317.31 
333.83 
330.70 
305.78 
296.28 
328.00 
307.25 
333.44 
278.27 
 
336.43 
379.72 
361.13 
319.55 
372.501 
380.52 
392.19 
364.79 
367.06 
327.47 
381.242 
349.70 
374.49 
346.55 
375.93 
358.78 
334.00 
347.24 
360.19 
345.40 
358.98 
308.39 
 
94.65 
101.63 
96.38 
84.18 
78.44 
85.66 
110.33 
97.63 
97.96 
86.27 
100.4 
92.1 
98.7 
91.3 
99.0 
94.5 
88.0 
91.5 
94.9 
91.0 
94.6 
81.2 
 
 
 
 
0 
0 
0 
0 
0 
1022.6 
992.1 
865.8 
924.1 
837.4 
0 
0 
0 
0 
0 
1022.6 
992.07 
865.80 
924.05 
837.38 
100 
98.48 
90.17 
97.15 
90.20 
 164 
 
 
 
 
 
 
 
Diclofenac pH 
5.5 
0 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
993.3 
497.5 
447.2 
459.1 
481.4 
424.9 
432.2 
440.9 
496.5 
518.9 
478.0 
492.0 
491.0 
137.0 
118.0 
94.4 
99.6 
89.0 
88.3 
105.4 
129.4 
125.0 
119.0 
117.5 
144.6 
 
0 
142.66 
127.05 
209.42 
154.30 
144.30 
115.14 
223.13 
160.74 
144.79 
194.78 
180.38 
178.44 
97.50 
149.24 
179.09 
57.98 
137.85 
67.44 
81.65 
81.22 
54.01 
99.50 
124.40 
127.46 
 
993.33 
640.11 
574.21 
668.48 
635.66 
569.15 
547.31 
664.08 
657.27 
663.68 
672.82 
672.38 
669.46 
234.52 
267.22 
273.51 
157.58 
226.87 
155.75 
187.09 
210.66 
179.03 
218.51 
241.89 
272.06 
 
105.76 
62.60 
57.00 
69.62 
66.83 
61.31 
58.27 
64.94 
65.25 
69.12 
70.74 
72.43 
71.28 
25.0 
28.5 
29.1 
16.8 
24.2 
16.6 
19.9 
22.4 
19.1 
23.3 
25.8 
29.0 
 
 0 
0 
703.9 
687.2 
0 
0 
703.91 
687.16 
100 
98.80 
 165 
 
 
 
 
 
 
 
 
Diclofenac pH  
7 
0 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
696.9 
653.4 
699.7 
688.6 
644.8 
618.8 
647.1 
581.8 
638.0 
622.1 
566.5 
594.7 
593.7 
629.6 
614.2 
581.8 
99.8 
98.6 
99.8 
79.0 
89.8 
82.1 
104.7 
95.6 
121.4 
91.9 
82.9 
0 
0 
0 
0 
54.31 
71.49 
45.58 
69.62 
38.03 
59.92 
74.30 
86.48 
91.90 
57.01 
72.91 
90.33 
21.51 
37.86 
22.33 
23.35 
39.08 
35.48 
13.75 
25.33 
47.01 
21.70 
10.95 
696.93 
653.40 
699.71 
688.64 
699.15 
690.31 
692.71 
651.46 
675.99 
682.07 
640.810 
681.19 
685.57 
686.58 
687.09 
672.16 
121.324 
136.48 
122.09 
102.39 
128.92 
117.57 
118.42 
120.90 
168.37 
113.55 
93.80 
100.13 
95.34 
101.67 
100.05 
99.32 
99.25 
99.53 
95.05 
98.22 
99.10 
91.04 
97.94 
98.50 
100.18 
99.84 
97.66 
17.6 
19.8 
17.7 
14.9 
18.7 
17.1 
17.2 
17.6 
24.5 
16.5 
13.6 
 166 
 
48 
 
65.3 
 
12.03 
 
77.38 
 
11.2 
 
 
 
 
 
 
Diclofenac pH 
8 
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
967.0 
1027.9 
965.2 
1005.8 
948.2 
947.4 
894.5 
851.2 
839.9 
825.4 
830.6 
815.8 
887.8 
846.4 
870.3 
836.0 
889.2 
873.0 
158.4 
109.0 
122.9 
113.1 
145.7 
162.5 
69.3 
50.8 
0 
0 
0 
0 
0 
0 
15.39 
8.73 
13.29 
16.81 
13.29 
17.62 
12.03 
13.31 
12.71 
18.73 
10.72 
11.13 
8.22 
6.30 
5.56 
3.65 
3.87 
4.94 
2.80 
3.78 
967.04 
1027.94 
965.18 
1005.81 
948.22 
947.41 
909.90 
859.93 
853.22 
842.20 
843.85 
833.41 
899.838 
859.76 
882.99 
854.76 
899.90 
884.16 
166.608 
115.34 
128.49 
116.73 
149.57 
167.44 
72.10 
54.53 
100 
103.05 
97.82 
101.44 
96.48 
96.98 
94.09 
86.21 
86.47 
84.94 
85.86 
85.31 
93.05 
86.19 
89.49 
86.21 
91.56 
90.50 
17.1 
11.8 
13.2 
11.9 
15.3 
17.1 
7.4 
5.6 
 167 
 
48 
48 
48 
48 
 
49.6 
44.7 
37.4 
41.4 
 
4.30 
4.95 
3.59 
4.65 
 
53.88 
49.65 
41.01 
46.03 
 
5.5 
5.1 
4.2 
4.7 
  
 
 
 
 
 
 
 
Diclofenac pH 
9 
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
1025.2 
900.1 
215.9 
976.4 
892.2 
1080.4 
694.3 
690.7 
146.0 
643.3 
694.6 
672.2 
673.2 
661.4 
681.1 
691.7 
676.8 
677.3 
70.6 
40.2 
72.6 
60.8 
74.9 
0 
0 
0 
0 
0 
0 
4.10 
6.08 
4.86 
3.71 
4.68 
4.10 
5.01 
5.34 
2.38 
2.96 
2.37 
3.54 
0.67 
1.68 
1.32 
1.17 
2.28 
1025.18 
900.11 
215.89 
976.36 
892.20 
1080.44 
698.410 
696.79 
150.88 
646.96 
699.31 
676.32 
678.206 
666.76 
683.44 
694.65 
679.17 
680.83 
71.254 
41.88 
73.92 
61.94 
77.17 
100 
93.50 
30.25 
125.27 
111.25 
127.36 
68.13 
72.38 
21.14 
83.01 
87.20 
79.72 
66.15 
69.26 
95.76 
89.13 
84.69 
80.25 
8.4 
4.9 
8.7 
7.3 
9.1 
 168 
 
36 
48 
48 
48 
48 
48 
48 
 
32.5 
65.3 
52.5 
73.0 
58.5 
56.0 
47.7 
 
1.25 
0.93 
1.38 
1.01 
1.75 
1.01 
1.28 
 
33.76 
66.28 
53.91 
73.99 
60.22 
57.03 
48.96 
 
4.0 
7.8 
6.4 
8.7 
7.1 
6.7 
5.8 
 
 
 
 
 
 
 
 
 
Ketoconazole 
pH 5.5  
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
412.5 
363.6 
447.6 
457.2 
379.8 
425.4 
423.9 
330.9 
360.9 
442.2 
287.1 
398.4 
442.2 
180.0 
395.7 
325.8 
416.4 
422.1 
133.2 
130.2 
0 
0 
0 
0 
0 
0 
9.72 
6.22 
15.88 
17.87 
12.97 
21.14 
13.28 
13.28 
16.49 
16.79 
19.06 
19.48 
11.58 
7.29 
412.4 
363.6 
447.5 
457.2 
379.80 
425.40 
433.62 
337.12 
376.78 
460.07 
300.07 
419.54 
455.48 
193.28 
412.19 
342.59 
435.46 
441.58 
144.78 
137.49 
100 
93.70 
109.73 
108.80 
92.15 
102.67 
105.12 
86.87 
92.37 
109.48 
72.81 
101.25 
110.42 
53.16 
106.22 
83.99 
105.66 
106.57 
34.94 
33.18 
 169 
 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
133.2 
126.9 
118.5 
135.0 
130.5 
123.0 
125.7 
135.0 
127.5 
129.3 
  
8.06 
9.05 
13.83 
13.83 
8.33 
5.42 
9.49 
6.08 
7.05 
7.73 
 
141.26 
135.95 
132.33 
148.83 
138.83 
128.42 
135.19 
141.08 
134.55 
137.03 
 
34.09 
32.81 
31.94 
35.92 
33.50 
30.99 
32.63 
34.05 
32.47 
33.07 
 
 
 
 
 
 
Ketoconazole 
pH 7 
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
473.7 
463.8 
452.1 
507.0 
421.8 
440.4 
531.3 
381.6 
382.8 
387.9 
408.3 
390.3 
359.7 
472.5 
354.0 
361.2 
532.8 
0 
0 
0 
0 
0 
0 
41.19 
52.89 
27.32 
50.23 
43.61 
25.29 
52.33 
48.42 
44.07 
35.31 
48.93 
473.67 
463.79 
452.09 
506.99 
421.80 
440.40 
572.49 
434.49 
410.11 
438.13 
451.91 
415.59 
412.04 
520.92 
398.07 
396.51 
581.73 
100 
98.94 
97.60 
106.93 
90.97 
95.78 
120.85 
92.69 
88.54 
92.40 
97.46 
90.39 
86.98 
111.13 
85.94 
83.63 
125.46 
 170 
 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
430.2 
138.0 
155.1 
136.5 
144.6 
196.5 
130.5 
235.5 
160.8 
157.2 
176.7 
130.2 
145.5 
 
35.20 
19.89 
21.18 
23.72 
35.07 
33.47 
24.33 
18.82 
31.04 
21.45 
24.51 
25.95 
28.77 
 
465.40 
157.89 
176.28 
160.22 
179.67 
229.96 
154.83 
254.33 
191.84 
178.65 
201.21 
156.15 
174.27 
 
101.22 
33.64 
37.55 
34.13 
38.28 
48.99 
32.98 
54.18 
40.87 
38.06 
42.87 
33.27 
37.13 
 
 
 
 
 
 
 
 
 
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
702.0 
574.2 
652.5 
675.9 
618.6 
684.3 
429.0 
438.0 
449.1 
433.5 
441.3 
438.3 
435.6 
433.8 
0 
0 
0 
0 
0 
0 
14.30 
10.72 
13.18 
11.18 
15.95 
9.52 
14.18 
16.82 
702 
574.2 
652.5 
675.9 
618.60 
684.30 
443.30 
448.72 
462.28 
444.68 
457.25 
447.82 
449.78 
450.62 
100 
89.99 
101.49 
103.80 
95.96 
105.07 
63.15 
70.32 
71.91 
68.29 
70.93 
68.76 
64.07 
70.62 
 171 
 
Ketoconazole 
pH 8 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
428.7 
436.5 
437.7 
434.1 
136.8 
125.1 
135.9 
136.5 
131.7 
132.6 
138.9 
152.4 
136.2 
131.1 
135.6 
120.0 
 
21.95 
17.20 
21.32 
17.47 
8.02 
7.66 
7.66 
10.25 
7.06 
5.47 
9.05 
6.29 
8.83 
8.83 
4.31 
7.94 
 
450.65 
453.70 
459.02 
451.57 
144.82 
132.76 
143.56 
146.75 
138.76 
138.07 
147.95 
158.69 
145.03 
139.93 
139.91 
127.94 
 
70.10 
69.68 
71.21 
69.34 
22.24 
20.39 
22.04 
22.53 
21.31 
21.20 
22.72 
24.37 
22.27 
21.49 
21.48 
19.65 
 
 
 
 
 
Ketoconazole 
pH 9 
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
953.7 
637.2 
769.5 
1073.4 
753.3 
816.0 
402.9 
413.1 
397.5 
402.6 
408.0 
0 
0 
0 
0 
0 
0 
54.35 
72.32 
51.41 
34.42 
27.65 
953.70 
637.20 
769.50 
1073.40 
753.30 
816.00 
457.25 
485.42 
448.91 
437.02 
435.65 
100 
80.11 
97.80 
125.04 
89.95 
97.86 
47.95 
61.02 
57.06 
50.91 
52.02 
 172 
 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
462.6 
433.8 
427.8 
411.0 
426.0 
403.5 
401.1 
137.1 
145.5 
139.8 
131.4 
126.3 
135.3 
132.6 
127.5 
133.2 
120.6 
138.9 
123.0 
 
28.33 
55.37 
44.99 
49.85 
45.02 
64.52 
63.95 
66.97 
45.89 
35.40 
37.02 
23.17 
37.01 
38.98 
28.49 
29.95 
27.14 
33.43 
29.83 
 
490.93 
489.17 
472.79 
460.85 
471.02 
468.02 
465.05 
204.07 
191.39 
175.20 
168.42 
149.47 
172.31 
171.58 
155.99 
163.15 
147.74 
172.33 
152.83 
 
58.87 
51.29 
59.44 
58.57 
54.87 
55.89 
55.77 
24.47 
22.95 
21.01 
20.20 
17.92 
20.66 
20.58 
18.71 
19.57 
17.72 
20.67 
18.33 
 
 
 
 
 
 
0 
0 
0 
0 
0 
12 
12 
12 
1001.09 
981.77 
1001.09 
981.77 
1010.63 
630.89 
500.89 
648.96 
0 
0 
0 
0 
0 
34.86 
34.94 
30.46 
1001 
982 
1001 
982 
1011 
665.74 
535.82 
679.42 
100 
99.03 
100.65 
99.03 
101.54 
66.50 
54.05 
68.31 
 173 
 
 
Norfluoxetine 
pH 5.5 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
647.03 
643.13 
666.77 
633.39 
617.34 
650.57 
627.86 
623.44 
628.39 
42.55 
39.06 
44.48 
38.91 
61.35 
39.22 
48.18 
40.63 
41.93 
34.64 
45.52 
36.98 
 
18.74 
33.25 
34.58 
57.68 
78.04 
68.05 
53.28 
53.09 
50.27 
56.01 
53.38 
47.00 
38.22 
78.75 
50.17 
44.96 
42.01 
35.18 
41.53 
65.73 
92.59 
 
665.78 
676.38 
701.35 
691.07 
695.39 
718.62 
681.14 
676.53 
678.66 
98.56 
92.45 
91.48 
77.12 
140.10 
89.39 
93.14 
82.63 
77.10 
76.16 
111.25 
129.57 
 
67.15 
67.96 
70.47 
69.03 
70.14 
72.25 
68.70 
67.97 
68.19 
10.70 
10.04 
9.93 
8.37 
15.21 
9.70 
10.11 
8.97 
8.37 
8.27 
12.08 
14.06 
 
 
 
 
0 
0 
0 
0 
0 
0 
795.89 
766.25 
763.07 
784.58 
814.43 
825.05 
0 
0 
0 
0 
0 
0 
796 
766 
763 
785 
814 
825 
100 
98.10 
98.45 
100.92 
103.77 
104.23 
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Norfluoxetine 
pH 7 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
642.66 
657.34 
647.50 
665.47 
638.33 
646.30 
610.63 
615.99 
611.72 
629.48 
640.10 
642.19 
50.68 
38.39 
35.78 
38.18 
38.96 
37.19 
58.70 
40.63 
54.95 
41.88 
46.15 
35.99 
  
116.44 
108.11 
112.56 
84.17 
110.98 
106.95 
131.78 
133.50 
115.89 
125.01 
127.89 
119.69 
126.89 
108.42 
104.53 
104.93 
117.31 
91.54 
104.74 
118.92 
133.35 
107.00 
141.68 
120.61 
  
759.10 
765.46 
760.06 
749.63 
749.31 
753.25 
742.41 
749.48 
727.61 
754.49 
768.00 
761.88 
177.56 
146.80 
140.31 
143.10 
156.27 
128.73 
163.44 
159.55 
188.29 
148.88 
187.83 
156.60 
  
95.38 
98.00 
98.06 
96.42 
95.47 
95.97 
93.28 
95.96 
93.88 
97.05 
97.85 
97.07 
23.18 
19.16 
18.32 
18.68 
20.40 
16.81 
21.34 
20.83 
24.58 
19.44 
24.52 
20.44 
 
 
 
0 
0 
0 
874.22 
797.34 
776.98 
0 
0 
0 
874 
797 
777 
100 
95.40 
95.20 
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Norfluoxetine 
pH 8 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
817.86 
784.11 
768.44 
509.64 
562.60 
503.07 
452.50 
495.52 
447.24 
415.31 
407.86 
478.59 
468.28 
388.44 
377.29 
60.21 
44.95 
44.79 
52.24 
33.28 
44.64 
53.75 
36.72 
62.40 
73.39 
73.39 
60.00 
 
0 
0 
0 
252.61 
233.49 
225.16 
263.88 
185.88 
260.91 
350.12 
337.51 
254.43 
289.74 
366.87 
365.55 
256.91 
215.94 
158.35 
425.01 
355.32 
383.54 
321.84 
281.45 
213.66 
279.40 
273.70 
250.89 
 
818 
784 
768 
762.25 
796.09 
728.24 
716.38 
681.40 
708.15 
765.43 
745.37 
733.03 
758.02 
755.31 
742.84 
317.12 
260.89 
203.15 
477.25 
388.60 
428.17 
375.59 
318.17 
276.06 
352.79 
347.08 
310.89 
 
100.15 
96.79 
95.68 
87.19 
95.25 
89.22 
87.73 
84.11 
87.41 
87.56 
89.18 
89.81 
92.83 
93.24 
91.70 
42.72 
35.14 
27.36 
64.29 
52.34 
57.67 
50.59 
42.86 
37.18 
47.52 
46.75 
41.88 
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Norfluoxetine 
pH 9 
0 
0 
0 
0 
0 
0 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
853.91 
850.16 
853.91 
808.80 
833.13 
803.80 
373.07 
370.78 
376.35 
346.98 
359.17 
346.20 
311.88 
261.88 
284.06 
211.61 
255.00 
376.30 
37.71 
36.46 
32.14 
33.70 
30.63 
27.86 
46.09 
40.89 
42.76 
0 
0 
0 
0 
0 
0 
414.62 
390.43 
414.11 
399.84 
402.02 
435.64 
420.78 
461.40 
499.49 
600.50 
503.60 
340.27 
283.39 
489.52 
391.62 
545.10 
365.51 
273.49 
496.01 
628.70 
509.86 
854 
850 
854 
809 
833 
804 
787.69 
761.21 
790.47 
746.82 
761.19 
781.84 
732.65 
723.28 
783.56 
812.11 
758.60 
716.58 
321.10 
525.98 
423.75 
578.80 
396.13 
301.36 
542.10 
669.58 
552.62 
100 
99.78 
100.15 
96.09 
99.18 
96.38 
92.25 
89.34 
92.71 
88.73 
90.62 
93.08 
85.80 
84.89 
91.90 
96.49 
90.31 
85.31 
42.60 
69.78 
56.21 
76.78 
52.55 
39.98 
71.92 
88.83 
73.31 
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48 
48 
48 
 
55.42 
70.73 
54.17 
 
465.53 
360.46 
743.14 
 
520.95 
431.19 
797.30 
 
69.11 
57.20 
105.77 
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Appendix C – Supporting Data for Chapter Four 
 
Sorption of ionisable active pharmaceuticals in four different types 
of sediments 
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Figure C. 1. Total carbon analyzed of the four sediments air-dried and autoclaved. 
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Figure C. 2. pH analyzed of the four sediments air-dried and autoclaved. 
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Figure C. 3. pH measurements of the four sediments during the sorption tests. 
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Appendix D – Supporting Data for Chapter Five 
Influence of sediment properties on the uptake of ionisable APIs 
into a sediment-dwelling invertebrate L. variegatus 
 
Data for the model 
The dataset consists of concentrations of the water (pmol/mL), concentrations of the 
compounds in the sediment (pmol/), concentrations in the worms (pmol/g wet 
weight) over time (hours) and mass of the worms (g). 
  
Amitriptyline Moors sediment 
 
Time  
(h) 
Csediment 
(pmol/g) 
Time  
(h) 
Cwater  
(pmol/mL) 
 
Time  
(h) 
Cint 
(pmol/g) 
Mass of 
the 
worms(g) 
0 18.9 12 0.12 12 320.7 0.023 
12 17.4 24 0.17 12 298.5 0.015 
24 13.5 36 0.14 12 195.8 0.017 
24.1 0.0 48 0.15 12 150.1 0.018 
36 0.1   12 252.7 0.023 
48 0.2   12 164.3 0.02 
    24 234.8 0.013 
    24 177.9 0.019 
    24 229.7 0.014 
    24 332.7 0.019 
    24 133.6 0.017 
    24 165.7 0.024 
    36 167.5 0.012 
    36 224.4 0.02 
    36 159.9 0.016 
 181 
 
    36 162.4 0.014 
    36 152.2 0.016 
    36 213.7 0.015 
    48 73.2 0.011 
    48 223.0 0.014 
    48 64.5 0.014 
    48 94.7 0.013 
    48 130.7 0.017 
    48  0.018 
 
Amitriptyline Barnsley sediment 
 
Time  
(h) 
Csediment 
(pmol/g) 
Time  
(h) 
Cwater  
(pmol/mL) 
 
Time  
(h) 
Cint 
(pmol/g) 
Mass of 
the 
worms(g) 
0 16 12 0.10 12 163.9 0.023 
12 17 24 0.10 12 210.9 0.021 
24 17 36 0.02 12 144.1 0.019 
24.1 0 48 0.06 12 119.5 0.018 
36 0.8   12 164.5 0.015 
48 0.7   12 458.7 0.021 
    24 469.0 0.023 
    24 426.3 0.017 
    24 214.1 0.018 
    24 233.9 0.016 
    24 174.8 0.019 
    24 113.1 0.021 
    36 97.3 0.018 
    36 114.7 0.013 
 182 
 
    36 99.3 0.014 
    36 126.3 0.017 
    36 88.1 0.017 
    36 88.1 0.016 
    48 58.1 0.018 
    48 55.9 0.02 
    48 90.9 0.014 
    48 93.9 0.018 
 
 
Diclofenac Moors sediment 
 
Time  
(h) 
Csediment 
(pmol/g) 
Time  
(h) 
Cwater  
(pmol/mL) 
 
Time  
(h) 
Cint 
(pmol/g) 
Mass of 
the 
worms(g) 
0 15.7 12 10 12 419.9 0.016 
12 16.5 24 10 12 279.7 0.01 
24 16.0 36 0.0 12 389.2 0.021 
24.1 0 48 1.60 12 401.0 0.016 
36 0.2   12 529.0 0.012 
48 0.8   12 545.3 0.013 
    24 523.3 0.018 
    24 636.8 0.011 
    24 449.4 0.017 
    24 422.3 0.018 
    24 584.7 0.014 
    24 340.2 0.017 
    36 230.5 0.011 
    36 200.5 0.015 
 183 
 
    36 183.1 0.012 
    36 163.2 0.015 
    36 219.1 0.014 
    36 200.8 0.015 
    48 135.2 0.015 
    48 159.5 0.015 
    48 133.3 0.013 
    48 135.0 0.017 
    48 134.1 0.016 
 
 
Diclofenac Barnsley sediment 
 
Time  
(h) 
Csediment 
(pmol/g) 
Time  
(h) 
Cwater  
(pmol/mL) 
 
Time  
(h) 
Cint 
(pmol/g) 
Mass of 
the 
worms(g) 
0 14 12 16 12 250.7 0.022 
12 14 24 17 12 362.1 0.018 
24 13.4 36 0.1 12 208.6 0.017 
24.1 0 48 1.15 12 350.7 0.02 
36 0.01   12 145.1 0.019 
48 0.3   12 127.8 0.016 
    24 299.1 0.012 
    24 262.6 0.019 
    24 84.2 0.014 
    24 105.8 0.012 
    24 84.0 0.013 
    24 114.3 0.017 
 184 
 
    36 116.3 0.017 
    36 42.3 0.016 
    36 117.0 0.015 
    36 57.5 0.019 
    36 36.9 0.018 
    36 24.6 0.018 
    48 18.4 0.014 
    48 59.7 0.018 
    48 63.4 0.013 
    48 31.2 0.015 
    48  0.01 
 
 
Norfluoxetine Moors sediment 
Time  
(h) 
Csediment 
(pmol/g) 
Time  
(h) 
Cwater  
(pmol/mL) 
 
Time  
(h) 
Cint 
(pmol/g) 
Mass of 
the 
worms(g) 
0 18.7 12 0.6 12 145.1 0.022 
12 17.6 24 0.7 12 133.8 0.021 
24 18.2 36 0.2 12 256.2 0.015 
24.1 0 48 0.13 12 239.4 0.019 
36 0.1   12 110.0 0.016 
48 0.2   12 103.1 0.019 
    24 345.3 0.023 
    24 462.6 0.024 
    24 301.0 0.024 
    24 264.4 0.021 
    24 341.3 0.023 
 185 
 
    24 152.7 0.024 
    36 116.1 0.023 
    36 91.6 0.012 
    36 139.7 0.016 
    36 89.8 0.011 
    36 86.1 0.017 
    36 112.2 0.018 
    48 54.3 0.014 
    48 108.6 0.018 
    48 119.8 0.013 
    48 89.2 0.012 
    48 73.2 0.016 
 
Norfluoxetine Barnsley sediment 
Time  
(h) 
Csediment 
(pmol/g) 
Time  
(h) 
Cwater  
(pmol/mL) 
 
Time  
(h) 
Cint 
(pmol/g) 
Mass of 
the 
worms(g) 
0 19.0 12 0.4 12 304.7 0.017 
12 17.4 24 0.4 12 256.1 0.023 
24 17.2 36 0.0 12 132.3 0.02 
24.1 0.0 48 0.02 12 119.8 0.021 
36 0.18   12 122.7 0.016 
48 0.19   12 97.5 0.024 
    24 97.5 0.026 
    24 124.1 0.02 
    24 67.5 0.025 
    24 90.9 0.027 
    24 59.5 0.018 
 186 
 
    24 67.9 0.024 
    36 42.4 0.017 
    36 79.4 0.02 
    36 37.6 0.018 
    36 74.9 0.02 
    36 78.0 0.017 
    36 67.6 0.018 
    48 46.9 0.018 
    48 42.1 0.023 
    48 30.4 0.017 
    48 52.6 0.018 
    48  0.015 
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Mass balance calculations of 24 h uptake and 24 h depuration of the three APIs.   
 Timepoint 
(h) 
Tot mass of 
API in water 
(pmol) 
Tot mass of API in 
sediment (pmol) 
Tot mass of API in 
the worms (pmol) 
Tot mass of API in 
the whole system 
(pmol) 
% of spiked API  
 
 
 
 
 
 
Amitriptyline 
Moors 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
17.5 
16.2 
16.8 
16.5 
16.3 
16.4 
17.3 
17.8 
18.0 
17.4 
17.4 
16.2 
15.5 
16.6 
18.2 
16.4 
18.0 
17.7 
17.1 
16.4 
17.2 
55.13 
56.74 
42.59 
55.71 
60.27 
50.67 
44.95 
52.02 
34.93 
35.98 
42.77 
3.91 
3.41 
3.50 
3.80 
3.58 
3.39 
3.71 
3.66 
3.75 
3.54 
7.38 
4.48 
3.33 
2.70 
5.81 
2.14 
4.46 
2.49 
4.36 
5.66 
3.21 
1.99 
3.35 
3.59 
2.24 
2.60 
2.28 
2.35 
1.02 
3.12 
0.84 
80.0 
77.4 
62.7 
74.9 
82.4 
69.2 
66.7 
72.4 
57.3 
59.0 
63.4 
22.1 
22.2 
23.7 
24.3 
22.6 
23.7 
23.8 
21.8 
23.3 
21.6 
110.15 
106.34 
91.83 
108.10 
116.39 
103.18 
103.14 
108.97 
90.96 
96.61 
106.12 
31.27 
31.41 
33.48 
34.32 
31.89 
33.47 
33.61 
30.81 
32.93 
30.50 
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48 
 
17.4 
 
3.72 
  
1.61 
  
22.8 
 
32.18 
 
 
 
 
 
 
 
Amitriptyline  
Barnsley 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
 
17.9 
16.8 
16.7 
17.3 
18.3 
17.9 
18.2 
16.8 
17.2 
17.5 
19.5 
16.1 
17.3 
14.8 
18.1 
16.3 
15.4 
15.9 
17.6 
18.1 
15.3 
18.6 
 
52.28 
54.84 
54.54 
54.36 
54.28 
52.04 
54.22 
56.68 
52.43 
53.53 
54.49 
4.88 
6.02 
6.10 
5.83 
5.52 
6.09 
4.20 
6.71 
6.00 
4.52 
6.82 
 
3.77 
4.43 
2.74 
2.15 
2.47 
9.63 
10.79 
7.25 
3.85 
3.74 
3.32 
2.04 
1.27 
1.61 
1.69 
2.15 
1.41 
1.59 
1.16 
1.27 
1.69 
1.13 
 
74.0 
76.1 
74.0 
73.8 
75.1 
79.6 
83.2 
80.7 
73.5 
74.8 
77.3 
23.0 
24.6 
22.5 
25.6 
24.0 
22.9 
21.7 
25.4 
25.4 
21.6 
26.6 
 
105.37 
107.28 
104.11 
103.71 
105.04 
111.44 
114.90 
110.69 
102.34 
104.36 
107.17 
32.16 
34.42 
31.46 
35.88 
33.54 
32.02 
30.29 
35.58 
35.53 
30.15 
37.15 
 
 
 
12 
12 
12 
229.2 
162.9 
171.9 
53.27 
54.12 
51.15 
6.72 
2.80 
8.17 
289.2 
219.8 
231.2 
102.38 
88.01 
96.01 
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Diclofenac 
Moors 
12 
12 
12 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
169.1 
162.9 
186.5 
171.9 
176.7 
184.0 
178.4 
177.5 
18.0 
16.5 
16.2 
15.5 
34.3 
24.9 
23.5 
16.0 
18.7 
51.0 
16.5 
18.0 
 
52.25 
54.64 
51.59 
51.02 
53.21 
50.38 
52.86 
51.30 
4.15 
3.40 
3.77 
4.36 
3.72 
3.85 
4.03 
5.97 
8.70 
7.34 
3.65 
4.21 
 
6.42 
6.35 
7.09 
9.42 
7.00 
7.64 
7.60 
0.53 
5.78 
2.53 
3.01 
2.20 
2.45 
3.07 
3.01 
2.03 
2.39 
1.73 
2.30 
2.14 
 
227.8 
223.9 
245.2 
232.3 
236.9 
242.0 
238.8 
229.4 
27.9 
22.4 
23.0 
22.1 
40.5 
31.8 
30.6 
24.0 
29.8 
60.0 
22.5 
24.3 
 
96.53 
96.38 
105.12 
104.23 
104.63 
105.65 
104.02 
99.97 
11.97 
9.61 
9.87 
9.46 
17.34 
13.63 
13.10 
10.27 
12.79 
25.74 
9.63 
10.42 
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Diclofenac  
Barnsley 
12 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
25 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
  
261.0 
258.8 
245.1 
265.4 
265.7 
268.9 
275.6 
278.0 
262.1 
260.4 
271.6 
273.9 
15.6 
17.4 
17.8 
16.4 
17.4 
18.5 
19.4 
16.5 
17.7 
15.9 
16.1 
  
45.48 
46.23 
47.58 
44.24 
44.71 
44.39 
42.13 
43.00 
45.74 
44.98 
43.76 
44.58 
4.12 
3.79 
3.57 
3.96 
3.57 
3.57 
4.75 
4.36 
3.70 
4.16 
3.98 
  
10.10 
4.26 
7.24 
3.96 
5.61 
1.74 
2.43 
4.19 
3.15 
1.10 
1.80 
1.43 
1.83 
1.74 
0.80 
2.11 
1.03 
0.52 
0.44 
0.24 
0.90 
0.63 
0.53 
 
315.2 
297.0 
316.9 
314.3 
318.9 
319.5 
323.4 
312.0 
308.6 
316.5 
320.3 
21.2 
23.0 
23.1 
21.2 
23.1 
23.1 
24.7 
21.3 
21.6 
21.0 
20.7 
25.7 
 
103.06 
98.52 
104.42 
103.11 
104.11 
100.55 
101.27 
98.90 
98.58 
100.96 
102.13 
6.91 
7.51 
7.54 
6.93 
7.54 
7.55 
8.07 
6.97 
7.06 
6.85 
6.77 
8.39 
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Norfluoxetine 
Moors 
 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
48 
 
22.4 
23.1 
23.2 
23.8 
23.1 
24.8 
24.0 
18.5 
26.1 
24.3 
18.0 
16.5 
16.2 
15.5 
34.3 
24.9 
23.5 
16.0 
18.7 
51.0 
16.5 
18.0 
 
57.77 
51.19 
60.22 
59.33 
51.76 
56.66 
56.77 
57.85 
58.47 
59.68 
3.39 
3.22 
3.70 
3.21 
3.23 
3.29 
3.70 
3.89 
3.51 
3.82 
3.64 
3.77 
 
3.19 
2.81 
3.84 
4.55 
1.76 
7.94 
18.58 
11.10 
6.32 
6.08 
3.51 
1.39 
1.47 
1.54 
1.53 
1.55 
1.57 
0.98 
1.41 
1.44 
1.43 
1.17 
 
83.3 
77.1 
87.2 
87.7 
76.6 
89.4 
99.3 
87.4 
90.9 
90.0 
24.9 
21.1 
21.4 
20.3 
39.0 
29.7 
28.8 
20.8 
23.7 
56.2 
21.6 
22.9 
 
103.98 
99.85 
110.02 
109.25 
96.81 
109.75 
122.47 
109.95 
112.54 
110.56 
31.46 
26.65 
27.03 
25.58 
49.31 
37.53 
36.37 
26.30 
29.88 
71.02 
27.28 
28.92 
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Norfluoxetine  
Barnsley 
12 
12 
12 
12 
12 
24 
24 
24 
24 
24 
36 
36 
36 
36 
36 
36 
48 
48 
48 
48 
48 
 
21.2 
20.7 
21.9 
21.8 
20.3 
22.0 
21.1 
21.8 
20.9 
21.1 
14.8 
18.0 
16.8 
15.8 
14.5 
15.5 
15.9 
15.8 
15.9 
14.6 
17.3 
 
53.10 
55.09 
55.66 
56.10 
56.67 
53.61 
55.13 
55.39 
54.30 
55.20 
3.90 
3.11 
3.63 
3.69 
3.84 
2.88 
3.47 
3.56 
3.78 
3.62 
3.52 
 
2.53 
1.95 
3.10 
1.82 
1.64 
1.15 
0.85 
1.43 
0.75 
1.27 
1.15 
0.85 
1.43 
0.75 
1.27 
1.40 
1.22 
1.08 
0.72 
0.55 
0.79 
 
76.8 
77.8 
80.7 
79.8 
78.6 
76.7 
77.1 
78.7 
75.9 
77.5 
19.8 
21.9 
21.8 
20.2 
19.6 
19.7 
20.6 
20.5 
20.4 
18.7 
21.6 
 
103.41 
103.61 
106.28 
104.38 
102.69 
101.53 
101.56 
103.04 
99.83 
101.89 
25.90 
28.66 
28.52 
26.43 
25.57 
25.81 
26.95 
26.74 
26.60 
24.48 
28.20 
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